TW200800026A - Substituted 6-phenyl-7-amino-[1,2,4]-triazolo[1,5-a] pyrimidines and their use for controlling harmful fungi - Google Patents
Substituted 6-phenyl-7-amino-[1,2,4]-triazolo[1,5-a] pyrimidines and their use for controlling harmful fungi Download PDFInfo
- Publication number
- TW200800026A TW200800026A TW96106679A TW96106679A TW200800026A TW 200800026 A TW200800026 A TW 200800026A TW 96106679 A TW96106679 A TW 96106679A TW 96106679 A TW96106679 A TW 96106679A TW 200800026 A TW200800026 A TW 200800026A
- Authority
- TW
- Taiwan
- Prior art keywords
- pyrimidine
- triazolo
- difluoro
- group
- methylphenyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
200800026 九、發明說明: 【發明所屬之技術領域】 本發明係關於經取代之6_苯基_7_胺基三唑并 [l,5-a]嘧啶及彼等於控制有害真菌之用途。本發明亦係關 於包含至少一種經取代之6_苯基_7_胺基三唑并_ [l,5_a]鳴咬之組合物。 【先前技術】 經取代之6-苯基-7-胺基-[ΐ52,4]_三唑并[na]嘧啶及彼 • 等於控制有害真菌之用途已閣述於多種出版物中。一般 地,自歐洲專利第A 71 792號及歐洲專利第A 55〇113號可 知5 -氣-6 -苯基_ 7 -胺基三σ坐并嘴σ定。 WO 99/48893闡述了 6-(2-鹵素-4-烷氧基苯基)·7_胺基_ [1,2,4]_三嗤并啶於控制有害真菌之用途。 WO 03/93271闡述了 6-(2•鹵素-4_烷基苯基)_7_胺基_ [1,2,4]_三唑并-[u'aj嘧啶於控制有害真菌之用途。 _ 美國專利第6,204,2·69號闡述了在7位胺氮處帶有對掌性 2’2’2 一氟"· l_(Ci-C4_烧基)乙基基團之光學活性胺基_%鹵 素-6-苯基[1,2,4]-三唑并[i,5-a]_嘧啶。 WO 02/02563尤其提出用於控制腫瘤之化合物5_氯_6_ (2,5-二氟-4-曱氧基·苯基)-7_((1,2,2_三甲基丙-^基)胺基)_ [1,2,4]三 α坐并 _[i,5_a]p密唆。 然而,已知6-苯基-7-胺基-[1,2,4]-三唑并-[i,5-a]嘧啶之 /舌性在許多情況下皆不能令人滿意。基於此,本發明之一 目的係提供具有經改良活性及/或更具廣譜活性之化合 118620.doc 200800026 令人驚異的是, I之經取代6-苯基_7 【發明内容】 ,該目的及其他目的皆可藉由下文所述式 7-胺基-[1,2,4]-三嗤并[i,5_a]嘯啶達成。 性真菌之用途: 因此,本發明係關於式〗之經取代6_苯基_7胺基-[丨,2,4卜 三嗤并[l,5-a]㈣及其農業上可接受之鹽於控:植物破壞200800026 IX. DESCRIPTION OF THE INVENTION: TECHNICAL FIELD OF THE INVENTION The present invention relates to substituted 6-phenyl-7-aminotriazolo[l,5-a]pyrimidines and their use in controlling harmful fungi. The invention is also directed to compositions comprising at least one substituted 6-phenyl-7-aminotriazolo-[l,5-a] bite. [Prior Art] Substituted 6-phenyl-7-amino-[ΐ52,4]-triazolo[na]pyrimidines and their use in controlling harmful fungi have been described in various publications. In general, it is known from the European Patent No. A 71 792 and the European Patent No. A 55 〇 113 that the 5- gas-6-phenyl-7-aminotrisium sigma is sinusoidal. WO 99/48893 describes the use of 6-(2-halo-4-alkoxyphenyl)-7-amino-[1,2,4]-triazentidine for the control of harmful fungi. WO 03/93271 describes the use of 6-(2•halo-4_alkylphenyl)-7-amino-[1,2,4]-triazolo-[u'aj pyrimidine for the control of harmful fungi. _ US Patent No. 6,204, 2.69 describes an optically active amine with a palmitic 2'2'2 fluoro"-l-(Ci-C4_alkyl)ethyl group at the 7-amine nitrogen Base_% halogen-6-phenyl[1,2,4]-triazolo[i,5-a]-pyrimidine. In particular, WO 02/02563 proposes a compound for the control of tumors 5-chloro-6-(2,5-difluoro-4-indolyloxyphenyl)-7-((1,2,2-trimethylpropane-^) Amino))[1,2,4]three alpha sits and _[i,5_a]p 唆. However, the / tongue properties of 6-phenyl-7-amino-[1,2,4]-triazolo-[i,5-a]pyrimidine are known to be unsatisfactory in many cases. Based on this, it is an object of the present invention to provide a compound having improved activity and/or a broader spectrum of activity 118620.doc 200800026. Surprisingly, a substituted 6-phenyl-7 of I [invention], The purpose and other objects can be attained by the formula 7-amino-[1,2,4]-trisino[i,5-a] stilbene described below. Use of sex fungi: Therefore, the present invention relates to substituted 6-phenyl-7 amino-[丨, 2,4b-tris-[l,5-a](iv) and its agriculturally acceptable Salt control: plant destruction
其中取代基係定義如下·· R1 係 cvc8_ 烷基、Cl-c8-_ 代烷基、C3_C8jf、烷基、C3-c8-鹵代環烷基、C2-C8-烯基、C2-(V鹵代烯基、c3-C6-環稀基、C3-C6- _代環烯基、c2-c8-炔基、C2-C8-鹵代炔基或苯基、萘基或一含有1、2、3或4個來自由 〇、N及S組成之群之雜原子之5或6員雜環, R2 係氫或針對R1所提及之基團之一, 其中在上文提及之取代基R1及/或汉2中,1、2、3或4 個氫原子可由相同或不同基團Ra替代:Wherein the substituents are defined as follows: R1 is cvc8_alkyl, Cl-c8-_alkyl, C3_C8jf, alkyl, C3-c8-halocycloalkyl, C2-C8-alkenyl, C2-(V halogen Alkenyl, c3-C6-cycloalkyl, C3-C6- _cycloalkenyl, c2-c8-alkynyl, C2-C8-haloalkynyl or phenyl, naphthyl or one containing 1, 2 3 or 4 heterocyclic rings derived from a hetero atom consisting of ruthenium, N and S, R2 hydrogen or one of the groups mentioned for R1, wherein the substituent R1 mentioned above And/or Han 2, 1, 2, 3 or 4 hydrogen atoms may be replaced by the same or different groups Ra:
Ra係氰基、硝基、羥基、(VCV烷基、Ci-Cp鹵代 炫基、Ci-Ce•烧基幾基、c3_C6-環烷基、CVCV烧 氧基、cvcv鹵代烷氧基、Ci_C6_烷氧基羰基、 cvcv燒硫基、cvcv烧基胺基、二-Cl-C6-烧基 118620.doc 胺基、C2-C8-烯基、c2-C8-鹵代烯基、c3-c8-環烯 基、C2-C6-烯氧基、c3_c6-鹵代烯氧基、C2-C6-炔 基、C2-CV鹵代炔基、c3-C6-炔氧基、c3-c6-鹵代 炔氧基、CrC6-環烷氧基、c3-C6-環烯氧基、氧 基-Ci-C:3-伸烷氧基、苯基、萘基、一含有1至4個 來自由〇、N及s組成之群之雜原子之5至10員飽 和雜環, 其中該等脂族、環脂族或芳族基團部分可部分或 完全經鹵化或可帶有1、2或3個基團Rb : R 係氰基、硝基、經基、疏基、胺基、羧基、 胺基羰基、胺基硫羰基、烷基、鹵代烷基、 烯基、烯氧基、炔氧基、烷氧基、鹵代烷氧 基、烷硫基、烷基胺基、二烷基胺基、曱醯 基、烷基羰基、烷基磺醯基、烷基次硫醯 基、烷氧基羰基、烷基羰氧基、烷基胺基羰 基、二烷基胺基羰基、烷基胺基硫羰基、二 烷基胺基硫羰基,其中該等基團中之烷基包 含1至6個碳原子且該等基團中所提及之烯基 或炔基包含2至8個碳原子; 及/或1至3個以下基團: 環烧基、環烧氧基、雜環基、雜環氧基,其 中該等環系統包含3至1〇個環成員;芳基、 芳氧基、芳硫基、芳基-Ci-Cr烷氧基、芳 基-Ci-C6_烧基、雜芳基、雜芳氧基、雜芳硫 200800026 基’其中該等芳基基團較佳包含6至1〇個環 成員,該等雜芳基基團包含5或6個環成員, 其中該等環系統可部分或全部經齒代或可經 烧基或齒代烧基取代;Ra is a cyano group, a nitro group, a hydroxyl group, (VCV alkyl group, Ci-Cp halogenated leucoyl group, Ci-Ce aryl group, c3_C6-cycloalkyl group, CVCV alkoxy group, cvcv haloalkoxy group, Ci_C6_) Alkoxycarbonyl, cvcv thiol, cvcv alkylamino, di-Cl-C6-alkyl 118620.doc amine, C2-C8-alkenyl, c2-C8-haloalkenyl, c3-c8- Cycloalkenyl, C2-C6-alkenyloxy, c3_c6-haloalkenyloxy, C2-C6-alkynyl, C2-CV haloalkynyl, c3-C6-alkynyloxy, c3-c6-haloalkyne Oxy, CrC6-cycloalkoxy, c3-C6-cycloalkenyloxy, oxy-Ci-C: 3-aralkyloxy, phenyl, naphthyl, one containing 1 to 4 from 〇, N And a 5 to 10 membered saturated heterocyclic ring of a hetero atom of the group consisting of s, wherein the aliphatic, cycloaliphatic or aromatic moiety may be partially or fully halogenated or may carry 1, 2 or 3 groups Rb : R is a cyano group, a nitro group, a thiol group, a sulfhydryl group, an amine group, a carboxyl group, an aminocarbonyl group, an aminothiocarbonyl group, an alkyl group, a halogenated alkyl group, an alkenyl group, an alkenyloxy group, an alkynyloxy group, an alkoxy group. , haloalkoxy, alkylthio, alkylamino, dialkylamino, fluorenyl, alkylcarbonyl, alkylsulfonyl, alkyl Anthracenyl, alkoxycarbonyl, alkylcarbonyloxy, alkylaminocarbonyl, dialkylaminocarbonyl, alkylaminothiocarbonyl, dialkylaminothiocarbonyl, wherein the alkane in the group The group contains 1 to 6 carbon atoms and the alkenyl or alkynyl group mentioned in the groups contains 2 to 8 carbon atoms; and/or 1 to 3 or less groups: a cycloalkyl group, a cycloalkyloxy group a heterocyclic group, a heterocyclic oxy group, wherein the ring system comprises 3 to 1 ring members; aryl, aryloxy, arylthio, aryl-Ci-Cr alkoxy, aryl-Ci- C6-alkyl, heteroaryl, heteroaryloxy, heteroaromatic sulfur 200800026, wherein the aryl groups preferably comprise from 6 to 1 ring members, the heteroaryl groups comprising 5 or 6 a ring member, wherein the ring systems may be partially or fully substituted by a tooth or may be substituted with a burnt or a dentate group;
或R1及R2與其所連接之氮原子合起來亦可形成一 5 或6員雜環,該雜環經由氮連接並進一步含有^ 個、2個或3個來自由〇、^s組成之群之雜原子作 為環成員且其可帶有1個、2個、3個或4個來自由 下列組成之群之取代基:画素、Ci_C6_烷基、Ci_ C6_鹵代烷基、c2-C6-烯基、C2_C6_鹵代烯基、Cl· c6-烷氧基、Cl_c6_鹵代烷氧基、烯氧基、 C3-C6-!S代烯氧基、(外)_Ci_c6-伸烷基及 氧基-Ci-Cs-伸烧氧基; 係Cnc4-烷基或C^CV烷氧基, 係氟、氣或C^Czr烷基, 係_素、氰基、CKC4-烧基' Cl_c4_鹵代烧基、CieCV 燒氧基鹵代烧氧基; 其中當R2係氫且X係鹵素時,R1不為式CH(CF3)气Ci_C4_烷 基)之基團。 本發明亦係關於上述式〖之6•苯基胺基丨,2,4]_三唑并 [l,5-a]嘧啶及其農業上可接受之鹽,其中Rl係式cH(CF3)_ (Ci C4烧基)之基團、R2係氫且X係鹵素之式I化合物及其 鹽除外,且此外化合物5_氯_6乂2,5-二氟-4_甲氧基苯基)_7_ ((1,2,2-二曱基丙-1-基)胺基)_[1,2,4]三唑并_[1,5_幻嘧啶及 I18620.doc -9- 200800026 其鹽除外。本發明亦係關於下述6_苯基_7_胺基—三 唑并[l,5-a]嘧啶及其農業上可接受之鹽·· -5-氯-6-(2,5-二氟-4-甲基苯基)-7q(2,2,2-三氟·1_甲基乙 基)胺基)_[1,2,4]二σ坐弁-[l,5-a]哺咬; -5-曱基-6-(2,5-二氟-4-甲基苯基)-7-((2,2,2-三氟_1_甲基 乙基)胺基)_[1,2,4]三唑并_[i,5_a]嘧啶; -5-氰基-6-(2,5-二氟-4-甲基苯基)-7-((2,2,2-三氟_i-曱基 乙基)胺基)_[1,2,4]三唑并_[i,5_a]嘧啶; -5-甲氧基·6-(2,5-二氟-4-甲基苯基兴7-((2,2,2-三氟-丨-曱 基乙基)-胺基)-[1,2,4]三唑并_[i,5-a]嘧啶; -5-甲基·6-(2,5-二氟-4-曱氧基苯基)-7-((252,2-三氟-1_甲 基乙基)-胺基)-[1,2,4]三唑并-[15-a]嘧啶; -5-氰基-6_(2,5-二氟-4_甲氧基苯基)_7-((2,2,2-三氟q-甲 基乙基)_胺基)-[1,2,4]三唑并_[i,5-a]嘧啶; _ 5-曱氧基·6-(2,5-二氟-4-甲氧基苯基)-7-((2,2,2-三氟_1_ 曱基乙基)-胺基)_[152,4]三唑并_[1,5-&]嘧啶; 及其於控制植物破壞性真菌之用途。 本發明另外提供一種用於控制植物破壞(=植物病原)真 菌之方法’其中係用有效量之至少一種式“匕合物及之 農業上可接受之鹽處理該等真菌或欲加以保護使其免受真 菌侵襲之材料、植物、土壤或種子。 本發明另外提供一種適於控制有害真菌之組合物,該組 合物包括至少一種式I化合物及/或其農業上可接受之鹽及 至少一種液體或固體載劑。 118620.doc -10- 200800026 本發明另外提供較佳以1克/100公斤種子至⑺卯克/丨⑼公Or R1 and R2 together with the nitrogen atom to which they are attached may also form a 5- or 6-membered heterocyclic ring which is linked via nitrogen and further contains ^, 2 or 3 groups consisting of 〇, ^s A hetero atom is a ring member and may carry 1, 2, 3 or 4 substituents from the group consisting of: a pixel, a Ci_C6_alkyl group, a Ci_C6_haloalkyl group, a c2-C6-alkenyl group , C2_C6_haloalkenyl, Cl·c6-alkoxy, Cl_c6-haloalkoxy, alkenyloxy, C3-C6-!S-alkenyloxy, (exo)_Ci_c6-alkylene and oxy-Ci -Cs-Extended alkoxy; Cnc4-alkyl or C^CV alkoxy, fluoro, gas or C^Czr alkyl, phenyl, cyano, CKC4-alkyl 'Cl_c4_haloalkyl CieCV is an alkoxy halogenated alkoxy group; wherein when R2 is hydrogen and X is halogen, R1 is not a group of the formula CH(CF3) gas Ci_C4_alkyl). The present invention also relates to the above formula: 6 phenylamino hydrazino, 2,4]-triazolo[l,5-a]pyrimidine and an agriculturally acceptable salt thereof, wherein R1 is a formula cH(CF3) a group of _(Ci C4 alkyl), a compound of the formula I wherein R2 is hydrogen and an X-based halogen, and a salt thereof, and further a compound 5-chloro-6 乂2,5-difluoro-4-methoxyphenyl )_7_((1,2,2-dimercaptopropen-1-yl)amino)-[1,2,4]triazolo-[1,5-uracil and I18620.doc -9- 200800026 Except salt. The present invention also relates to the following 6-phenyl-7-amino-triazolo[l,5-a]pyrimidine and its agriculturally acceptable salt··5-chloro-6-(2,5- Difluoro-4-methylphenyl)-7q(2,2,2-trifluoro-l-methylethyl)amino)_[1,2,4]di-sigma-[l,5- a] bite; -5-mercapto-6-(2,5-difluoro-4-methylphenyl)-7-((2,2,2-trifluoro-1-methylethyl)amine )[1,2,4]triazolo-[i,5_a]pyrimidine; -5-cyano-6-(2,5-difluoro-4-methylphenyl)-7-(2 , 2,2-trifluoro-i-mercaptoethyl)amino)-[1,2,4]triazolo-[i,5-a]pyrimidine; -5-methoxy·6-(2,5 -difluoro-4-methylphenyl-7-((2,2,2-trifluoro-fluorenylfluorenyl)-amino)-[1,2,4]triazolo-[i, 5-a]pyrimidine; -5-methyl·6-(2,5-difluoro-4-decyloxyphenyl)-7-((252,2-trifluoro-1_methylethyl)- Amino)-[1,2,4]triazolo-[15-a]pyrimidine; -5-cyano-6-(2,5-difluoro-4-methoxyphenyl)_7-(2 , 2,2-trifluoroq-methylethyl)-amino)-[1,2,4]triazolo-[i,5-a]pyrimidine; _ 5-decyloxy-6-(2 ,5-difluoro-4-methoxyphenyl)-7-((2,2,2-trifluoro_1-decylethyl)-amino)-[152,4]triazolo-[1 ,5-&pyrimidine And the use thereof for controlling plant destructive fungi. The invention further provides a method for controlling a plant damage (= phytopathogenic) fungus, wherein an effective amount of at least one of the formulas "the compound and the agriculturally acceptable Salt treating the fungus or material, plant, soil or seed to be protected from fungal attack. The invention further provides a composition suitable for controlling a harmful fungus, the composition comprising at least one compound of the formula I and/or An agriculturally acceptable salt thereof and at least one liquid or solid carrier. 118620.doc -10- 200800026 The present invention additionally provides preferably from 1 g/100 kg of seed to (7) g / g (9)
斤種子之量包含至少一種式][化合物及/或其農業上可接2 之鹽之種子。 X 農業上可用之鹽尤其係其陽離子及陰離子對式I化合物 之殺真菌作用分別不具有不利影響的彼等陽離子之鹽或彼 等酸之酸加成鹽。因此適宜陽離子特別係以下之離子:鹼 金屬,較佳係鈉及卸;鹼土金屬,較佳係鈣、鎭及鋇;過 渡金屬,較佳係錳、銅、鋅及鐵;以及(若需要)可帶有丄至 4個6-(:4-烷基取代基及/或一個苯基或节基取代基之銨離 子,較佳係二異丙基銨、四甲基銨、四丁基銨、三甲基苄 基銨;另外鱗離子;銃離子,較佳係三(Ci_C4_烷基)銃; 及氧銕離子,較佳係三(C^CU-烷基)氧銃。 可用酸加成鹽之陰離子主要係氯化物、溴化物、氟化 物、硫酸氫鹽、石荒酸鹽、鱗酸二氮鹽、填酸氮鹽、麟酸 鹽、硝酸鹽、碳酸氫鹽'碳酸鹽、六氟石夕酸鹽、六氣鱗酸 鹽、苯甲酸鹽之陰離子及Cl_C4·鏈烷酸(較佳為甲酸鹽、乙 酸鹽、丙酸鹽及丁酸鹽)之陰離子。其可藉由1與一對應陰 離子之酸(較佳係鹽酸、氫溴酸、硫酸、磷酸或硝酸)起反 應而形成。 在上文式中所給出變量之定義中,使用了統稱,其通常 係所述取代基之代表。術語^^表示每一情況下在所述 取代基或取代基部分中之可能的碳原子數目: 鹵素:氟、氯、溴及碘; 烷基·具有1至4、6或8個碳原子之飽和直鏈或具支鏈烴 118620.doc -11 · 200800026 基團’舉例而言’Ci-C6_烧基’例如曱基、乙基、丙基、 1-甲基乙基、丁基、1-甲基丙基、2-曱基丙基、ι,;μ二甲 基乙基、戊基、1-曱基丁基、2-甲基丁基、3 -曱基丁基、 2,2-二甲基丙基、1-乙基丙基、己基、二甲基丙基、 1,2-二曱基丙基、1-甲基戊基、2-甲基戊基、3 -甲基戊 基、4-曱基戊基、1,1-二甲基丁基、it二曱基丁基、 ’ 一曱基丁基、2,2·二曱基丁基、2,3-二甲基丁基、3,3-二甲 基丁基、1 -乙基丁基、2-乙基丁基、1,丨,2_三甲基丙基、 ^ H2-二甲基丙基、1-乙基-1-曱基丙基及1-乙基-2-曱基丙 基; ,鹵代烧基·具有1至2、4、6或8個碳原子之直鏈或具支 鏈之烧基(如上述),其中該等基團中的某些或全部氫原子 可由如上所述鹵素原子替代:尤其Cl_c2_鹵代烷基,例如 氯曱基、溴曱基、二氣曱基、三氣甲基、氟曱基、二氟甲 基、三氟曱基、氣氟甲基、二氣氟曱基、氯二氟曱基、“ 馨 氟乙基、1-、/臭乙基、1-敗乙基、2-氟乙基、2,2-二I乙 基、2,2,2-二氟乙基、2-氯-2-氟乙基、2-氯-2,2_二氟乙 基、2,2_二氯-2-氟乙基、2,2,2-三氯乙基、五氟乙基及 ’ 1,1,1_三氟丙-2-基; ‘ 烯基:具有2至4、6或8個碳原子及於任何位置之1或2個 雙鍵之不飽和直鏈或具支鏈烴基圑,舉例而言,(^_(^_烯 基例如乙烯基、1-丙烯基、2-丙烯基、1-甲基乙烯基、 丁烯基、2-丁烯基、3-丁烯基、1-甲基-1-丙烯基、2-甲基_ 1-丙烯基、1-甲基-2-丙烯基、2-甲基-2-丙烯基、1-戊烯 118620.doc -12- 200800026 基、2-戊烯基、3-戊烯基、4-戊烯基、1-甲基-1-丁烯基、 2-曱基-1-丁烯基、3-曱基-1-丁烯基、:U曱基-2-丁烯基、2-甲基-2-丁烯基、3-曱基-2-丁烯基、1-甲基-3-丁稀基、2-甲基-3-丁烯基、3-曱基-3-丁烯基、1,1-二甲基-2-丙烯基、 1,2-二甲基-1-丙烯基、L2-二甲基_2_丙烯基、1-乙基-1-丙 烯基、1-乙基-2·丙烯基、1_己烯基、2-己烯基、3-己烯 基、4-己烯基、5-己晞基、1-甲基-1-戊烯基、2-曱基-1-戊 烯基、3-曱基-1-戊烯基、4-甲基-1 —戊烯基、1-甲基-2-戍 烯基、2-甲基-2-戊烯基、3-甲基-2-戊烯基、4-甲基-2-戊 烯基、1-曱基-3-戊烯基、2-曱基-3-戊烯基、3-曱基-3-戊 烯基、4-曱基-3-戍烯基、1-甲基-4-戊烯基、2-甲基-4-戊 烯基、3-甲基-4-戊烯基、4-曱基-4-戊烯基、l,l-二曱基-2-丁烯基、1,1-二甲基-3-丁烯基、1,2-二甲基-1-丁烯基、 1,2-二曱基-2-丁烯基、l,2-二甲基-3-丁烯基、1,3-二甲基· 1- 丁烯基、1,3·二甲基-2-丁烯基、1,3-二甲基-3-丁烯基、 2.2- 二曱基-3_丁烯基、2,3-二曱基-1-丁烯基、2,3-二甲基- 2- 丁烯基、2,3-二曱基-3-丁烯基、3,3-二甲基-1-丁烯基、 3.3- 二甲基-2-丁烯基、1-乙基-1-丁烯基、乙基丁烯 基、1-乙基-3· 丁浠基、2-乙基-1-丁浠基、2-乙基-2-丁烯 基、2-乙基-3 - 丁烯基、1,1,2-三甲基-2-丙浠基、1-乙基- l_ 曱基-2-丙稀基、1-乙基-2-甲基-1-丙稀基、1·乙基甲基_ 2·丙烯基; 鹵代烯基:具有2至8個碳原子及如上所述位於任何位置 之1或2個雙鍵之不飽和直鏈或具支鏈烴基團,其中該等基 118620.doc -13- 200800026 團中的某些或全部氫原子可由上述ώ素原子(尤其氟、氯 及溴)替代;The amount of the seed contains at least one seed of the formula [the compound and/or its agriculturally acceptable salt 2). X The salts which are useful in agriculture are, in particular, the salts of their cations or the acid addition salts of these acids which do not adversely affect the fungicidal action of the cations and anions of the compounds of the formula I, respectively. Therefore, suitable cations are particularly selected from the group consisting of alkali metals, preferably sodium and unloading; alkaline earth metals, preferably calcium, barium and strontium; transition metals, preferably manganese, copper, zinc and iron; and (if needed) Ammonium ion having up to 4 6-(:4-alkyl substituents and/or a phenyl or a benzyl substituent, preferably diisopropylammonium, tetramethylammonium, tetrabutylammonium , trimethylbenzylammonium; additional scaly ion; cerium ion, preferably tris(Ci_C4_alkyl) fluorene; and oxonium ion, preferably tris(C^CU-alkyl) oxonium. The anions of salt formation are mainly chloride, bromide, fluoride, hydrogen sulfate, sulphate, sulphate, acid nitrogen, sulphate, nitrate, bicarbonate 'carbonate, six An anion of fluorite, hexahydrate, benzoate anion and Cl_C4·alkanoic acid (preferably formate, acetate, propionate and butyrate) 1 is formed by reacting with a corresponding anionic acid (preferably hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid or nitric acid). The variables given in the above formula are determined. In the above, a general term is used, which is usually a representative of the substituent. The term ^^ denotes the number of possible carbon atoms in the substituent or substituent moiety in each case: halogen: fluorine, chlorine, bromine and iodine Alkyl·saturated linear or branched hydrocarbon having from 1 to 4, 6 or 8 carbon atoms 118620.doc -11 · 200800026 Group 'for example 'Ci-C6_alkyl group' eg thiol, B Base, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-mercaptopropyl, iota; μ dimethylethyl, pentyl, 1-decyl butyl, 2 -methylbutyl, 3-nonylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, hexyl, dimethylpropyl, 1,2-dimercaptopropyl, 1- Methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-mercaptopentyl, 1,1-dimethylbutyl, it-didecylbutyl, '-decylbutyl, 2,2·dimercaptobutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1, hydrazine, 2_ Trimethyl propyl, ^ H2-dimethylpropyl, 1-ethyl-1-mercaptopropyl and 1-ethyl-2-mercaptopropyl; haloalkyl · 1 to 2 4, 6 or 8 a linear or branched alkyl group of a carbon atom (as described above) wherein some or all of the hydrogen atoms of the group may be replaced by a halogen atom as described above: especially a Cl_c2_haloalkyl group, such as a chloroantimonyl group, bromine Sulfhydryl, digas sulfhydryl, trimethylmethyl, fluoroindolyl, difluoromethyl, trifluoromethyl, fluorofluoromethyl, difluorofluoroindolyl, chlorodifluoroindolyl, "sweet fluoroethyl, 1-, / stinky ethyl, 1-decylethyl, 2-fluoroethyl, 2,2-di-Iethyl, 2,2,2-difluoroethyl, 2-chloro-2-fluoroethyl, 2-Chloro-2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl, pentafluoroethyl and '1,1,1_three Fluoropropan-2-yl; 'alkenyl: an unsaturated straight or branched hydrocarbon group having 2 to 4, 6 or 8 carbon atoms and 1 or 2 double bonds at any position, for example, ^_(^_Alkenyl group such as vinyl, 1-propenyl, 2-propenyl, 1-methylvinyl, butenyl, 2-butenyl, 3-butenyl, 1-methyl-1 -propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl, 1-pentene 118620.doc -12- 200800026, 2-pentyl Alkenyl, 3-pentenyl, 4- Alkenyl, 1-methyl-1-butenyl, 2-mercapto-1-butenyl, 3-mercapto-1-butenyl, U-mercapto-2-butenyl, 2-methyl 2-butenyl, 3-mercapto-2-butenyl, 1-methyl-3-butenyl, 2-methyl-3-butenyl, 3-mercapto-3-butene 1,1,1-dimethyl-2-propenyl, 1,2-dimethyl-1-propenyl, L2-dimethyl-2-propenyl, 1-ethyl-1-propenyl, 1 -ethyl-2.propenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexyldecyl, 1-methyl-1-pentenyl, 2-mercapto-1-pentenyl, 3-mercapto-1-pentenyl, 4-methyl-1-pentenyl, 1-methyl-2-nonenyl, 2-methyl-2 -pentenyl, 3-methyl-2-pentenyl, 4-methyl-2-pentenyl, 1-decyl-3-pentenyl, 2-mercapto-3-pentenyl, 3 -mercapto-3-pentenyl, 4-mercapto-3-nonenyl, 1-methyl-4-pentenyl, 2-methyl-4-pentenyl, 3-methyl-4- Pentenyl, 4-mercapto-4-pentenyl, l,l-dimercapto-2-butenyl, 1,1-dimethyl-3-butenyl, 1,2-dimethyl 1-butenyl, 1,2-dimercapto-2-butenyl, 1,2-dimethyl-3-butenyl, 1,3-dimethyl-1-butenyl, 1 , 3·2 2-butenyl, 1,3-dimethyl-3-butenyl, 2.2-dimercapto-3-butenyl, 2,3-dimercapto-1-butenyl, 2, 3-dimethyl-2-butenyl, 2,3-dimercapto-3-butenyl, 3,3-dimethyl-1-butenyl, 3.3-dimethyl-2-butene Base, 1-ethyl-1-butenyl, ethylbutenyl, 1-ethyl-3-butanyl, 2-ethyl-1-butenyl, 2-ethyl-2-butene , 2-ethyl-3-butenyl, 1,1,2-trimethyl-2-propenyl, 1-ethyl-l-decyl-2-propenyl, 1-ethyl-2 -Methyl-1-propenyl, 1 ethylmethyl-2-propenyl; haloalkenyl: 1 or 2 double bonds having 2 to 8 carbon atoms and located at any position as described above a saturated linear or branched hydrocarbon group wherein some or all of the hydrogen atoms of the group 118620.doc -13 - 200800026 are replaced by the above halogen atoms (especially fluorine, chlorine and bromine);
炔基:具有2至4、6或8個碳原子及於任何位置之丨或2個 三鍵之直鏈或具支鏈烴基團,舉例而言,c2_c6_炔基,例 如乙炔基、1-丙炔基、2-丙炔基、^丁炔基、2_丁炔基、 3-丁炔基、1-甲基-2-丙炔基、丨_戊炔基、孓戊炔基、3_戊 炔基、4-戊炔基、1-曱基-2·丁炔基、^曱基_3_丁炔基、2_ 甲基_3-丁炔基、3_甲基_丨·丁炔基、二甲基_2_丙炔基、 1-乙基-2-丙炔基、1-己炔基、2_己炔基、3·己炔基、‘己 炔基、5-己炔基、i-甲基I戊炔基、丨_甲基:戊炔基、 甲基-4-戊炔基、2-曱基-3-戊炔基、甲基戊炔基、3_ 甲基小戊炔基、3-甲基-4-戊炔基、4_曱基+戊炔基、4_ 甲基-2-戊炔基、1,1_二甲基_2_丁炔基、^卜二甲基_3_丁炔 基、1,2-二甲基-3-丁炔基、2,2_二甲基_3_丁炔基、3,3_二 曱基小丁炔基、1-乙基-2-丁炔基、卜乙基_3_丁炔基、 乙基-3-丁炔基及1-乙基-丨_曱基_2_丙炔基; 環烧基:I有3至6個或8個碳環成員之單環或雙環飽和 基、環戊基、環己基、環庚基及環辛基; 烷硫基:經由一硫原子連接之上述Ci_Cp烷基; 烷基次硫醯基(亦稱作燒基亞績酿基):經由一so基團連 接之上述^^^烷基; 烧基續醯基:經由10)2基圏連接之上述 術語5至1G員雜環或5員或雜環包含分別具有5或6個 118620.doc -14- 200800026 及5、6、7、8、9或10個原子作為環成員之飽和及部分不 飽和雜環基團(雜環基)及芳族雜環基團(雜芳基),其中丄、 2 3或4個该等原子係來自由0、N及s組成之群之雜原 子其中具體而言該等雜環基團具有1、2、3或4個氮原子 或1或2個選自氧及硫之雜原子以及(若適合)另外丨或2個選 自氮之雜原子作為環成員。該等尤其包括: -含有1至3個氮原子及/或1個氧或硫原子或丨或2個氧及/或 硫原子之5、6或7員雜環基,例如2_四氫呋喃基、3_四 氫呋喃基、2-四氫噻吩基、3-四氫噻吩基、2_吡咯啶 基、3-吡咯啶基、3-異噁唑啶基、4_異噁唑啶基、5_異 噁唑啶基、3-異噻唑啶基、4-異噻唑啶基、5_異噻唑啶 基、3-吡唑啶基、4-吡唑啶基、5_吡唑啶基、2_噁唑啶 基、4_噁唑啶基、5_噁唑啶基、2_噻唑啶基、4_噻唑啶 基、5-嗟唑啶基、2-咪唑啶基、4-咪唑啶基、2-吡咯琳· 2基、比洛琳-3-基、3_σ比洛琳-2-基、3_吼洛琳_3-基、 2_六氫。比啶基、3-六氫吡啶基、4·六氫吡啶基、1夂一 噁烷-5-基、2_四氫吡喃基、4-四氫吡喃基、2_四氫噻吩 基' 3-六氫嗒嗪基、4-六氫嗒嗪基、2-六氫嘧啶基、4_ 六氫嘧啶基、5-六氫嘧啶基及2-哌畊基;5、6或7員雜 環基,其經由氮連接且除碳環成員外亦包含L個、2個或 3個氮原子或i個、2個或3個氮原子及1個硫或氧原子作 為環成員,例如1 - η比嘻咬基、3 - °比嘻琳· 1-基、丨_哺嗤唆 基、2-咪嗤琳-1-基、1-六氫π比唆基、1_派p井基、嗎琳 基,、硫嗎啉-4_基及4H-1,3,4-噻二嗪-4-基; 118620.doc 200800026 -包含1至4個氮原子或1至3個氮原子及/或1個硫或氧原子 之5員雜芳基:除碳原子外可包含1至4個氮原子或1至3 個氮原子及1個硫或氧原子作為環成員之5員雜芳基,例 如2-呋喃基、3-呋喃基、2-噻吩基、3-噻吩基、2-吡咯 基、3-吼略基、3_σ比峻基、4-11比嗤基、5- °比嗤基、2-。惡 唑基、4-噁唑基、5-噁唑基、2-噻唑基、4-噻唑基、5_ 噻唑基、2-咪唑基、4-咪唑基及1,3,4-三唑-2-基;經由 氮連接且除碳環成員外亦含有1、2、3或4個氮原子作為 環成員之5員雜芳基,例如1Η-吡咯-1-基、1Η-吡唑 基、1Η-味唾-1-基、1,2,3-三唾-1-基、1,2,4-三嗤_1_基、 1Η-四唑-1-基及2Η-四唑·2·基; -包含1至3個或1至4個氮原子之6員雜芳基:除碳原子外 可包含1至3個或1至4個氮原子作為環成員之6員雜芳 基,例如2-吼咬基、3-吼咬基、4-吼咬基、3-塔嗪基、 4-塔嗪基、2-嘧啶基、4-嘧啶基、5-嘧啶基及2-吡嗪 基; 伸烧基:含1至6個CH2基團之二價無支鏈鏈,例如 ch2、ch2ch2、ch2ch2ch2、ch2ch2ch2ch2、 CH2CH2CH2CH2CH2及 CH2CH2CH2CH2CH2CH2 ; 氧伸烷基:其中一個價位經由一氧原子連接至骨架上之 含2至4個CH2基團之二價無支鏈鏈,例如〇CH2CH2、 och2ch2ch2aoch2ch2ch2ch2 ; 氧伸烷氧基:其中兩個價位經由一氧原子連接至該骨架 之含1至3個CH2基團之二價無支鏈鏈,例如〇c 〇、 118620.doc -16 - 200800026 OCH2CH2〇及 〇CH2CH2CH2〇。 本發明之範圍包括具有對掌性中心之式合物的化)_和 (S)-同分異構體及外消旋物。 考慮到式I之三唑并嘧啶之預期用途,優先選擇該等取 代基之以下含義,在每一情況下彼等皆係獨立或組合使 用: 式I中L1較佳係CVC4 —烷氧基,尤其曱氧基。 車又仏者同樣係其中L1係C^C4·烷基且尤其係曱基之式以匕 合物。 L2較佳係氟、氣或曱基且尤其係氟。 根據第一尤佳實施例,L1係曱氧基且l2係氟。 根據第二尤佳實施例,Li係曱基且乙2係I。 R1較佳係C4-C8-烷基、c3_c8_環烷基、C3_C8_鹵代環烷 基、c3-c8-烯基、C3-C8-鹵代稀基、C3_C6_環稀基、C3_C6_ 鹵代環烯基、Q-C8-炔基、C^C8—自代炔基或苯基、萘基 或一包含1、2、3或4個來自由0、N及s組成之群之雜原子 之5或6員雜環,其中基團尺1中1、2、3或4個氫原子可如上 所述經取代。其中,較佳者係下列彼等化合物:其中 R1係C4-C8-烷基或C3-C8-烯基且尤其選自由CH2CH(CH3)2、 CH(CH3)-CH2CH3 > CH(CH3)-CH(CH3)2 > CH(CH3)-C(CH3)3 > CH2CH=CH2 及 ch2c(ch3)=ch2 組成之群。 一尤佳實施例係關於下述式I化合物,其中 R2 係氫、甲基或乙基;且 R1係C4-C8-烧基、c3-c8-烯基、Cl_c2_由代烧基或c3_c6· 118620.doc 200800026 環烷基,其中該等基團可在適合時帶有以下基團中的 一個: R 係鼠基、硝基、經基、Ci-C6 -烧基魏基、C3-C6-環烷基、CVC6-烷氧基、cvc6-烷氧基羰基、CV c6-烷硫基、Cl-C6-烷基胺基、二-CVCV烷基胺 基、c3-c8-環烯基、C2-C6-烯氧基、C3-C6-炔氧 基、C^CV環烷氧基、c3-C6-環烯氧基、氧基-Ci-C3-伸烷氧基、苯基、萘基、一含有1至4個來 自由Ο、N及S組成之群之雜原子之5至10員飽和 雜環, 其中該等環基團自身可部分或全部經鹵化或可帶有1至3個 基團Rb。其中,較佳者係下述彼等式j化合物:其中Ri係 όνον院基、cvc:2·氟烧基或C3_C8-烯基且係尤其選自由 CH2CF3、CH2CH(CH3)2、CH(CH3)-CH2CH3、ch(ch3)_ ch(ch3)2 、 CH(CH3)_C(CH3)3 、 ch2ch=ch2 及 CH2C(CH3)=CH2組成之群。 其中,較佳者亦係其中式I中2NR1R2基團係一式A之基 團之式I化合物:Alkynyl: a straight or branched hydrocarbon group having from 2 to 4, 6 or 8 carbon atoms and at any position or two triple bonds, for example, c2_c6-alkynyl, for example ethynyl, 1- Propynyl, 2-propynyl, ^butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl, indolyl, pentynyl, 3 _Pentynyl, 4-pentynyl, 1-indolyl-2-butynyl, hydrazino-3-butynyl, 2-methyl-3-butynyl, 3-methyl-hydrazine Alkynyl, dimethyl-2-propynyl, 1-ethyl-2-propynyl, 1-hexynyl, 2-hexynyl, 3-hexynyl, 'hexynyl, 5-hexyl Alkynyl, i-methyl Ipentynyl, 丨-methyl:pentynyl, methyl-4-pentynyl, 2-mercapto-3-pentynyl, methylpentynyl, 3-methyl Small pentynyl, 3-methyl-4-pentynyl, 4-mercapto + pentynyl, 4-methyl-2-pentynyl, 1,1-dimethyl-2-butynyl, ^ Dimethyl_3_butynyl, 1,2-dimethyl-3-butynyl, 2,2-dimethyl-3-butynyl, 3,3-diindenylbutynyl , 1-ethyl-2-butynyl, bethyl-3-butynyl, ethyl-3-butynyl and 1-ethyl-fluorenyl-2-ylpropynyl; cycloalkyl: I There are 3 a monocyclic or bicyclic saturated group of 6 or 8 carbon ring members, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group and a cyclooctyl group; an alkylthio group: the above Ci_Cp alkyl group bonded via a sulfur atom; Sulfhydryl (also known as alkyl): the above-mentioned alkyl group attached via a so group; alkyl group: the above-mentioned term 5 to 1G heterocyclic ring bonded via 10) 2 hydrazine Or a 5-membered or heterocyclic ring containing a saturated or partially unsaturated heterocyclic group having 5 or 6 118620.doc -14-200800026 and 5, 6, 7, 8, 9 or 10 atoms as ring members, respectively And an aromatic heterocyclic group (heteroaryl), wherein 丄, 2 3 or 4 of the atoms are derived from a hetero atom of a group consisting of 0, N and s, wherein the heterocyclic groups are specifically There are 1, 2, 3 or 4 nitrogen atoms or 1 or 2 heteroatoms selected from oxygen and sulfur and, if appropriate, another hydrazine or 2 heteroatoms selected from nitrogen as ring members. These include, inter alia: a 5, 6 or 7 membered heterocyclic group containing from 1 to 3 nitrogen atoms and/or 1 oxygen or sulfur atom or 2 or 2 oxygen and/or sulfur atoms, for example 2 to tetrahydrofuranyl, 3_tetrahydrofuranyl, 2-tetrahydrothiophenyl, 3-tetrahydrothiophenyl, 2-pyrrolidinyl, 3-pyrrolidinyl, 3-isoxazolidinyl, 4-isoxazolidinyl, 5-iso Oxazolidine, 3-isothiazolidinyl, 4-isothiazolidinyl, 5-isothiazolidinyl, 3-pyrazolidinyl, 4-pyrazolidinyl, 5-pyrazolidine, 2-ox Zyridinyl, 4-oxazolidinyl, 5-oxazolidinyl, 2-thiazolyl, 4-thiazolidinyl, 5-oxazolidinyl, 2-imidazolidinyl, 4-imidazolidinyl, 2 - pyrroline 2 base, bilorin-3-yl, 3_σ bilorin-2-yl, 3_吼洛琳_3-yl, 2_hexahydro. Bipyridyl, 3-hexahydropyridyl, 4·hexahydropyridyl, 1 decyl-5-yl, 2-tetrahydropyranyl, 4-tetrahydropyranyl, 2-tetrahydrothiophenyl '3-Hexhydropyridazinyl, 4-hexahydropyridazinyl, 2-hexahydropyrimidinyl, 4-hexahydropyrimidinyl, 5-hexahydropyrimidinyl and 2-piperidinyl; 5, 6 or 7-membered a ring group which is bonded via a nitrogen and which, in addition to a carbon ring member, also contains L, 2 or 3 nitrogen atoms or i, 2 or 3 nitrogen atoms and 1 sulfur or oxygen atom as a ring member, for example 1 - η is more than a bite base, 3 - ° is more than 嘻 · 1-l base, 丨 嗤唆 嗤唆 、, 2-imiline-1-yl, 1-hexahydro π 唆 、, 1 _ _ p well base, Benzinyl, thiomorpholin-4_yl and 4H-1,3,4-thiadiazin-4-yl; 118620.doc 200800026 - contains 1 to 4 nitrogen atoms or 1 to 3 nitrogen atoms and / Or a 5-membered heteroaryl group of a sulfur or an oxygen atom: a 5-membered heteroaryl group which may have 1 to 4 nitrogen atoms or 1 to 3 nitrogen atoms and 1 sulfur or oxygen atom as a ring member in addition to a carbon atom, For example, 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyrrolyl, 3-indolyl, 3- σ 峻 基, 4-11 fluorenyl, 5-° fluorenyl ,2-. Oxazolyl, 4-oxazolyl, 5-oxazolyl, 2-thiazolyl, 4-thiazolyl, 5-thiazolyl, 2-imidazolyl, 4-imidazolyl and 1,3,4-triazole-2 a 5-membered heteroaryl group which is attached to the nitrogen and which, in addition to the carbon ring member, also contains 1, 2, 3 or 4 nitrogen atoms as a ring member, for example, 1 Η-pyrrol-1-yl, 1 Η-pyrazolyl, 1 Η -Saliva-1-yl, 1,2,3-tris-s-l-yl, 1,2,4-tris-1-yl, 1-tetrazol-1-yl and 2Η-tetrazole·2· a 6-membered heteroaryl group containing 1 to 3 or 1 to 4 nitrogen atoms: a 6-membered heteroaryl group which may have 1 to 3 or 1 to 4 nitrogen atoms as a ring member in addition to a carbon atom, for example 2-吼, 3-吼, 4-吼, 3-oxazinyl, 4-oxazinyl, 2-pyrimidinyl, 4-pyrimidinyl, 5-pyrimidinyl and 2-pyrazinyl Stretching base: a divalent unbranched chain containing 1 to 6 CH2 groups, such as ch2, ch2ch2, ch2ch2ch2, ch2ch2ch2ch2, CH2CH2CH2CH2CH2, and CH2CH2CH2CH2CH2CH2; oxyalkylene: one of the valences is attached to the backbone via an oxygen atom; a divalent unbranched chain containing 2 to 4 CH2 groups, for example, 〇CH2CH2, och2ch2ch2aoch2ch2ch2ch2; oxyalkyleneoxy: The two valencies are linked via an oxygen atom to a divalent unbranched chain of the backbone containing from 1 to 3 CH2 groups, such as 〇c 〇, 118620.doc -16 - 200800026 OCH2CH2 〇 and 〇CH2CH2CH2 〇. The scope of the present invention includes the compounds of the formula having a palmitic center and the (S)-isomers and racemates. In view of the intended use of the triazolopyrimidines of formula I, the following meanings of the substituents are preferred, and in each case they are used independently or in combination: L1 in formula I is preferably CVC4-alkoxy, Especially oxime. The latter is also a compound of the formula wherein the L1 system is C^C4.alkyl and especially the thiol group. L2 is preferably a fluorine, gas or sulfhydryl group and is especially fluorine. According to a first preferred embodiment, L1 is a decyloxy group and l2 is a fluorine. According to a second preferred embodiment, Li is a fluorenyl group and a B is a system I. R1 is preferably C4-C8-alkyl, c3_c8-cycloalkyl, C3_C8-halocycloalkyl, c3-c8-alkenyl, C3-C8-halogenated, C3_C6_cycloalkyl, C3_C6_halo Cycloalkenyl, Q-C8-alkynyl, C^C8-self-alkynyl or phenyl, naphthyl or a hetero atom comprising 1, 2, 3 or 4 from a group consisting of 0, N and s A 5- or 6-membered heterocyclic ring in which 1, 2, 3 or 4 hydrogen atoms in the group 1, can be substituted as described above. Among them, preferred are the following compounds: wherein R1 is C4-C8-alkyl or C3-C8-alkenyl and is especially selected from CH2CH(CH3)2, CH(CH3)-CH2CH3 > CH(CH3)- CH(CH3)2 > CH(CH3)-C(CH3)3 > CH2CH=CH2 and ch2c(ch3)=ch2 group. A particularly preferred embodiment relates to a compound of formula I wherein R2 is hydrogen, methyl or ethyl; and R1 is C4-C8-alkyl, c3-c8-alkenyl, Cl_c2_ by alkyl or c3_c6. 118620.doc 200800026 A cycloalkyl group, wherein such groups may, when appropriate, carry one of the following groups: R-based murine, nitro, thiol, Ci-C6-alkyl-based thio, C3-C6- Cycloalkyl, CVC6-alkoxy, cvc6-alkoxycarbonyl, CV c6-alkylthio, Cl-C6-alkylamino, di-CVCV alkylamino, c3-c8-cycloalkenyl, C2 -C6-alkenyloxy, C3-C6-alkynyloxy, C^CV cycloalkoxy, c3-C6-cycloalkenyloxy, oxy-Ci-C3-alkylalkoxy, phenyl, naphthyl, a 5 to 10 membered saturated heterocyclic ring containing 1 to 4 hetero atoms derived from a group consisting of ruthenium, N and S, wherein the ring groups themselves may be partially or fully halogenated or may have 1 to 3 groups Group Rb. Wherein, preferred is a compound of the following formula j: wherein Ri is όνον, cvc:2·fluoroalkyl or C3_C8-alkenyl and is especially selected from CH2CF3, CH2CH(CH3)2, CH(CH3) A group consisting of -CH2CH3, ch(ch3)_ch(ch3)2, CH(CH3)_C(CH3)3, ch2ch=ch2, and CH2C(CH3)=CH2. Among them, preferred are also compounds of the formula I in which the 2NR1R2 group of the formula I is a group of formula A:
H3C I (a) 其中G係CrC6-烧基,尤其乙基、正丙基及異丙基、正、 第二及第三丁基;及烷氧基甲基,尤其乙氧基甲 基;或C^C6-環烷基,尤其環戊基或環己基;R2係如上定 118620.doc -18- 200800026 義且尤其係鼠或曱基,且#表示至三也并嘴咬骨架之連接 點。 較佳者亦係其中R1係基團B之式I化合物:H3C I (a) wherein G is a CrC6-alkyl group, especially ethyl, n-propyl and isopropyl, normal, second and third butyl; and alkoxymethyl, especially ethoxymethyl; C^C6-cycloalkyl, especially cyclopentyl or cyclohexyl; R2 is as defined above, 118620.doc -18-200800026 and especially is a murine or sulfhydryl group, and # represents the point of attachment to the trisole. Preferred are also compounds of formula I wherein R1 is a group B:
F FF F
F---(CH2)—CHR— B Z1 Z2 其中 q 係o或l ; z1係氫、氟或氟烷基,尤其係氫、氟或三氟曱 基, Z 係氫或IL,或 z及Z共同形成一雙鍵; r3 係氫或甲基。 此外’較佳者係其中R1係可經Ci-Cr烷基取代之c3-c6-環燒基且尤其係環戊基或環己基之式][化合物。 R2較佳係氫、CVC3-烷基或CVC3-鹵代烷基,尤其氫、 甲基或乙基。尤佳者係其中R2係氫之式J化合物。較佳者 同樣係其中R2係曱基或乙基之式I化合物。 較佳者亦係其中Ri係〇2_(:8_鹵代烷基,尤其係c2_c8_氟 烧基且R2係CVC3-烷基或(VC3-鹵代烷基,尤其係甲基或 乙基之式I化合物。 較佳者亦係其中R1係一式B之基團,尤其2,2,3,3,3-五氟 丙基或2,2,33354,4,4-七氟丁基且尺2係氫之式1化合物。 較佳者亦係其中R1係一式CH^CFsHCkCV烷基)之基團 且尤其係CH(CF3)-(CH3)之式I化合物。在該等基團中,帶 118620.doc -19- 200800026 有CF3基團之碳原子係對掌性且較佳具有s構型。若該等基 團中R2係氫,則X較佳選自由氰基、CVC4-烷基、CVCV烷 氧基及Cr-C2·鹵代烧氧基組成之群且尤其選自由cn、甲基 及甲氧基組成之群。 若R1及/或R2含有具有對掌性中心的鹵代烷基或鹵代烯 基,則該等基團較佳係(S)-異構體。對於在Ri*R2中具有 對掌性中心的不含鹵素之烧基或烯基而言,較佳者係(R) 構型之異構體。 較佳者亦係下述式I化合物··其中R1&R2以及其所連接 之氮原子共同形成一經由氮連接之5或6員雜環且其可進一 步含有1、2或3個來自由〇' N及S組成之群之雜原子作為 環成員且其可帶有i、2、3或4個由下列組成之群之取代 基:參素、(VCV烷基、CVCV鹵代烷基、C2-C6-烯基、 c2-c6-鹵代烯基、Ci_C6-烷氧基、Ci_c6_鹵代烷氧基、F---(CH2)-CHR- B Z1 Z2 wherein q is o or l; z1 is hydrogen, fluorine or fluoroalkyl, especially hydrogen, fluorine or trifluoromethyl, Z-hydrogen or IL, or z and Z together form a double bond; r3 is hydrogen or methyl. Further, 'preferably, the compound wherein R1 is a c3-c6-cycloalkyl group which may be substituted by a Ci-Cr alkyl group and especially a cyclopentyl group or a cyclohexyl group]. R2 is preferably hydrogen, CVC3-alkyl or CVC3-haloalkyl, especially hydrogen, methyl or ethyl. Particularly preferred are compounds of formula J wherein R2 is hydrogen. Preferred are likewise compounds of the formula I in which the R2 is decyl or ethyl. Preference is also given to compounds of the formula I in which Ri is 〇2_(:8-haloalkyl, especially c2_c8-fluoroalkyl and R2 is CVC3-alkyl or (VC3-haloalkyl, especially methyl or ethyl). Preferred is also a group wherein R1 is a formula B, especially 2,2,3,3,3-pentafluoropropyl or 2,2,33354,4,4-heptafluorobutyl and 2 is hydrogen A compound of formula 1 is also preferably a compound of formula I wherein R1 is a group of formula CH^CFsHCkCV alkyl) and especially CH(CF3)-(CH3). In such groups, the band 118620.doc - 19-200800026 A carbon atom having a CF3 group is palmarous and preferably has an s configuration. If R2 is hydrogen in the group, X is preferably selected from the group consisting of a cyano group, a CVC4-alkyl group, and a CVCV alkoxy group. And a group consisting of Cr-C2·halogenated alkoxy groups and especially selected from the group consisting of cn, methyl and methoxy. If R1 and/or R2 contain a haloalkyl or haloalkenyl group having a palmitic center, Preferably, the groups are (S)-isomers. For halogen-free alkyl or alkenyl groups having a palmitic center in Ri*R2, preferred is the (R) configuration. Isomers. Preferred are also compounds of formula I below: wherein R1 & R2 and The attached nitrogen atoms together form a 5 or 6 membered heterocyclic ring via a nitrogen linkage and which may further contain 1, 2 or 3 heteroatoms from the group consisting of 〇'N and S as ring members and which may carry i, 2, 3 or 4 substituents of the group consisting of: ginseng, (VCV alkyl, CVCV haloalkyl, C2-C6-alkenyl, c2-c6-haloalkenyl, Ci_C6-alkoxy , Ci_c6_haloalkoxy,
Cr烯氧基、CrC6-鹵代烯氧基、(外)-Cl_C6-伸烷基及氧基· Ci-C3-伸烷氧基。 其中’尤佳者係下述式〗化合物:其中R1&R2以及其所 連接之氮原子共同形成六氫啦啶基、嗎啉基或硫嗎啉基 環,尤其六氫吡啶基環,其中上述基團可帶有i個、2個或 3個上述取代基,尤其選自鹵素、Ci_C4_烷基及Ci_C4_鹵代 烧基之取代基。尤佳者係其中R1及R2以及其所連接之氮原 子/、同形成2-甲基_、3_曱基_或4-甲基六氫η比咬環之化合 物。 、 此外’杈佳者係其中R1及R2以及其所連接之氮原子共同 118620.doc -20- 200800026 形成上述5員飽和或不飽和環或嗎啉基或硫嗎啉基環中的 一個之式I化合物,其中該等環可經之丨至3個鹵素、Ci_C4_ 烧基或CKC4-鹵代烷基取代。 此外’本發明尤佳提供下述式I化合物:其中Ri&R2以 及其所連接之氮原子共同形成一吡唑或吡咯啶環,該吡唑 或咣咯啶環可經丨或】個_素、Cl-C4_烷基或Ci_C4-鹵代烷 基取代,尤其係3,5-二甲基吡唑、3,5-二_(三氟甲基)咄 嗤' 2-甲基吡咯啶或3_甲基吡咯啶。 在式I化合物中,尤佳者係其中义係_素且尤其係氯之彼 等化合物。 較佳者亦係其中X係氰基之式Hb合物。 較隹者同樣係其中又係^^4·烷基且尤其係甲基之式I化 合物。 較佳者同樣係其中又係^^4-烷氧基鹵代烷氧基 且尤其係曱氧基或乙氧基之式I化合物。 尤佳者係式Ι-Α、I-B、Ι-C及Ι-D之化合物:Cr alkenyloxy, CrC6-haloalkenyloxy, (exo)-Cl_C6-alkylene and oxy·Ci-C3-aralkyloxy. Wherein the 'preferably' is a compound of the formula: wherein R 1 & R 2 and the nitrogen atom to which they are attached together form a hexahydropyridinyl, morpholinyl or thiomorpholinyl ring, especially a hexahydropyridyl ring, wherein The group may carry i, 2 or 3 of the abovementioned substituents, especially those selected from the group consisting of halogen, Ci_C4_alkyl and Ci_C4_halogen. Particularly preferred are compounds wherein R1 and R2, and the nitrogen atom to which they are attached, form a 2-methyl-, 3-methyl- or 4-methylhexahydro-n-biter ring. Further, 'the best one is one in which R1 and R2 together with the nitrogen atom to which they are attached 118620.doc -20- 200800026 form one of the above five-membered saturated or unsaturated ring or morpholinyl or thiomorpholinyl ring. A compound wherein the rings are substituted with 3 halogens, Ci_C4_alkyl or CKC4-haloalkyl. Further, the present invention provides, in particular, a compound of the formula I in which Ri&R2 and the nitrogen atom to which it is attached form a pyrazole or pyrrolidine ring which may be passed through a ruthenium or a ruthenium ring. , Cl-C4_alkyl or Ci_C4-haloalkyl substituted, especially 3,5-dimethylpyrazole, 3,5-di-(trifluoromethyl)fluorene' 2-methylpyrrolidine or 3_ Methyl pyrrolidine. Among the compounds of the formula I, especially preferred are those in which the sage is a sulphur and especially the chlorin. Preferred are also Hb compounds of the formula X-based cyano group. The latter is also a compound of the formula I in which is a methyl group and especially a methyl group. Preferred are likewise compounds of the formula I in which the alkoxyhaloalkoxy group and especially the decyloxy or ethoxy group are attached. Especially preferred are compounds of Ι-Α, I-B, Ι-C and Ι-D:
F FF F
118620.doc -21- 200800026 其中R1及R2係如上定義且χ係氯、甲基、曱氧基或cn且尤 其係氯或曱基,及其農業上可接受之鹽。 特別是考慮到其用途,較佳者此彙集於下表中的式以匕 合物。另外,表中所提及適合用作一取代基之基團本身 (獨立於該等基團於其中被提及之組合)係一所述取代基之 尤佳實施例。 表1 : 式Ι-A之化合物,其中X係氣且每一情形下化合物之…及 R組合對應於表A中的一排,第5 1、54及57排除外。 表2 : 式I-B之化合物,其中X係氯且每一情形下化合物之…及 R2組合對應於表A中的一排,第51、54及η排除外。 表3 : 式Ι-C之化合物,其中X係氯且每一情形下化合物之汉1及 R2組合對應於表A中的一排,第5 1、54及5 7排除外。 表4 : 式Ι-D之化合物,其中X係氯且每一情形下化合物之Ri及 R2組合對應於表A中的一排,第5 1、54及57排除外。 表5 : 式I-A之化合物,其中X係甲基且每一情形下化合物之化1 及R2組合對應於表A中的一排。 表6 : 式I-B之化合物’其中X係甲基且每一情形下化合物之r1 及R2組合對應於表A中的一排。 I18620.doc -22- 200800026 表7 ·· 式^之化合物,其中X係曱基且每一情形下化合物之… 及R2組合對應於表A中的一排。 表8 : 式^之化合物’其中X係甲基且每一情形下化合物之… 及R2組合對應於表A中的一排。 表9 : 式Ί-Α之化合物’其中X係氰基且每一情形下化合物之… 及R2組合對應於表A中的一排。 表 10 ·· 式I-B之化合物’其中X係氰基且每一情形下化合物之… 及R2組合對應於表A中的一排。 表11 : 式Ι-C之化合物’其中X係氰基且每一情形下化合物之尺i 及R2組合對應於表A中的一排。 表12 : 式Ι-D之化合物’其中X係氣基且每一情形下化合物之r1 及R2組合對應於表A中的一排。 表13 : 式I-A之化合物,其中X係甲氧基且每一情形下化合物之 R1及R2組合對應於表A中的一排。 表14 : 式I-B之化合物’其中X係甲氧基且每一情形下化合物之 R1及R2組合對應於表A中的一排。 118620.doc -23- 200800026 表 15 ·· 式Ι-C之化合物,其中X係甲氧基且每一情形下化合物之 R1及R2組合對應於表A中的一排。 表16 : 式Ι-D之化合物,其中X係曱氧基且每一情形下化合物之 " R1及R2組合對應於表A中的一排。 * 表A : 編號 R1 R2 A-1 ch3 H A-2 ch3 CHs A-3 ch2ch3 H A-4 ch2ch3 ch3 A-5 CH2CH3 CH2CH3 A-6 CH2CF3 H A-7 ch2cf3 CHs A-8 CH2CF3 CH2CH3 A-9 CH2CC13 H A-10 CH2CC13 CHs A-11 CH2CC13 ch2ch3 A-12 CH2CH2CH3 H A-13 CH2CH2CH3 ch3 A-14 ch2ch2ch3 ch2ch3 A-15 ch2ch2ch3 CH2CH2CH3 A-16 ch(ch3)2 H A-17 CH(CH3)2 CH3 A_18 CH(CH3)2 CH2CH3 A-19 CH2CH2CH2CH3 H A-20 CH2CH2CH2CH3 ch3 A-21 ch2ch2ch2ch3 CH2CH3 A-22 CH2CH2CH2CH3 ch2ch2ch3 A-23 C2CH2ai2CH3 CH2CH2CH2CH3 A-24 (土) ch(ch3)-ch2ch3 H A-25 (土) ch(ch3)-ch2ch3 ch3 A-26 (士) CH(CH3)-CH2CH3 CH2CH3 A - 27 (s) CH(CH3)-CH2CH3 H A-28 (S) CH(CH3)-CH2CH3 ch3 118620.doc -24- 200800026118620.doc -21- 200800026 wherein R1 and R2 are as defined above and are chloro, methyl, decyloxy or cn and are especially chloro or decyl, and agriculturally acceptable salts thereof. In particular, in view of its use, it is preferred to incorporate the compounds of the formulas in the table below. Further, the groups mentioned in the table which are suitable as a substituent are themselves (independent of the combination in which the groups are mentioned) are a preferred embodiment of the substituent. Table 1: Compounds of the formula Ι-A, wherein X is a gas and in each case the ... and R combinations of the compounds correspond to a row in Table A, except for the exclusion of the 5th, 54th and 57th. Table 2: Compounds of formula I-B wherein X is chlorine and in each case the combination of ... and R2 corresponds to one row in Table A, with exceptions 51, 54 and η excluded. Table 3: Compounds of the formula Ι-C, wherein X is chlorine and in each case the combination of the compounds 1 and R2 corresponds to a row in Table A, and the exceptions are excluded from the 5th, 54th and 5th. Table 4: Compounds of the formula Ι-D wherein X is chlorine and in each case the Ri and R2 combinations of the compounds correspond to a row in Table A, except for the exclusion of the 5th, 54th and 57th. Table 5: Compounds of Formula I-A wherein X is methyl and in each case the compound 1 and R2 combinations correspond to one row in Table A. Table 6: Compound of Formula I-B 'where X is methyl and the combination of R1 and R2 of the compound in each case corresponds to one row in Table A. I18620.doc -22- 200800026 Table 7 · Compounds of the formula ^, wherein the X-based thiol group and in each case the compound... and the R2 combination correspond to a row in Table A. Table 8: Compound of formula ^ wherein X is methyl and in each case the compound... and the R2 combination correspond to a row in Table A. Table 9: Compounds of the formula Ί-Α wherein the X-based cyano group and in each case the compound... and the R2 combination correspond to a row in Table A. Table 10 · Compounds of Formula I-B 'where X is a cyano group and in each case the compound... and the R2 combination correspond to a row in Table A. Table 11: Compounds of the formula Ι-C where X is a cyano group and in each case the combination of the size i and R2 of the compound corresponds to one row in Table A. Table 12: Compound of the formula Ι-D where X is a gas group and in each case the combination of r1 and R2 of the compound corresponds to a row in Table A. Table 13: Compounds of Formula I-A wherein X is a methoxy group and in each case the R1 and R2 combinations of the compounds correspond to a row in Table A. Table 14: Compounds of Formula I-B 'where X is methoxy and the R1 and R2 combinations of the compounds in each case correspond to one row in Table A. 118620.doc -23- 200800026 Table 15 · Compounds of the formula Ι-C, wherein X is a methoxy group and in each case the R1 and R2 combinations of the compounds correspond to a row in Table A. Table 16: Compounds of the formula Ι-D wherein X is a decyloxy group and in each case the " R1 and R2 combinations of the compounds correspond to a row in Table A. * Table A: No. R1 R2 A-1 ch3 H A-2 ch3 CHs A-3 ch2ch3 H A-4 ch2ch3 ch3 A-5 CH2CH3 CH2CH3 A-6 CH2CF3 H A-7 ch2cf3 CHs A-8 CH2CF3 CH2CH3 A-9 CH2CC13 H A-10 CH2CC13 CHs A-11 CH2CC13 ch2ch3 A-12 CH2CH2CH3 H A-13 CH2CH2CH3 ch3 A-14 ch2ch2ch3 ch2ch3 A-15 ch2ch2ch3 CH2CH2CH3 A-16 ch(ch3)2 H A-17 CH(CH3)2 CH3 A_18 CH(CH3)2 CH2CH3 A-19 CH2CH2CH2CH3 H A-20 CH2CH2CH2CH3 ch3 A-21 ch2ch2ch2ch3 CH2CH3 A-22 CH2CH2CH2CH3 ch2ch2ch3 A-23 C2CH2ai2CH3 CH2CH2CH2CH3 A-24 (soil) ch(ch3)-ch2ch3 H A-25 (soil CH(CH3)-ch2ch3 ch3 A-26 -24- 200800026
編號 R1 R2 A-29 (s) CH(CH3)-CH2CH3 CH2CH3 A-30 (R) CH(CH3)-CH2CH3 H A-31 (R) CH(CH3)-CH2CH3 ch3 A-32 (R) CH(CH3)-CH2CH3 ch2ch3 A_33 ㈤ ch(ch3)-ch(ch3)2 H A-34 ㈤ ch(ch3)-ch(ch3)2 ch3 A-35 (士) ch(ch3)-ch(ch3)2 CH2CH3 A_36 ⑸ CH(CH3VCH(CH3)2 H A-37 (S) CH(CH3)-CH(CH3)2 ch3 A-38 (S) CH(CH3)-CH(CH3)2 CH2CH3 A-39 (R) CH(CH3)-CH(CH3)2 H A-40 (R) CH(CH3)-CH(CH3)2 ce3 A-41 ⑻ ch(ch3)_ch(ch3)2 ch2ch3 A-42 ㈤ ch(ch3)-c(ch3)3 H A-43 (土) ch(ch3)-c(ch3)3 gh3 A-44 (土) ch(ch3)-c(ch3)3 CH2CH3 A-45 (s) ch(ch3)-c(ch3)3 H A-46 (s) ch(ch3)-c(ch3)3 ch3 A-47 (s) ch(ch3)-c(ch3)3 CH2CH3 A-48 (R) CH(CH3)-C(CH3)3 H A-49 (R) CH(CH3)-C(CH3)3 ch3 A-50 (R) CH(CH3)-C(CH3)3 CH2CH3 A-51 ㈤ ch(ch3)-cf3 H A-52 (士) ch(ch3)-cf3 ch3 A_53 (±) CH(CH3)-CF3 CH2CH3 A-54 (S) GH(CH3)-CF3 H A-55 (S) CH(CH3)-CF3 ch3 A-56 (S) CH(CH3)-CF3 CH2GH3 A-5.7 (R) CH(CH3)-CF3 H A-58 (R) CH(CH3)-CF3 ch3 A-59 (R) CH(CH3)-CF3 CH2CH3 A-60 (±) CH(CH3)-CC13 H A-61 (土) CH(CH3)-CC13 ch3 A-62 (土) ch(ch3)-cci3 CH2CH3 A-63 (S) CH(CH3)-CC13 H A-64 (S) CH(CH3)-CC13 ch3 A-65 (S) CH(CH3)-CC13 CH2CH3 A-66 (R) CH(CH3)‘CC13 H A-67 (R) CH(CH3)-CC13 ch3 A-68 (R) CH(CH3)-CC13 CH2CH3 A-69 CH2GF2CF3 H 118620.doc -25- 200800026 編號 R1 Rz A-70 ch2cf2gf3 ch3 A-71 ch2cf2cf3 CH2CH3 A-72 CH2(CF2)2CF3 H A-73 ch2(cf2)2cf3 ch3 A-74 ch2(cf2)2cf3 CH2CH3 A-75 CH2C(CH3)=CH2 H A-76 CH2C(GH3)=CH2 ch3 A-77 CH2C(CH3)=CH2 CH2GH3 A-78 ch2ch=ch2 H A-79 ch2ch=ch2 CH3 A-80 ch2ch=ch2 CH2CH3 A-81 CH(CH3)CH=CH2 H A-82 ch(ch3)ch=ch2 ch3 A-83 ch(ch3)ch=ch2 CH2CH3 A-84 ch(ch3)c(ch3)=ch2 H A-85 CH(CH3)C(CH3)=CH2 ch3 A-86 CH(CH3}C(CH3)=CH2 CH2GH3 A-87 ch2-c=ch H A-88 CHrC 三 CH ch3 A-89 CHrC 三 CH CH2CH3 A-90 環戊基 H A-91 環戊基 ch3 A-92 環戊基 CH2CH3 A-93 環己棊 H A-94 環己基 ch3 A_95 環己基 CH2CH3 A-96 ch2-c6h5 H A-97 ch2-c6h5 ch3 A-98 ch2-c6h5 CH2GH3 A-99 -(CH2)2CH=CHCH2- A-100 -(CH2)2C(CH3)=CHCH2- A-101 -CH(CH3)CH2-CH=CHCH2- A-102 -(CH2)3CHFCH2- A-103 -(ch2)2chf(ch2)2- A-104 -ch2chf(ch2)3- A-105 -(CH2)2CH(CH3)(CH2)2. A-106 -(CH2)20(CH2)2- A-107 -(ch2)2s(ch2)2- A-108 -(CH2)4- A-109 -ch2ch=chch2-No. R1 R2 A-29 (s) CH(CH3)-CH2CH3 CH2CH3 A-30 (R) CH(CH3)-CH2CH3 H A-31 (R) CH(CH3)-CH2CH3 ch3 A-32 (R) CH( CH3)-CH2CH3 ch2ch3 A_33 (5) ch(ch3)-ch(ch3)2 H A-34 (5) ch(ch3)-ch(ch3)2 ch3 A-35 (s) ch(ch3)-ch(ch3)2 CH2CH3 A_36 (5) CH(CH3VCH(CH3)2 H A-37 (S) CH(CH3)-CH(CH3)2 ch3 A-38 (S) CH(CH3)-CH(CH3)2 CH2CH3 A-39 (R) CH(CH3)-CH(CH3)2 H A-40 (R) CH(CH3)-CH(CH3)2 ce3 A-41 (8) ch(ch3)_ch(ch3)2 ch2ch3 A-42 (v) ch(ch3) -c(ch3)3 H A-43 (earth) ch(ch3)-c(ch3)3 gh3 A-44 (earth) ch(ch3)-c(ch3)3 CH2CH3 A-45 (s) ch(ch3 )-c(ch3)3 H A-46 (s) ch(ch3)-c(ch3)3 ch3 A-47 (s) ch(ch3)-c(ch3)3 CH2CH3 A-48 (R) CH( CH3)-C(CH3)3H A-49 (R) CH(CH3)-C(CH3)3 ch3 A-50 (R) CH(CH3)-C(CH3)3 CH2CH3 A-51 (v) ch(ch3 )-cf3 H A-52 (士) ch(ch3)-cf3 ch3 A_53 (±) CH(CH3)-CF3 CH2CH3 A-54 (S) GH(CH3)-CF3 H A-55 (S) CH(CH3 )-CF3 ch3 A-56 (S) CH(CH3)-CF3 CH2GH3 A-5.7 (R) CH(CH3)-CF3 H A-58 (R) CH(CH3)-CF3 ch3 A-59 (R) CH (CH3)-CF3 CH2CH3 A-60 (±) CH(CH3)-CC13 H A-61 (earth) CH(CH3)-CC13 ch3 A-62 (soil) Ch(ch3)-cci3 CH2CH3 A-63 (S) CH(CH3)-CC13 H A-64 (S) CH(CH3)-CC13 ch3 A-65 (S) CH(CH3)-CC13 CH2CH3 A-66 ( R) CH(CH3)'CC13 H A-67 (R) CH(CH3)-CC13 ch3 A-68 (R) CH(CH3)-CC13 CH2CH3 A-69 CH2GF2CF3 H 118620.doc -25- 200800026 No. R1 Rz A-70 ch2cf2gf3 ch3 A-71 ch2cf2cf3 CH2CH3 A-72 CH2(CF2)2CF3 H A-73 ch2(cf2)2cf3 ch3 A-74 ch2(cf2)2cf3 CH2CH3 A-75 CH2C(CH3)=CH2 H A-76 CH2C(GH3)=CH2 ch3 A-77 CH2C(CH3)=CH2 CH2GH3 A-78 ch2ch=ch2 H A-79 ch2ch=ch2 CH3 A-80 ch2ch=ch2 CH2CH3 A-81 CH(CH3)CH=CH2 H A -82 ch(ch3)ch=ch2 ch3 A-83 ch(ch3)ch=ch2 CH2CH3 A-84 ch(ch3)c(ch3)=ch2 H A-85 CH(CH3)C(CH3)=CH2 ch3 A -86 CH(CH3}C(CH3)=CH2 CH2GH3 A-87 ch2-c=ch H A-88 CHrC Tri CH ch3 A-89 CHrC Tri CH CH2CH3 A-90 Cyclopentyl H A-91 Cyclopentyl ch3 A-92 cyclopentyl CH2CH3 A-93 cyclohexanyl H A-94 cyclohexyl ch3 A_95 cyclohexyl CH2CH3 A-96 ch2-c6h5 H A-97 ch2-c6h5 ch3 A-98 ch2-c6h5 CH2GH3 A-99 - ( CH2)2CH=CHCH2- A-100 -(CH2)2C(CH3)=CHCH2- A-101 -CH(CH3)CH2-CH=CHCH2- A-102 -(CH2)3CHFCH2- A-10 3 -(ch2)2chf(ch2)2- A-104 -ch2chf(ch2)3- A-105 -(CH2)2CH(CH3)(CH2)2. A-106 -(CH2)20(CH2)2- A-107 -(ch2)2s(ch2)2- A-108 -(CH2)4- A-109 -ch2ch=chch2-
118620.doc -26 - 200800026 編號 R1 R2 A-110 ‘CH(CH3)(CH2)r A-111 -CH2CH(CH3)(CH2)2- A-112 -ch(ch3mch2)2-ch(ch3)- A-113 -CH(CH3MCH2)4- A-114 -CHrCH(CH3)-(CH2)3- A-115 -(ch2)-ch(ch3)-ch2-ch(c^-^ A-116 -ch(ch2ch3mch2)4- A-117 -(CH2)rN(CH3HCH2)2_ A_118 -N=CH-CH=CH- Α-1Γ9 -N=C(CH3)-CH=C(CH3)- A-120 -N=C(CF3)-CH=C(CF3)- A-121 -(CH2)2CH(CH3)(CH2)2- A-122 -(CH2V 其中,尤佳者係以下化合物: -5-氣·6-(2,5-二氣-4-甲基苯基)-7-(3 -甲基口比咯咬-1 -基)-[1,2,4]三唑并-[l,5-a]嘧啶; -5-甲基-6-(2,5-二亂-4-甲基苯基)-7-(3 -曱基°比洛^定-1 -基)-[1,2,4]三唑并-[l,5-a]嘧啶; -5-甲氧基-6-(2,5-二氣-4-甲基苯基)-7-(3 -曱基ϋ比洛。定-1_ 基)-[1,2,4]三唑并-[l,5-a]嘧啶; -5 -氣基-6 - ( 2,5 -二氣-4 -甲基苯基)_ 7 - ( 3 -曱基°比哈咬_ 1 -基)-[1,2,4]三唑并-[l,5-a]嘧啶; -5-氯-6-(2,5-二氟-4-甲氧基苯基)-7-(3-甲基吼咯啶-1-基)-[1,2,4]三唑并-[l,5-a]嘧啶; -5-甲基·6-(2,5 -二貌-4-甲氧基苯基)-7-(3 -甲基11比咯咬-1 -基)-[1,2,4]三唑并-[l,5-a]嘧啶; -5-甲氧基-6-(2,5-二氟-4-甲氧基苯基)-7-(3-甲基吡咯啶-1-基)-[1,2,4]三唑并-[l,5-a]嘧啶; -5-氰基-6-(2,5-二氟-4-甲氧基苯基)-7-((3-甲基吼咯啶-1- 118620.doc -27- 200800026 基)-[1,2,4]三唑并-[l,5-a]嘧啶; -5 -氯-6-(2,5 -二氣-4-甲基苯基)-7-(2-曱基D比11 各唆-1-基)_ [1,2,4]三唑并-[l,5-a]嘧啶; -5-甲基-6-(2,5·二氟-4-曱基苯基)-7-(2-曱基吡咯啶-1-基)-[1,2,4]三唑并-[l,5-a]嘧啶; ^ - 5-甲氧基-6-(2,5-二氟-4-甲基苯基)-7-(2-甲基吡咯啶-1- - 基)-[1,2,4]三唑并-[l,5-a]嘧啶; -5 -氣基-6 - ( 2,5 -二氣-4 -甲基苯基)-7 - ( 2 -甲基°比洛ϋ定-1 -基)_ • [1,2,4]三唑并-[l,5-a]嘧啶; -5 -氣-6 - ( 2,5 -二氣-4 -甲氧基苯基)· 7 - ( 2 -甲基11比嘻σ定-1 -基)~ [1,2,4]三唑并 _[l,5-a]嘧啶; -5-甲基-6-(2,5-二氣-4-甲氧基苯基)-7·(2-甲基11比咯咬-1 · 基)-[1,2,4]三唑并-[l,5-a]嘧啶; -5-甲氧基-6-(2,5-二氟-4-甲氧基苯基)-7-(2-甲基吡咯啶-1-基)-[1,2,4]三唑并-[l,5-a]嘧啶; - 5-氣基-6 -(2,5 -二亂-4-甲乳基苯基)-7-(2-甲基σ比咯唆-1 _ 基)-[1,2,4]三唑并-[l,5-a]嘧啶; -5 -氣-6-(2,5 -二鼠-4 -甲基苯基)-7-(2 -甲基六氮σ比唆-1-基)_ * [1,2,4]-三唑并[l,5-a]嘧啶; = -5-曱基-6-(2,5-二氟-4-曱基苯基)-7-(2-曱基六氫吡啶-1- 基)-[1,2,4]-三唑并[l,5-a]嘧啶; -5-甲氧基-6-(2,5 -二氣-4-甲基苯基)-7-(2-甲基六氮0比咬_ 1-基)-[1,2,4]-三唑并[l,5-a]嘧啶; -5-鼠基-6-(2,5-二亂-4-甲基苯基)-7-(2-曱基六鼠^比°定-1 - 118620.doc -28- 200800026 基)-[1,2,4]-二吨并[i,5_a]嘴咬; 5-氯-6-(2,5-二14-甲氧基笨基):(2_甲基六氮〇比咬小 基)-[1,2,4]-二峻并[ΐ35-α]ρ^σ定; 5曱基-6-(2,5-一氟-4-甲氧基笨基)_7_(2_曱基六氫咕啶_ 1-基)-[1,2,4]-三唑并[l55_a]嘧啶; 5·曱氧基_6-(2,5_二氟+甲氧基苯基)-7-(2-甲基六氫口比 咬小基Hl,2,4]-三唾并[l55_a],啶; 5氰基6-(2,5-一氟-4-甲氧基笨基)_7·(2_曱基六氫吡啶_ 1-基)-[1,2,4]-三唑并[i,5_a]嘧啶; -5-氯-6-(2,5·二氟-4-甲基笨基)_7_(4_甲基六氫〇比啶d•基)_ [1,2,4]-三唑并[l,5_a]嘧,定; -5-曱基-6-(2,5-二氟-心甲基苯基)々_(心甲基六氮口比咬小 基)-[1,2,4]-二嗤并·, -5-甲氧基-6_(2,5-二氟_4·甲基笨基)_7_(心曱基六氫吨唆_ 1-基)-[1,2,4]_ 三嗤并·, -5-氰基-6-(2,5-二氟_4_甲基苯基)_7-(4-甲基六氫吨咬小 基)-[1,2,4]-二嗤并[1,5-a]^!!定·, _ 5_氯-6_(2,5-二氟_4-甲氧基苯基)-7-(4-甲基六氫吡啶-1 -基)-[1,2,4]-三哇并[i,5_a]嘧唆; _ 5-甲基-6-(2,5-二氟_4_甲氧基苯基)_7_(4_甲基六氫吡啶_ 1-基Hl,2,4]-三唾并[l55_a]嘧咬; _ 5-甲氧基-6-(2,5_二就_4·曱氧基苯基)_7_(4·甲基六氫吨 咬-1-基)-[1,2,4]_三唾并以,%^喷啶; -5-氰基-6-(2,5-二氟_4_甲氧基苯基)_7_(4_曱基六氫。比啶_ 118620.doc -29- 200800026 1-基)-[1,2,4]-三唑并嘧啶; 5H(2’5_H甲基笨基)_7·(3-甲基六氫吨咬-1-基)-[1,2,4]-三峻并[1,5_&]嗜。定; 5-甲基 _6-(2,5-二氟、4_ 审 i , 甲基本基)-7-(3-甲基六氫。比咬-l-基X1,2,4]-三唑并[l,5-a]嘧啶; 5甲氧基-6-(2,5-一敗{甲基苯基)罐7《3_甲基六氮吼咬_ 1-基)-[1,2,4]-三唑并[l55_a]嘯啶; 5-氰基-6-(2,5_二κ甲基苯基)_7_(3_甲基六氫。比咬小 基)_[1,2,4]-三唑并[l55_a]嘧啶; 5-亂-6-(2,5-二氟-4_曱氧基苯基)_7_(3_甲基六氫11比啶小 基)_[1,2,4]-三唑并[i,5_a]嘧啶; 5-曱基-6-(2,5_二氣_4_甲氧基苯基)-7_(3•曱基六氮吼咬-1-基)-[1,2,4]-三唑并[i,5_a]嘧啶; 5甲氧基-6-(2,5_二氟-4-甲氧基苯基)-7-(3 -甲基六氫吡 啶-1·基)-[1,2,4]-三唑并pj-a]嘧啶; 5-氰基-6-(2,5-二氟-4-甲氧基苯基)_7_(3_甲基六氫〇比啶· 1-基)-[1,2,4]-三唾并[i,5_a]嘴 ϋ定; 5-氯-6-(2,5-二氟甲氧基苯基)-7_(氮雜環庚烷“―基)— [1,2,4]二嗤弁_[1,5-&]續咬; 5·甲基-6-(2,5-二氟·4·甲氧基苯基)_7·(氮雜環庚烧+ 基)-[1,2,4]三唑并-[1,5-a]嘧啶; 5-甲氧基邻,5·二氟_4_甲氧基苯基)_7•(氮雜環庚烧小 基)·Π,2,4]三唑并_[i,5-a]嘧啶; 5-氰基蝴-二氟·4·甲氧基苯基+ 118620.doc -30- 200800026 基)-[1,2,4]三唑并-[l,5-a]嘧啶; -5-氯-6-(2,5-二氟-4-曱基苯基)-7-(氮雜環庚烷-1-基)-[1,2,4]三唑并-[l,5-a]嘧啶; -5-曱基-6-(2,5-二氟-4-甲基苯基)-7-(氮雜環庚烷-1-基)-[1,2,4]三唑并-[l,5-a]嘧啶; -5-甲氧基-6-(2,5-二氟-4-曱基苯基)-7-(氮雜環庚烷-1-基Hl,2,4]三唑并-[l,5-a]嘧啶; -5-氰基-6-(2,5-二氟-4-曱基苯基)-7-(氮雜環庚烷-1-基)-[1,2,4]三嗤并-[l,5-a]嘴淀; -5-氯-6-(2,5-二氟-4-甲氧基苯基)-7-(環丙基胺基Hl,2,4] 三ο坐并-[1,5 - a]嘴σ定; -5-曱基-6-(2,5-二氟-4-甲氧基苯基)-7-(環丙基胺基)-[1,2,4]三唑并-[l,5-a]嘧啶; -5-曱氧基-6-(2,5-二氟-4-甲氧基苯基)-7_(環丙基胺基)_ [1,2,4]三唑并-[l,5_a]嘧啶; -5-氰基-6-(2,5-二氟-4-甲氧基苯基)-7-(環丙基胺基)-[1,2,4]三唑并-[l,5-a]嘧啶; -5-氯-6-(2,5-二氟-4-甲基苯基)-7_(環丙基胺基)-[1,2,4]三 嗤并-[1,5-a]^ σ定; -5-甲基-6-(2,5-二氟-4-曱基苯基)-7-(環丙基胺基)-[1,2,4] 三嗤并-[l,5-a]嘴唆; -5-甲氧基-6-(2,5-二氟-4-甲基苯基)-7-(環丙基胺基)-[1,2,4]三唑并-[l,5-a]嘧啶; -5 -氣基- 6- (2,5 -二氣-4 -甲基苯基)-7-(環丙基胺基)-[1,2,4] 118620.doc -31- 200800026 三唑并-[l,5-a]嘧啶; _ 5-氯-6·(2,5-二氟-4-甲氧基苯基)-7-(環己基胺基)-[H4] 三唑并-[l,5-a]嘧啶; -5-甲基-6-(2,5-二氟-4_甲氧基苯基Κ7_(環己基胺基)_ [1,2,4]三唑并-[l,5-a]嘧啶; -5-甲氧基-6-(2,5-二氟-4-甲氧基苯基)-7_c環己基胺基)_ [1,2,4]三嗤并-[l,5_a]嘴咬; -5-氰基-6-(2,5-二氟-4-甲氧基苯基)_7_(環己基胺基)_ [1,2,4]三唑并-[l,5-a]嘧啶; -5 -氣- 6-(2,5-二氟-4 -甲基苯基)-7-(環己基胺基)-[ι,2,4]三 唑并-[l,5-a]嘧啶; -5-甲基-6·(2,5-二氟-4-曱基苯基)-7-(環己基胺基)-[1,2,4] 三嗤并-[1,5-a]鳴唆; -5-甲氧基-6-(2,5-二氟-4-甲基苯基)-7-(環己基胺基)-[1,2,4]三唑并-[1,51]嘧啶; -5-氰基-6-(2,5-二氟-4-曱基苯基)-7-(環己基胺基)_[1,2,4] 三嗤并-[l,5-a]嘴唆; -5-氯-6-(2,5-二氟-4-曱氧基苯基)-7-(環戊基胺基)-[1,2,4] 三σ坐并-[l,5-a]哺咬; -5-甲基-6-(2,5-二氟-4-曱氧基苯基)-7-(環戊基胺基)- [1,2,4]三嗅并-[l,5-a]哺唆; -5-甲氧基-6…(2,5-二氟-4-甲氧基苯基)-7-(環戊基胺基)-[1,2,4]三唑并-[l,5-a]嘧啶; -5-氰基-6-(2,5-二氟-4-甲氧基苯基)-7-(環戊基胺基)- •32- 118620.doc 200800026 [1,2,4]三嗤并-[l,5-a],唆; -5-氯-6-(2,5-二氟-4-甲基苯基)-7-(環戊基胺基Hl,2,4]三 吐并-[l,5-ap密咬; -5-甲基-6-(2,5_二氟-4-甲基苯基)-7_(環戊基胺基 三嗅并-[l,5-a]嘧咬; * - 5-甲氧基-6-(2,5-二氟-4—甲基苯基)-7-(環戊基胺基)- 、 [1,2,4]三嗅并-[l,5-a]«密咬; 5-氰基-6-(2,5-二氟_4_曱基苯基)-7-(環戊基胺基)-[1,2,4] ® 三唑并-[l,5-a]嘧啶; -5-氣-6-(2,5-二氟-4_甲基苯基)-7-(N_(2_曱基丙烯-1-基)-N-乙基-胺基)-[1,2,4]三唑并_[i,5-a]嘧啶; -5-甲基-6-(2,5-二氟-4-甲基苯基)-7-(N-(2-甲基丙烯-1-基)-N-乙基-胺基)_[1,2,4]三唑并- [i,5-a]嘧啶; -5-甲氧基-6-(2,5-二氟_4_甲基苯基甲基丙烯_1β 基)_Ν-乙基·胺基)-[1,2,4]三唑并-[i,5-a]嘧啶; _ - 5_氰基_6-(2,5-二氟I甲基苯基曱基丙烯·卜 基)-N-乙基·胺基)-[i,2,4]三唑并-[i,5-a]嘧啶; -5-氣-6-(2,5_二氟_4_甲氧基苯基>7_(N_(2_曱基丙烯小 基)-N-乙基-胺基)-[1,2,4]三唑并_[i,5-a]嘧啶; ‘ _ 5_甲基_6·(2,5·二氟-4-甲氧基苯基甲基丙烯 基)-Ν-乙基-胺基)-[1,2,4]三唑并-[i,5-a]嘧啶; -5-甲氧基-6-(2,5-二氟-4-甲氧基苯基)_7_(N_(2_甲基丙烯_ 1-基)-1^-乙基胺基)-[152,4]三唑并_[1,54]嘧啶; -5-氰基-6-(2,5-二氟-4_甲氧基苯基兴7-(Ν兴2-曱基丙烯 118620.doc •33- 200800026 基)-N-乙基胺基)-[1,2,4]三唑并-[1,5-&]嘧啶; -5 -氯- 6·(2,5 -二氟-4-曱基苯基)-7-(2,2,2-三氟乙基胺基)_ [1,2,4]三唑并-[l,5-a]嘧啶; -5-甲基-6-(2,5-二敦-4-甲基苯基)-7-(2,2,2-三氟^乙基胺 基)-[1,2,4]三唑并-[l,5-a]嘧啶; ^ - 5·甲氧基-6-(2,5-二氟_4·甲基苯基)-7-(2,2,2-三氟乙基胺 , 基)-[1,2,4]三也并-[l,5-a],淀; -5-氰基-6-(2,5-二氟-4-甲基苯基)-7-(2,2,2-三氟乙基胺 • 基)-[1,2,4]三唑并-[l,5-a]嘧啶; -5-氯-6-(2,5-二氟-4-甲氧基苯基)-7-(2,2,2-三氟乙基胺 基)-[1,2,4]三唑并-[l,5-a]嘧啶; -5_甲基- 6- (2,5 -二氟-4-甲氧基苯基)-7-(2,2,2-二氣乙基胺 基)-[1,2,4]三唑并-[l,5-a]嘧啶; -5 -甲氧基-6-(2,5 -二1-4 -甲氧基苯基)-7-(2,2,2-三I乙基 胺基)-[1,2,4]三唑并-[l,5-a]嘧啶; -5 -氰基- 6-(2,5-二氧-4 -曱氧基苯基)-7-(2,2,2-三氟乙基胺 ^ 基)-[1,2,4]三唑并-[l,5-a]嘧啶; -5 -甲基- 6·(2,5 -二氟^-4-曱氧基苯基)-7-((1,2,2-三甲基丙-, 1-基)胺基)-[1,2,4]三唑并_[l,5-a]嘧啶; , -5-氰基-6-(2,5-二氟_4_曱氧基苯基)-7-((1,2,2-三曱基丙- 1-基)胺基)-[1,2,4]三唑并-[l,5-a]嘧啶; ,-5-甲氧基-6-(2,5-二氟-4-甲氧基苯基)-7-((1,2,2-三甲基 丙-1-基)胺基)_[1,2,4]三唑并-[l,5-a]嘧啶; -5-氯-6-(2,5-二氟-4-甲基苯基)-7_((1,2,2-三甲基丙-1-基) 118620.doc -34- 200800026 胺基Hl,2,4]三唑并-[l,5-a]嘧啶; -5·甲基_6-(2,5-二氟-4-曱基苯基)-7-((l,2,2-三甲基丙-1· 基)胺基)-[1,2,4]三唑并-[l,5-a]嘧啶; -5-氰基-6-(2,5-二氟-4-甲基苯基)-7-((1,2,2-三甲基丙-1-基)胺基)-[1,2,4]三唑并-[l,5-a]嘧啶; -5_曱乳基-6-(2,5 -二氣-4-甲基苯基)-7-((1,2,2-二甲基丙_ • 1_基)胺基)-[1,2,4]三唑并-[l,5-a]嘧啶; -5-氣-6-(2,5-二氟-4-甲基苯基)-7_((1,2,2-三甲基丙-1-基) • 胺基)_[1,2,4]三唑并-[l,5-a]嘧啶; -5-氣-6-(2,5-二氟-4-甲基苯基)-7-(1,2-二甲基丙基胺基)-[1,2,4]三吐并-[l,5-a]喷唆; -5 -甲基-6_(2,5 -二氟-4-甲基苯基)-7-(1,2-二曱基丙基胺 基)-[1,2,4]三唑并-[l,5-a]嘧啶; -5_甲氧基-6_(2,5 -二氟·4_甲基苯基)_7-(1,2-二甲基丙基胺 基)-[1,2,4]三唑并-[l,5-a]嘧啶; -5 -氣基_6-(2,5 -二鼠-4-甲基苯基)-7·(1,2-二甲基丙基胺 基)-[1,2,4]三唑并-[l,5-a]嘧啶; -5 -氣-6- (2,5 -二氣-4-甲氧基苯基)-7-(1,2-二曱基丙基胺 ^ 基)-[1,2,4]三唑并-[l,5-a]嘧啶; . -5-甲基-6-(2,5-二氟-4-甲氧基苯基)-7-(1,2-二甲基丙基胺 基Hl,2,4]三唑并_[l,5-a]嘧啶; -5 -甲氧基-6 - ( 2,5 ·二氣_ 4 -甲氧基苯基)-7 - (1,2 -二曱基丙基 胺基)-[1,2,4]三唑并-[l,5-a]嘧啶; -5-鼠基-6-(2,5-二氣-4-曱氧基苯基)-7-(1,2-二甲基丙基胺 118620.doc -35- 200800026 基)-[1,2,4]三唑并_[l,5-a]嘧啶; -5-氯-6-(2,5-二氟-4-甲基苯基)-7-(1-曱基丙基胺基)-[1,2,4]三唑并-[l,5-a]嘧啶; -5-曱基-6-(2,5-二氟-4-甲基苯基)_7-(1-甲基丙基胺基)-[1,2,4]三唑并-[l,5_a]嘧啶; ' -5-甲氧基-6-(2,5-二氟-4-曱基苯基)-7-(1-曱基丙基胺基)- - [1,2,4]三唑并-[l,5-a]嘧啶; -5-氰基-6-(2,5-二氟-4-曱基苯基)-7-(1-曱基丙基胺基)-• [1,2,4]三唑并-[l,5-a]嘧啶; -5-氯-6-(2,5-二氟-4-甲氧基苯基)-7-(1-曱基丙基胺基)-[1,2,4]三唑并-[l,5-a]嘧啶; -5 -甲基-6- (2,5 -二亂-4-甲乳基苯基)-7-(1-曱基丙基胺基)_ [1,2,4]三唑并-[l,5-a]嘧啶; -5-甲氧基-6·(2,5-二氟-4-甲氧基苯基)-7-(1-甲基丙基胺 基)-[1,2,4]三唑并-[l,5-a]嘧啶; _ - 5-氰基-6-(2,5-二氟-4-甲氧基苯基)-7-(1-曱基丙基胺基)- [1,2,4]三唑并-[l,5-a]嘧啶; -5-氣-6-(2,5-二氣-4-甲基苯基)-7-(2-甲基丙基胺基)_ • [1,2,4]三唑并-[l,5-a]嘧啶; - - 5 -甲基-6 - (2,5 -二氟^ - 4 -甲基苯基)-7-(2-甲基丙基胺基)· [1,2,4]三唑并-[l,5_a]嘧啶; -5 -甲氧基·6-(2,5-二氣-4-甲基苯基)-7 -(2-甲基丙基胺基)-[1,2,4]三唆并-[l,5-a]癌唆; -5-鼠基- 6- (2,5 -二氣-4-甲基苯基)-7-(2-甲基丙基胺基)- 118620.doc •36- 200800026 [1,2,4]二嗤弁-[1,5_&]喊17定; 5-氯-6-(2,5-二氟-4-甲氧基苯基)-7-(2-甲基丙基胺基)- [1,2,4]二唾弁_[1,5_&]喊咬; 5-甲基-6-(2,5-二氟-4-甲氧基苯基)-7_(2_曱基丙基胺基)· [152,4]二唾弁_[1,5_3]癌唆; 5-甲氧基-6-(2,5-二氟-4-甲氧基苯基)_7_(2_甲基丙基胺 基)-[1,2,4]三唑并_[i,5-a]嘧啶; 5-氰基-6-(2,5-二氟-4-甲氧基苯基)_7_(2_甲基丙基胺基)_ [1,2,4]三唾并 _[i,5-a]嘧咬; 5-氯-6-(2,5-二氟-4-甲基苯基)—7-(2,2,3,3,4,4,4-七氟丁基 胺基)-[1,2,4]三唑并_[i,5-a]嘧啶; 5-甲基冬(2,5_二氟-4-甲基苯基氟丁 基胺基)-[1,2,4]三峻并_[i,5-a]哺唆; 5-甲氧基-6_(2,5-二氟_4_甲基苯基七氟 丁基-胺基)-[1,2,4]三唑并_[i,5-a]嘧啶; 5-氰基-6-(2,5_ 二氟-4-甲基苯基)_7_(2,253,3,4,4,4_七氟丁 基胺基)-[1,2,4]三唑并嘧啶; 5-氯冬(2,5-二氟|甲氧基苯基)_7_(2,2,3,3,4,4,4_七氟丁 基-胺基Hl,2,4]三唑并嘧啶; 5-甲基-6-(2,5-二氟 _4_ 甲氧基苯基)7_(2,2,3,3,4,4,4_七氣 丁基-胺基)-[1,2,4]三唑并_[15_a]嘴啶; 5 甲氧基·6-(2,5·二氟 曱氧基苯基)_7·(2,2,3,3,4,4,4-七 敗丁基_胺基)-[1,2,4]三嗤并.[1,5-&]哺咬; 5-氰基冬(2,5-二氟|甲氧基苯基以似^七心七氟 118620.doc -37- 200800026 丁基_胺基)-[1,2,4]三唑并〈na]嘧啶; 及其農業上可接受之鹽。 本發明之化合物可藉由不同途徑獲得。彼等最好藉由式 II之5_月女基二唑與式叩之經適當取代之苯基丙二酸酯(其中 R係烧基、較佳係Cl-C6_燒基、尤佳係甲基或乙基)根據反 應圖1中所顯示之合成途徑反應來製備。 反應圖1 :118620.doc -26 - 200800026 No. R1 R2 A-110 'CH(CH3)(CH2)r A-111 -CH2CH(CH3)(CH2)2- A-112 -ch(ch3mch2)2-ch(ch3)- A-113 -CH(CH3MCH2)4- A-114 -CHrCH(CH3)-(CH2)3- A-115 -(ch2)-ch(ch3)-ch2-ch(c^-^ A-116 -ch (ch2ch3mch2)4- A-117 -(CH2)rN(CH3HCH2)2_ A_118 -N=CH-CH=CH- Α-1Γ9 -N=C(CH3)-CH=C(CH3)- A-120 -N =C(CF3)-CH=C(CF3)- A-121 -(CH2)2CH(CH3)(CH2)2- A-122 -(CH2V Among them, especially the following compounds: -5-gas·6 -(2,5-dioxa-4-methylphenyl)-7-(3-methyl-methylpyrazine-1 -yl)-[1,2,4]triazolo-[l,5- a]pyrimidine; -5-methyl-6-(2,5-disorgano-4-methylphenyl)-7-(3-indolylpyrazine-1 -yl)-[1,2 , 4] triazolo-[l,5-a]pyrimidine; -5-methoxy-6-(2,5-dioxa-4-methylphenyl)-7-(3-indenylpyrazine洛-1.yl)-[1,2,4]triazolo-[l,5-a]pyrimidine; -5 - gasyl-6 - ( 2,5 -digas-4 -methylphenyl ) 7 - ( 3 - fluorenyl ° Biha _ 1 -yl) - [1, 2, 4] triazolo-[l,5-a] pyrimidine; -5-chloro-6-(2,5 -difluoro-4-methoxyphenyl)-7-(3-methylindole-1-yl)-[1,2,4]triazolo-[l,5-a] -5-methyl·6-(2,5-dimorph-4-methoxyphenyl)-7-(3-methyl-11-bito-1-yl)-[1,2,4 Triazolo-[l,5-a]pyrimidine; -5-methoxy-6-(2,5-difluoro-4-methoxyphenyl)-7-(3-methylpyrrolidine- 1-yl)-[1,2,4]triazolo-[l,5-a]pyrimidine; -5-cyano-6-(2,5-difluoro-4-methoxyphenyl)- 7-((3-methylpyrrolidine-1-118620.doc -27- 200800026 base)-[1,2,4]triazolo-[l,5-a]pyrimidine; -5-chloro-6 -(2,5-dioxa-4-methylphenyl)-7-(2-indolyl D ratio 11 唆-1-yl)_[1,2,4]triazolo-[l,5 -a]pyrimidine; -5-methyl-6-(2,5·difluoro-4-mercaptophenyl)-7-(2-decylpyrrolidin-1-yl)-[1,2,4 Triazolo-[l,5-a]pyrimidine; ^ -5-methoxy-6-(2,5-difluoro-4-methylphenyl)-7-(2-methylpyrrolidine- 1-(yl)-[1,2,4]triazolo-[l,5-a]pyrimidine; -5-carbyl-6-(2,5-di-gas-4-methylphenyl)- 7 - (2-methyl-pyrrolidine-1 -yl)_ • [1,2,4]triazolo-[l,5-a]pyrimidine; -5 -gas-6 - ( 2,5 -digas-4-methoxyphenyl)· 7 - (2-methyl-11 嘻σ定-1 -yl)~ [1,2,4]triazolo-[l,5-a]pyrimidine ; -5-A -6-(2,5-dioxa-4-methoxyphenyl)-7·(2-methyl 11 ratio leptin-1 ·yl)-[1,2,4]triazolo-[l , 5-a]pyrimidine; -5-methoxy-6-(2,5-difluoro-4-methoxyphenyl)-7-(2-methylpyrrolidin-1-yl)-[1 , 2,4]triazolo-[l,5-a]pyrimidine; - 5-carbyl-6-(2,5-disorder-4-methyllacylphenyl)-7-(2-methyl σ 唆 唆 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -7-(2-methylhexaza σ-pyridin-1-yl)_*[1,2,4]-triazolo[l,5-a]pyrimidine; =-5-mercapto-6 -(2,5-difluoro-4-indolylphenyl)-7-(2-mercaptohexahydropyridin-1-yl)-[1,2,4]-triazolo[l,5-a Pyrimidine; -5-methoxy-6-(2,5-dioxa-4-methylphenyl)-7-(2-methylhexanitrogen 0 to bite-1-yl)-[1,2 , 4]-triazolo[l,5-a]pyrimidine; -5-murine-6-(2,5-disorder-4-methylphenyl)-7-(2-mercapto-6) Ratio °-1 - 118620.doc -28- 200800026 base)-[1,2,4]-two tons and [i,5_a] mouth bite; 5-chloro-6-(2,5-di 14-A Oxyl stupyl): (2-methylhexaazepine than biting small base)-[1,2,4]-dijunz[ΐ35-α]ρ^σ定; 5曱基-6-(2, 5-fluoro-4-methoxy Stupid)_7_(2_decylhexahydroacridine-1-yl)-[1,2,4]-triazolo[l55_a]pyrimidine; 5·decyloxy-6-(2,5-difluoro +methoxyphenyl)-7-(2-methylhexahydroperylation than biting small group Hl,2,4]-tris-[a55-a], pyridine; 5 cyano 6-(2,5-fluoro 4-methoxyphenyl)_7·(2_decylpiperidine-1-yl)-[1,2,4]-triazolo[i,5-a]pyrimidine; -5-chloro-6- (2,5·difluoro-4-methylphenyl)_7_(4-methylhexahydroindolepyridinyl)-[1,2,4]-triazolo[l,5_a]pyrimidine ; -5-mercapto-6-(2,5-difluoro-cardiomethylphenyl)indole_(heart methyl hexaazide mouth bite small base)-[1,2,4]-diindole , -5-methoxy-6_(2,5-difluoro_4.methylphenyl)_7_(indenyl hexahydro ton 唆 1-yl)-[1,2,4]_ triterpene ·, -5-Cyano-6-(2,5-difluoro_4-methylphenyl)_7-(4-methylhexahydrotoxin)-[1,2,4]-dioxin And [1,5-a]^!!定·, _ 5_chloro-6_(2,5-difluoro_4-methoxyphenyl)-7-(4-methylhexahydropyridine-1 - Base)-[1,2,4]-triwax[i,5_a]pyrimidine; _ 5-methyl-6-(2,5-difluoro_4-methoxyphenyl)_7_(4_ Methylhexahydropyridine_1-yl Hl,2,4]-tris-[l55_a]pyrimidine; _ 5-methoxy-6-(2,5 _二就_4·曱oxyphenyl)_7_(4·methylhexahydrotoxin-1-yl)-[1,2,4]_three-salt, %^piperidine; -5-cyanide Base-6-(2,5-difluoro_4-methoxyphenyl)_7_(4-fluorenylhexahydro. Bipyridine _ 118620.doc -29- 200800026 1-yl)-[1,2,4]-triazolopyrimidine; 5H(2'5_H methyl phenyl)_7·(3-methylhexahydro ton bite- 1-Base)-[1,2,4]-Sanjun and [1,5_&]. 5-methyl-6-(2,5-difluoro, 4-review, methyl-based)-7-(3-methylhexahydro. than bite-l-ylyl X1,2,4]-three Azolo[l,5-a]pyrimidine; 5methoxy-6-(2,5-one-failed {methylphenyl) can 7 "3_methylhexaazepine bit _ 1-yl)-[1 , 2,4]-triazolo[l55_a] 啸 ;; 5-cyano-6-(2,5_bisκmethylphenyl)_7_(3-methylhexahydro. 1,2,4]-triazolo[l55_a]pyrimidine; 5-disorder-6-(2,5-difluoro-4-hydroxyphenyl)_7_(3-methylhexahydro 11-pyridine small base )_[1,2,4]-triazolo[i,5_a]pyrimidine; 5-mercapto-6-(2,5_diox_4-methoxyphenyl)-7_(3•fluorenyl) Hexazapine-1-yl)-[1,2,4]-triazolo[i,5-a]pyrimidine; 5methoxy-6-(2,5-difluoro-4-methoxyphenyl) - 7-(3-methylhexahydropyridin-1yl)-[1,2,4]-triazolo-pj-a]pyrimidine; 5-cyano-6-(2,5-difluoro- 4-methoxyphenyl)_7_(3-methylhexahydropyridinium-1-yl)-[1,2,4]-tris-[i,5_a] oxime; 5-chloro-6 -(2,5-difluoromethoxyphenyl)-7-(azepane "-yl)-[1,2,4]dioxin_[1,5-&] continued bite; ·Methyl-6-(2,5-difluoro.4.methoxyphenyl)_7·(nitrogen heterocycle Calcined + yl)-[1,2,4]triazolo-[1,5-a]pyrimidine; 5-methoxy-o-,5-difluoro-4-yloxyphenyl)_7•(aza Cycloheptane-based small base)·Π, 2,4]triazolo-[i,5-a]pyrimidine; 5-cyanopterin-difluoro·4·methoxyphenyl+ 118620.doc -30- 200800026 -[1,2,4]triazolo-[l,5-a]pyrimidine; -5-chloro-6-(2,5-difluoro-4-indolylphenyl)-7-(nitrogen Heterocyclic heptane-1-yl)-[1,2,4]triazolo-[l,5-a]pyrimidine; -5-mercapto-6-(2,5-difluoro-4-methyl Phenyl)-7-(azepan-1-yl)-[1,2,4]triazolo-[l,5-a]pyrimidine; -5-methoxy-6-(2, 5-difluoro-4-indolylphenyl)-7-(azepan-1-ylHl,2,4]triazolo-[l,5-a]pyrimidine; -5-cyano- 6-(2,5-difluoro-4-mercaptophenyl)-7-(azepan-1-yl)-[1,2,4]triindolo-[l,5-a] Mouth; 5-5-chloro-6-(2,5-difluoro-4-methoxyphenyl)-7-(cyclopropylamino Hl,2,4] three-seat-[1,5 - a] mouth σ set; -5-mercapto-6-(2,5-difluoro-4-methoxyphenyl)-7-(cyclopropylamino)-[1,2,4] three Zydro-[l,5-a]pyrimidine; -5-decyloxy-6-(2,5-difluoro-4-methoxyphenyl)-7-(cyclopropylamino)_ [1, 2,4]three And -[l,5_a]pyrimidine; -5-cyano-6-(2,5-difluoro-4-methoxyphenyl)-7-(cyclopropylamino)-[1,2,4 Triazolo-[l,5-a]pyrimidine; -5-chloro-6-(2,5-difluoro-4-methylphenyl)-7-(cyclopropylamino)-[1,2 , 4]trim-[1,5-a]^ sigma; -5-methyl-6-(2,5-difluoro-4-mercaptophenyl)-7-(cyclopropylamino )-[1,2,4] triterpenoid-[l,5-a] oxime; -5-methoxy-6-(2,5-difluoro-4-methylphenyl)-7- (cyclopropylamino)-[1,2,4]triazolo-[l,5-a]pyrimidine; -5-carbyl-6-(2,5-di-gas-4-methylphenyl )-7-(cyclopropylamino)-[1,2,4] 118620.doc -31- 200800026 Triazolo-[l,5-a]pyrimidine; _ 5-chloro-6·(2,5 -difluoro-4-methoxyphenyl)-7-(cyclohexylamino)-[H4]triazolo-[l,5-a]pyrimidine; -5-methyl-6-(2,5 -difluoro-4_methoxyphenylindole 7_(cyclohexylamino)-[1,2,4]triazolo-[l,5-a]pyrimidine; -5-methoxy-6-(2 ,5-difluoro-4-methoxyphenyl)-7_ccyclohexylamino)_[1,2,4]triazino-[l,5_a] mouth bite; -5-cyano-6-( 2,5-difluoro-4-methoxyphenyl)_7_(cyclohexylamino)_[1,2,4]triazolo-[l,5-a]pyrimidine; -5 - gas - 6-(2,5-difluoro-4-methylphenyl)-7-(cyclohexylamino)-[ι,2,4]triazolo-[l,5-a]pyrimidine; -5 -Methyl-6·(2,5-difluoro-4-mercaptophenyl)-7-(cyclohexylamino)-[1,2,4]triazino-[1,5-a] 5; -5-methoxy-6-(2,5-difluoro-4-methylphenyl)-7-(cyclohexylamino)-[1,2,4]triazolo-[1, 51]pyrimidine; -5-cyano-6-(2,5-difluoro-4-indolylphenyl)-7-(cyclohexylamino)-[1,2,4]triindole-[l , 5-a] 唆 唆; -5-chloro-6-(2,5-difluoro-4-methoxyphenyl)-7-(cyclopentylamino)-[1,2,4] σ sits and -[l,5-a] bites; -5-methyl-6-(2,5-difluoro-4-methoxyphenyl)-7-(cyclopentylamino)-[ 1,2,4]trisole-[l,5-a] feeding; -5-methoxy-6...(2,5-difluoro-4-methoxyphenyl)-7-(cyclic Amylamino)-[1,2,4]triazolo-[l,5-a]pyrimidine; -5-cyano-6-(2,5-difluoro-4-methoxyphenyl) -7-(cyclopentylamino)- •32- 118620.doc 200800026 [1,2,4]trim-[l,5-a], hydrazine; -5-chloro-6-(2,5 -difluoro-4-methylphenyl)-7-(cyclopentylamino H1,2,4]trin-[l,5-ap-bite; -5-methyl-6-(2, 5_difluoro-4-methylphenyl)-7 _(cyclopentylaminotrienol-[l,5-a]pyrimidine; *- 5-methoxy-6-(2,5-difluoro-4-methylphenyl)-7-( Cyclopentylamino)-, [1,2,4]trisole-[l,5-a]«-bite; 5-cyano-6-(2,5-difluoro-4-indolylbenzene -7-(cyclopentylamino)-[1,2,4] ® triazolo-[l,5-a]pyrimidine; -5-gas-6-(2,5-difluoro-4 _Methylphenyl)-7-(N_(2-mercaptopropen-1-yl)-N-ethyl-amino)-[1,2,4]triazolo-[i,5-a] Pyrimidine; 5-methyl-6-(2,5-difluoro-4-methylphenyl)-7-(N-(2-methylpropen-1-yl)-N-ethyl-amino )_[1,2,4]triazolo-[i,5-a]pyrimidine; -5-methoxy-6-(2,5-difluoro_4-methylphenylmethylpropene_1β ())-ethyl-amino)-[1,2,4]triazolo-[i,5-a]pyrimidine; _-5-cyano-6-(2,5-difluoro-I methyl Phenylmercaptopropene·buki)-N-ethyl-amino)-[i,2,4]triazolo-[i,5-a]pyrimidine; -5-gas-6-(2,5 _Difluoro_4_methoxyphenyl>7_(N_(2_mercaptopropenyl)-N-ethyl-amino)-[1,2,4]triazolo-[i,5 -a]pyrimidine; ' _ 5_methyl_6·(2,5·difluoro-4-methoxyphenylmethacryloyl)-oxime-ethyl-amino)-[1,2,4 ] Zyrazolo-[i,5-a]pyrimidine; -5-methoxy-6-(2,5-difluoro-4-methoxyphenyl)_7_(N_(2-methacryl-1-yl) -1^-ethylamino)-[152,4]triazolo-[1,54]pyrimidine; -5-cyano-6-(2,5-difluoro-4-methoxyphenyl) Xing 7-(Ν兴2-曱-based propylene 118620.doc •33- 200800026 base)-N-ethylamino)-[1,2,4]triazolo-[1,5-&]pyrimidine; -5-Chloro-6 (2,5-difluoro-4-mercaptophenyl)-7-(2,2,2-trifluoroethylamino)-[1,2,4]triazole -[l,5-a]pyrimidine; -5-methyl-6-(2,5-ditun-4-methylphenyl)-7-(2,2,2-trifluoroethylamino) )-[1,2,4]triazolo-[l,5-a]pyrimidine; ^ - 5·methoxy-6-(2,5-difluoro_4·methylphenyl)-7- (2,2,2-trifluoroethylamine, yl)-[1,2,4]tris-[l,5-a], decidyl; -5-cyano-6-(2,5- Difluoro-4-methylphenyl)-7-(2,2,2-trifluoroethylamine•yl)-[1,2,4]triazolo-[l,5-a]pyrimidine; 5-Chloro-6-(2,5-difluoro-4-methoxyphenyl)-7-(2,2,2-trifluoroethylamino)-[1,2,4]triazole -[l,5-a]pyrimidine; -5-methyl-6-(2,5-difluoro-4-methoxyphenyl)-7-(2,2,2-dioxaethylamino )-[1,2,4]triazolo-[l,5- a]pyrimidine; -5-methoxy-6-(2,5-di1-4-methoxyphenyl)-7-(2,2,2-tri-Iethylamino)-[1, 2,4]triazolo-[l,5-a]pyrimidine; -5-cyano-6-(2,5-dioxo-4-oxooxyphenyl)-7-(2,2,2 -trifluoroethylamine)-[1,2,4]triazolo-[l,5-a]pyrimidine; -5-methyl- 6·(2,5-difluoro^-4-曱Oxyphenyl)-7-((1,2,2-trimethylpropan-, 1-yl)amino)-[1,2,4]triazolo-[l,5-a]pyrimidine; , -5-Cyano-6-(2,5-difluoro-4-yloxyphenyl)-7-((1,2,2-tridecylprop-1-yl)amino)-[ 1,2,4]triazolo-[l,5-a]pyrimidine; ,-5-methoxy-6-(2,5-difluoro-4-methoxyphenyl)-7-(( 1,2,2-trimethylpropan-1-yl)amino)-[1,2,4]triazolo-[l,5-a]pyrimidine; -5-chloro-6-(2,5 -difluoro-4-methylphenyl)-7-((1,2,2-trimethylprop-1-yl) 118620.doc -34- 200800026 Amino-Hl,2,4]triazolo-[ l,5-a]pyrimidine; -5·methyl_6-(2,5-difluoro-4-mercaptophenyl)-7-((l,2,2-trimethylpropan-1·yl) Amino)-[1,2,4]triazolo-[l,5-a]pyrimidine; -5-cyano-6-(2,5-difluoro-4-methylphenyl)-7 -((1,2,2-trimethylprop-1-yl) Amino)-[1,2,4]triazolo-[l,5-a]pyrimidine; -5_曱lactyl-6-(2,5-dioxa-4-methylphenyl)-7 -((1,2,2-dimethylpropan-1-yl)amino)-[1,2,4]triazolo-[l,5-a]pyrimidine; -5-gas-6- (2,5-Difluoro-4-methylphenyl)-7-((1,2,2-trimethylprop-1-yl)•amino)_[1,2,4]triazolo- [l,5-a]pyrimidine; -5-gas-6-(2,5-difluoro-4-methylphenyl)-7-(1,2-dimethylpropylamino)-[1 , 2,4] triple spitting-[l,5-a] sneezing; -5-methyl-6_(2,5-difluoro-4-methylphenyl)-7-(1,2-di Mercaptopropylamino)-[1,2,4]triazolo-[l,5-a]pyrimidine; -5-methoxy-6-(2,5-difluoro-4-ylphenyl) )_7-(1,2-dimethylpropylamino)-[1,2,4]triazolo-[l,5-a]pyrimidine; -5 - gas group _6-(2,5 - Dimethyl-4-methylphenyl)-7·(1,2-dimethylpropylamino)-[1,2,4]triazolo-[l,5-a]pyrimidine; -5 - Gas-6-(2,5-dioxa-4-methoxyphenyl)-7-(1,2-dimercaptopropylamine)-[1,2,4]triazolo-[ l,5-a]pyrimidine; -5-methyl-6-(2,5-difluoro-4-methoxyphenyl)-7-(1,2-dimethylpropylamino H1, 2,4]triazolo-[l,5-a]pyrimidine -5-methoxy-6 - ( 2,5 · di- gas - 4 -methoxyphenyl)-7 - (1,2-dimercaptopropylamino)-[1,2,4 Triazolo-[l,5-a]pyrimidine; -5-murine-6-(2,5-diox-4-methoxyphenyl)-7-(1,2-dimethylpropane Base amine 118620.doc -35- 200800026 base)-[1,2,4]triazolo-[l,5-a]pyrimidine; -5-chloro-6-(2,5-difluoro-4-methyl Phenyl)-7-(1-mercaptopropylamino)-[1,2,4]triazolo-[l,5-a]pyrimidine; -5-mercapto-6-(2,5 -difluoro-4-methylphenyl)_7-(1-methylpropylamino)-[1,2,4]triazolo-[l,5-a]pyrimidine; '-5-methoxy- 6-(2,5-Difluoro-4-mercaptophenyl)-7-(1-mercaptopropylamino)-[1,2,4]triazolo-[l,5-a] Pyrimidine; -5-cyano-6-(2,5-difluoro-4-indolylphenyl)-7-(1-mercaptopropylamino)-•[1,2,4]triazole -[l,5-a]pyrimidine; -5-chloro-6-(2,5-difluoro-4-methoxyphenyl)-7-(1-mercaptopropylamino)-[1, 2,4]triazolo-[l,5-a]pyrimidine; -5-methyl-6-(2,5-disorder-4-methyllacylphenyl)-7-(1-mercaptopropyl Amino))-[1,2,4]triazolo-[l,5-a]pyrimidine; -5-methoxy-6.(2,5-difluoro-4-methoxyphenyl) -7-(1- Propylamino)-[1,2,4]triazolo-[l,5-a]pyrimidine; _-5-cyano-6-(2,5-difluoro-4-methoxybenzene -7-(1-mercaptopropylamino)-[1,2,4]triazolo-[l,5-a]pyrimidine; -5-gas-6-(2,5-digas 4-methylphenyl)-7-(2-methylpropylamino)_ • [1,2,4]triazolo-[l,5-a]pyrimidine; --5-methyl- 6 - (2,5-difluoro^-4-methylphenyl)-7-(2-methylpropylamino)·[1,2,4]triazolo-[l,5-a]pyrimidine; -5-methoxy·6-(2,5-dioxa-4-methylphenyl)-7-(2-methylpropylamino)-[1,2,4]triindole-[ l,5-a]carcinoma; -5-murine- 6-(2,5-dioxa-4-methylphenyl)-7-(2-methylpropylamino)- 118620.doc • 36- 200800026 [1,2,4]二嗤弁-[1,5_&] shouting 17; 5-chloro-6-(2,5-difluoro-4-methoxyphenyl)-7-( 2-methylpropylamino)-[1,2,4]dipyridinium_[1,5_&] shouting; 5-methyl-6-(2,5-difluoro-4-methoxy Phenyl)-7_(2_mercaptopropylamino)· [152,4]dipyridinium_[1,5_3]carcinoma; 5-methoxy-6-(2,5-difluoro-4 -methoxyphenyl)_7_(2-methylpropylamino)-[1,2,4]triazolo-[i,5-a]pyrimidine; 5- Cyano-6-(2,5-difluoro-4-methoxyphenyl)_7_(2-methylpropylamino)_[1,2,4]tris-[i,5-a Pyrimidine; 5-chloro-6-(2,5-difluoro-4-methylphenyl)-7-(2,2,3,3,4,4,4-heptafluorobutylamino) -[1,2,4]triazolo-[i,5-a]pyrimidine; 5-methyl winter (2,5-difluoro-4-methylphenylfluorobutylamino)-[1, 2,4]三峻和_[i,5-a] feeding; 5-methoxy-6_(2,5-difluoro_4_methylphenylheptafluorobutyl-amino)-[1 , 2,4]triazolo-[i,5-a]pyrimidine; 5-cyano-6-(2,5-difluoro-4-methylphenyl)_7_(2,253,3,4,4,4 _heptafluorobutylamino)-[1,2,4]triazolopyrimidine; 5-chlorobutyl (2,5-difluoro |methoxyphenyl)_7_(2,2,3,3,4 , 4,4_heptafluorobutyl-amino Hl,2,4]triazolopyrimidine; 5-methyl-6-(2,5-difluoro_4_methoxyphenyl)7_(2,2 ,3,3,4,4,4_heptabutyl-amino)-[1,2,4]triazolo-[15_a]-nosine; 5 methoxy·6-(2,5·2 Fluoromethoxyphenyl)_7·(2,2,3,3,4,4,4-heptabutyl-amino)-[1,2,4]triterpene.[1,5-& ;]Nursing; 5-cyano winter (2,5-difluoro | methoxyphenyl to resemble seven-hearted heptafluoro 118620.doc -37- 200800026 butyl-amino group)-[1,2,4 ] Triazolo[na]pyrimidine; and agriculturally acceptable salts thereof. The compounds of the invention can be obtained by different routes. Preferably, they are suitably substituted with a phenylmalonate of the formula 5-a-female oxadiazole and a hydrazine of the formula (wherein R is a calcinyl group, preferably a Cl-C6_alkyl group, a particularly preferred system). Methyl or ethyl) is prepared according to the synthetic route reaction shown in Figure 1. Reaction Figure 1:
在反應圖1中,R1、R2、L1、L2係如上定義。Hal係鹵 素,尤其係氯且R係烷基,較佳係^弋。烷基。胺基三唑π 與經取代之苯基丙二酸S旨ΠΙ之反應通常在介於go。(3至250 °C間、較佳自120°C至180°C之溫度下於無溶劑情況下或於 一惰性有機溶劑中於一鹼存在下[參照歐洲專利第A 770 615]或於乙酸存在下於自Adv· Het· Chem. 57,p. 81 ff. 118620.doc -38- 200800026 (I"3)已知之蜂件下實施。 適宜的溶劑係脂族烴、芳族烴(例如,曱苯、鄰-、間-及 對-二曱苯)、鹵化烴、醚、腈、酮、醇以及义甲基吡咯啶 酮、二甲基亞砜、二曱基曱醯胺及二甲基乙醯胺。尤佳 地’該反應係在無溶劑之情況下或於氯苯、二甲苯、二甲 基亞硪或N-甲基吡咯啶酮中實施。亦可能使用所述溶劑之 混合物。 概言之,適宜的鹼係無機化合物,例如鹼金屬及鹼土金 屬氫氧化物、驗金屬及驗土金屬氧化物、驗金屬及驗土金 屬氫化物、驗金屬胺化物、鹼金屬及鹼土金屬碳酸鹽以及 驗金屬碳酸氫鹽,有機金屬化合物,具體而言係鹼金屬烷 基化物、烧基鎮鹵化物以及鹼金屬及鹼土金屬烷氧化物及 二曱氧基鎮;亦可為有機鹼,例如,三級胺,如三曱基 胺、三乙胺、二異丙基乙基胺、三丁基胺及凡_甲基六氫吡 啶、N-甲基嗎啉、吡啶、經取代吡啶(例如:三甲基吡啶 (collidine)、二曱基π比π定(iutidine)及4_二甲基胺基吼咬)以 及雙環胺類。特別佳的情形為使用三級胺,例如二異丙基 乙基胺、三丁基胺、N-曱基嗎啉或N_甲基六氫吡啶。 該等鹼通常係以催化量使用;然而,其亦可以等莫耳 量、過量使用或(若適合)作為溶劑使用。 該等起始材料通常彼此以等莫耳量反應。在產率方面, 較佳可使用以二嗤為基準計之過量鹼及丙二酸酯m。 式III之苯基丙二酸酯較佳自經適當取代之溴苯與二烷基 丙一酸醋於Cu(I)催化下[參照chemistry Letters (1981),第 118620.doc -39- 200800026 367-370頁;歐洲專利第A i㈣2m號]之反應獲得。 式IV及V之化合物為新穎且亦構成本申請案標的物之一 部分。 隨後用有機化學之標準方法(例如自w〇_A 94/2〇5〇1已知 之條件)將式IV之二經基三唾并•轉化成式v之二^代三 唑并嘧啶’其中Hal係鹵素原子,較佳係溴原子或氯原 子,尤佳係氣原子。所用_化劑[HAL]較佳係一氣化劑或 一溴化劑(例如磷醯溴或磷醯氯)(若適合)於一溶劑存在下 使用。該反應通常在(^至^❹它下,較佳在80。0至125。〇 下[參區人洲專利第a 7 7 〇 615 ]實施。 然後使式v之二卤代三唑并嘧啶進一步與式VI之胺(其中 R及R係如式1中所定義)反應,得到式VII之5-鹵素-三唑 并嘧啶。化合物VII對應於其中χ=鹵素之式以匕合物。 車又為有利的是v與VI之此反應在〇它至7〇它下、較佳在 1 〇 C至3 5 c:下、較佳於一情性溶劑(例如醚,例如二氧雜 一 一乙喊或尤其四氫吱喃;_化烴,例如二氯甲 烷’或芳族烴’例如曱苯)存在下[參照W〇-A 98/46608] 實施。 較佳者係使用一鹼(例如三級胺,例如三乙胺; ^ 4\\\ 機驗’例如碳酸鉀);亦可將式VI之過量胺用作鹼。 其中X係氰基、CKCV烷氧基或Cl_C2_鹵代烷氧基之 化合物可以一較佳方式藉由使其中X係鹵素、較佳係氯之 式I化合物與化合物Μ_χ,(式VIII)反應來獲得。依據待引入 基團X’之含義,化合物VIII係無機氰化物、烷氧化物或鹵 118620.doc 200800026 代烧氧化物。該反應較佳於一惰性、、突γ | 丨月r生/谷劑存在下實施。式 VIII中陽離子Μ不重要;出於實際月 只丨不原因,銨、四烷基銨或 驗金屬或驗土金屬鹽通常較佳。 l(x=鹵素) + M-Xf 〜^^ VIII '(χ = χ,) 反應溫度通常係自0°C至UOt:,較佳自1(rCi4(rc [參 見厂《^61*〇(^〇1.(:1^111.,第12卷,第861至 863 頁(1975)]。In the reaction scheme 1, R1, R2, L1, and L2 are as defined above. Hal Halogens, especially chlorine and R alkyl groups, are preferred. alkyl. The reaction of the aminotriazole π with the substituted phenylmalonic acid S is usually between go. (between 3 to 250 ° C, preferably from 120 ° C to 180 ° C in the absence of solvent or in the presence of a base in an inert organic solvent [see European Patent No. A 770 615] or in acetic acid In the presence of a bee member known from Adv. Het. Chem. 57, p. 81 ff. 118620. doc-38-200800026 (I" 3) Suitable solvents are aliphatic hydrocarbons, aromatic hydrocarbons (for example, Benzene, o-, m- and p-biphenyl), halogenated hydrocarbons, ethers, nitriles, ketones, alcohols, and methylpyrrolidone, dimethyl sulfoxide, dimethyl decyl amide and dimethyl Acetamide. More preferably, the reaction is carried out in the absence of a solvent or in chlorobenzene, xylene, dimethylhydrazine or N-methylpyrrolidone. It is also possible to use a mixture of such solvents. In summary, suitable base inorganic compounds, such as alkali metal and alkaline earth metal hydroxides, metal and soil metal oxides, metal and soil metal hydrides, metal amines, alkali metals and alkaline earth metal carbonates Salt and metal hydrogencarbonate, organometallic compounds, in particular alkali metal alkylates, alkyl halides And an alkali metal and an alkaline earth metal alkoxide and a dimethoxy group; or an organic base, for example, a tertiary amine such as tridecylamine, triethylamine, diisopropylethylamine, tributylamine And _methylhexahydropyridine, N-methylmorpholine, pyridine, substituted pyridine (for example: collidine, dimercapto π ratio iutidine and 4 dimethylamino group Bite) and bicyclic amines. Particularly preferred is the use of tertiary amines such as diisopropylethylamine, tributylamine, N-mercaptomorpholine or N-methylhexahydropyridine. It is usually used in a catalytic amount; however, it can also be used in molar amounts, in excess or, if appropriate, as a solvent. The starting materials are usually reacted with each other in molar excess. Excess base and malonate m based on diterpenes are used. The phenylmalonate of formula III is preferably catalyzed by Cu(I) by appropriately substituted bromobenzene and dialkyl propionate [Refer to chemistry Letters (1981), pp. 118620.doc-39-200800026 pp. 367-370; European Patent No. A i(4) 2m]. Obtained by Formula IV and V The composition is novel and also forms part of the subject matter of the present application. Subsequent to the standard method of organic chemistry (for example, the conditions known from w〇_A 94/2〇5〇1) • Conversion to a di-azolopyrimidine of the formula v wherein Hal is a halogen atom, preferably a bromine atom or a chlorine atom, particularly preferably a gas atom. The _chemical agent [HAL] used is preferably a gasifying agent or a A brominating agent (e.g., phosphonium bromide or phosphonium chloride), if appropriate, is used in the presence of a solvent. The reaction is usually carried out under conditions of from 0. 0 to 125. 〇 [Shenfang Renzhou Patent No. 7 7 〇 615] was implemented. The dihalotriazolopyrimidine of formula v is then further reacted with an amine of formula VI wherein R and R are as defined in formula 1 to provide a 5-halo-triazolopyrimidine of formula VII. Compound VII corresponds to a ruthenium wherein χ = halogen. It is also advantageous for the vehicle to react with v and VI at a temperature of from 7 〇C to 3 5 c: preferably from an inert solvent (e.g., an ether such as dioxa In the presence of a fluorinated or especially tetrahydrofuran; a hydrocarbon such as methylene chloride or an aromatic hydrocarbon such as toluene (refer to W〇-A 98/46608). Preferably, a base (e.g., a tertiary amine such as triethylamine; ^4\\\ machine test, such as potassium carbonate) is used; an excess of the amine of formula VI can also be used as the base. The compound wherein X is a cyano group, a CKCV alkoxy group or a Cl_C2_haloalkoxy group can be obtained in a preferred manner by reacting a compound of the formula I wherein X is a halogen, preferably a chlorine group, with the compound Μ_χ, (Formula VIII). . Depending on the group X' to be introduced, the compound VIII is an inorganic cyanide, alkoxide or a halogen 118620.doc 200800026 a burned oxide. The reaction is preferably carried out in the presence of an inert, gamma | 丨月r raw/troreal. The cation enthalpy in formula VIII is not critical; ammonium, tetraalkylammonium or metal or soil metal salts are generally preferred for practical reasons. l(x=halogen) + M-Xf~^^ VIII '(χ = χ,) The reaction temperature is usually from 0 °C to UOt:, preferably from 1 (rCi4(rc [see factory "^61*〇( ^〇1.(:1^111., Vol. 12, pp. 861-863 (1975)].
適宜溶劑包含醚(例如二氧雜環己烷、二乙醚及較佳四 氫吱喃)、ώ化煙(例如一氣甲烧)及芳族烴(例如曱苯)。 其中乂係^^4-烧基之式I化合物可以一較佳方式藉由以 下合成途徑獲得: 反應圖2Suitable solvents include ethers (e.g., dioxane, diethyl ether, and preferably tetrahydrofuran), sulphuric acid (e.g., monomethyl) and aromatic hydrocarbons (e.g., toluene). The compound of the formula I wherein the oxime system is substituted can be obtained in a preferred manner by the following synthesis route:
在反應圖2中’ R1、R、L1、L2係如上定義。Hai係鹵 素、尤其氣’ R係烧基、較佳Ci_C6_燒基。以顏|醋iiia起 始’獲得5-烧基-7-經基-6-苯基三嗤并哺咬iva。在式Hia 及IVa中’ X1係Ci-C4·炫基或Ci-CV鹵代燒基。藉由使用可 谷易獲得之之2 -苯基乙酿乙酸醋(Ilia其中辞得5 118620.doc -41 - 200800026 甲基-7-羥基_6_苯基三唑并嘧啶[參照Chem. pharm. Bull.,9, 8〇1 (1961)]。起始化合物ma較佳於歐洲專利第a 10 02 788號中所述條件下製備。 所得5-烷基-7-羥基-6-苯基三唑并嘧啶iva於上文進一步 闊述之條件下與鹵化劑[HAL]反應,得到式%之7_鹵代三 嗤并鳴啶。較佳者係使用氯化劑或溴化劑,例如磷醯溴、 碟酿氯、亞硫醯氯、亞硫醯溴或磺醯氯。該反應可以純淨 形式或於一溶劑存在下實施。習用反應溫度係〇〇c至l5〇〇c 或較佳自80°C至25°C。In the reaction scheme 2, 'R1, R, L1, and L2 are as defined above. The Hai is a halogen, especially a gas 'R-based alkyl group, preferably a Ci_C6_alkyl group. Starting with 颜| vinegar iiia, '5-alkyl-7-ylamino-6-phenyl triterpene was obtained and iva was taken. In the formulas Hia and IVa, 'X1 is a Ci-C4·Hyun group or a Ci-CV halogenated group. Acetic acid vinegar obtained by the use of Keqi Yi (Ilia which resigned 5 118620.doc -41 - 200800026 methyl-7-hydroxy_6_phenyltriazolopyrimidine [Ref. Chem. pharm Bull., 9, 8〇1 (1961)] The starting compound ma is preferably prepared under the conditions described in European Patent No. a 10 02 788. The resulting 5-alkyl-7-hydroxy-6-phenyl group The triazolopyrimidine iva is reacted with a halogenating agent [HAL] under the conditions described above to obtain a 7-halogenated tris-hydrazine and a pyridine. Preferably, a chlorinating agent or a brominating agent is used, for example. Phosphonium bromide, disc brewing chlorine, sulfoxide chlorine, sulfinium bromide or sulfonium chloride. The reaction can be carried out in pure form or in the presence of a solvent. The conventional reaction temperature is 〇〇c to l5〇〇c or preferably. From 80 ° C to 25 ° C.
Va與胺VI之反應係於上文進一步所述之條件下實施。 式IVa及Va化合物較新穎且亦構成本申請案標的物之一 部分。 或者’其中又係(:1-(:4-烷基之式I化合物亦可自其中X尤 其係氣之化合物VII及式IX之丙二酸酯製備。在式IX中, X”係氫或CrCy烷基且R係烷基。彼等反應可得到式X化合 物且經脫羧得到化合物I[參照美國專利第5,994,360號]。 反應圖3 :The reaction of Va with amine VI is carried out under conditions as further described above. The compounds of the formulae IVa and Va are relatively novel and also form part of the subject matter of this application. Or 'wherein (: 1-(4-alkyl compound of formula I can also be prepared from compound VII wherein X is especially gaseous and malonate of formula IX. In formula IX, X" is hydrogen or CrCy alkyl and R are alkyl. These reactions give compounds of formula X and are decarboxylated to give compound I [see U.S. Patent No. 5,994,360].
Δ/Η+ X 在反應圖3中Δ / Η + X in the reaction diagram 3
Ri 、 R2 、 L1 I (X=C 1 -C焼基) L2係如上定義。R係烷基, 較佳Ci-CV烷基。丙二酸酯(IX)可自參考文獻[J· Am· Chem· 118620.doc -42- 200800026Ri, R2, L1 I (X=C 1 -C焼) L2 is as defined above. R is an alkyl group, preferably a Ci-CV alkyl group. Malonate (IX) is available from the reference [J· Am·Chem· 118620.doc -42- 200800026
Soc. 64 (1942) ?714 · τ ^ ^ , ,J· 0rg· Chem. 39 (1974),2172; Helv·Soc. 64 (1942) ?714 · τ ^ ^ , , J· 0rg· Chem. 39 (1974), 2172; Helv·
Chim. Acta 61 (1 〇7r\ i c/cci , ),565]已知,或者其可按照所引用參 考文獻加以製備。 後於般自用條件下實施醋χ之水解。端視不同結構 元素而疋化合物X進行鹼性或酸性水解可較為有利。在 ,水解條件下,可能已經完全或部分脫緩成卜 脫叛通常在20。(:至180。(::、較佳自5〇。(:至12〇。(:之溫度下 在一惰性溶劑中(若適合)於一酸存在下實施。 適且酉文係鹽g文、硫酸、磷酸、甲酸、乙酸、對-曱苯石黃 酸。適宜的溶劑係水、脂族烴(例如,戊烷、己烷、環己 烷及石油醚)、芳族烴(例如,曱苯、鄰…間_及對-二甲 笨)、鹵化煙(例如,二氯曱烷、氣仿及氣苯)、醚(例如, 二乙醚、二異丙醚、第三_ 丁基甲基醚、二氧雜環己烷、 苯甲醚及四氫呋喃)、腈(例如,乙腈及丙腈)、酮(例如, 丙酮、甲基乙基酮、二乙基酮及第三_丁基甲基酮)、醇(例 如,曱醇、乙醇、正-丙醇、異丙醇、正_丁醇及第三_丁醇) 以及二甲基亞硬、二曱基曱醯胺及二曱基乙醯胺;尤佳 地,該反應係於鹽酸或乙酸中實施。亦可使用所述溶劑之 混合物。 其中乂係心^4·烷基之式I化合物亦可藉由使式γη之5_鹵 代三唑并嘧啶與式XI之有機金屬試劑反應獲得。在該方法 一實施例中,該反應係用過渡金屬觸媒(例如Ni觸媒或Pd 觸媒)加以實施。 118620.doc -43- 200800026 Ι(χ=(ν(:4-烷基) νιι + My(-xu)y χι 在式XI中’ ΝΙ係一價數為Υ之金屬離子,例如Β、Ζη或 Sn且X”係CkCU-烷基。該反應可以(例如)類似以下之方法 加以實施·· J· Chem· Soc. Perkin Trans· 1,1187 (1994),ibid· 1,2345 (1996) ; WO-A 99/41255 ; AUst. J· Chem.,第 43 卷,733 (1990) ; J· Org· Chem·,第 43卷,358 (1978) ; J,Chim. Acta 61 (1 〇 7r\ i c/cci, ), 565] is known or can be prepared according to the cited references. The hydrolysis of vinegar is carried out under normal use conditions. It may be advantageous to carry out alkaline or acidic hydrolysis of the compound X by looking at different structural elements. Under the conditions of hydrolysis, it may have been completely or partially slowed down into a deficient usually at 20. (: to 180. (::, preferably from 5 〇. (: to 12 〇. (: at a temperature in an inert solvent (if appropriate) in the presence of a single acid. , sulfuric acid, phosphoric acid, formic acid, acetic acid, p-benzoic acid. Suitable solvents are water, aliphatic hydrocarbons (eg, pentane, hexane, cyclohexane, and petroleum ether), aromatic hydrocarbons (eg, hydrazine). Benzene, o-... and p-diphenyl, halogenated fumes (eg, dichlorodecane, gas and benzene), ethers (eg, diethyl ether, diisopropyl ether, third butyl ketone, Dioxane, anisole and tetrahydrofuran), nitriles (for example, acetonitrile and propionitrile), ketones (for example, acetone, methyl ethyl ketone, diethyl ketone and third butyl ketone), alcohol (e.g., decyl alcohol, ethanol, n-propanol, isopropanol, n-butanol, and third-butanol) and dimethyl sulfite, dimethyl decylamine and dimercaptoacetamide; Preferably, the reaction is carried out in hydrochloric acid or acetic acid. A mixture of the solvents may also be used. The compound of formula I wherein the oxime is 4* alkyl may also be obtained by making the formula γη 5_halo The oxazolopyrimidine is obtained by reacting with an organometallic reagent of the formula XI. In one embodiment of the process, the reaction is carried out using a transition metal catalyst such as Ni catalyst or Pd catalyst. 118620.doc -43- 200800026 Ι (χ=(ν(:4-alkyl) νιι + My(-xu)y χι In Formula XI 'The lanthanide is a metal ion with a valence of Υ, such as Β, Ζη or Sn and X" is a CkCU-alkane The reaction can be carried out, for example, by a method similar to the following: J. Chem. Soc. Perkin Trans. 1, 1187 (1994), ibid. 1, 2345 (1996); WO-A 99/41255; AUst. J. Chem., Vol. 43, 733 (1990); J. Org Chem, Vol. 43, 358 (1978); J,
Chem. Soc. Chem. Commun. 866 (1979) ; Tetrahedron Lett·,第 34卷,8267 (1993) ; ibid·第 33卷,413 (1992)。 $亥專反應混合物以一習用方式處理,例如藉由與水混 合、相分離及(若適合)層析純化粗產物。某些中間體及最 終產物係以無色或輕微褐色黏性油狀物之形式獲得,該等 黏性油狀物在減壓下及在適度提高的溫度下純化或使之不 含揮發性組份。若該等中間物及最終產物係作為固體獲 知’亦可藉由重結晶或蒸煮實施純化。 倘若個別化合物〗不能藉由上述途徑獲得,則其可藉由 其他化合物I之衍生製得。 、若該合成產生異構體混合物,則通常無需實施分離,因 為個別異構體在某些情況下名乂 湘門m产丄 τ在使用刖處理期間或在施用 期間(例如’在光、酸或驗之作 於使用後發生,例如,4^ k 44轉變亦可 於所欲控制的有害真菌中發生。 中成 式I化合物適於用作殺真菌劑。其因呈抵 別之廣譜植物病原直菌 k自下列類 /、囷之顯者功效而著名:子囊菌 ㈣所声如)、半知 襄囷、、岡 固綱⑺崎_^如)、卵菌綱 118620.doc -44- 200800026 (〇⑽;^如)及擔子菌綱(5⑽·山·⑽如),且尤其是印菌綱 類真菌。某些本發明之化合物以内吸式方式有效且其可作 為葉片殺真菌劑、拌種用殺真菌劑及土壤殺真菌劑用於植 物保護中。 其在控制各種栽培植物,例如小麥、黑麥、大夫燕 麥、稻米、玉米、草、香蕉、棉花、大豆、咖啡、甘蔗: 葡萄藤、水果及觀賞性植物,及蔬菜(例如黃瓜、豆類、 西紅柿、馬鈴薯及葫蘆)上,及該等植物之種子上之大量 真菌方面尤為重要。 其尤其適用於控制下述植物疾病: -蔬菜、油菜籽、甜菜及水果及稻米上之鏈袼孢菌 ⑽r⑷屬(例如馬鈴薯及番茄上之底腐病菌(儿 •yo/anz·)或煙卓赤星病菌(儿; -甜采及植物上之絲囊徽屬;Chem. Soc. Chem. Commun. 866 (1979); Tetrahedron Lett., vol. 34, 8267 (1993); ibid. Vol. 33, 413 (1992). The reaction mixture is treated in a conventional manner, for example by mixing with water, phase separation and, if appropriate, chromatography. Certain intermediates and final products are obtained in the form of a colorless or slightly brown viscous oil which is purified under reduced pressure and at moderately elevated temperatures or free of volatile components. . If the intermediates and final products are known as solids, they can also be purified by recrystallization or cooking. If an individual compound cannot be obtained by the above route, it can be obtained by derivatization of another compound I. If the synthesis produces a mixture of isomers, it is usually not necessary to carry out the separation, since in some cases the individual isomers are known to be produced during the treatment of hydrazine or during application (eg 'light, acid' Or the test occurs after use, for example, the 4^ k 44 transition can also occur in the harmful fungi to be controlled. The compound of formula I is suitable for use as a fungicide. The pathogen bacterium K is known for its efficacy from the following classes and sputum: ascomycetes (four), as well as semi-sense sputum, scutellaria (7) saki _^), oomycetes 118620.doc -44- 200800026 (〇(10);^如) and Basidiomycetes (5(10)·山·(10)), and especially the Agrobacterium-like fungi. Certain of the compounds of this invention are effective in a systemic manner and are useful as plant fungicides, seed dressing fungicides and soil fungicides for plant protection. It is controlling a variety of cultivated plants, such as wheat, rye, doctor oats, rice, corn, grass, bananas, cotton, soybeans, coffee, sugar cane: vines, fruits and ornamental plants, and vegetables (such as cucumbers, beans, tomatoes) , potatoes and cucurbits, and a large number of fungi on the seeds of these plants are particularly important. It is especially suitable for controlling the following plant diseases: - vegetables, rapeseed, sugar beets and fruits and the genus of Fusarium oxysporum (10) r(4) on rice (eg bottom rot (Potato yo/anz·) or tobacco on potato and tomato Alternaria (children; - sweet-smelling and silky genus on plants;
-玉米、穀物、稻米及草坪上之雙極黴及德氏 黴(Drech/eraJ屬(例如大麥上之大麥網斑内臍螺孢菌(D 如㈣、小麥上之小麥黃斑葉枯病菌(D triHci_ repentis)); -毅類上之禾谷白粉病菌(^S/wmer/α 白粉病); -草莓、蔬菜、花及葡萄藤上之灰葡萄孢菌 C7wrea)(灰黴病(gray m〇id)); -病 ^上之露菌病/aeiwcae); -玉米、大豆、稻米及甜菜上之尾孢黴(Cereo印oraj屬(例 如甜菜上之甜菜生尾孢(C. Z^z_cw/<2)); 118620.doc -45- 200800026 -玉米、榖物、稻米上之旋孢腔菌(CW/z/iok/z^)屬(例如 穀物上之禾旋孢腔菌,稻米上之 旋抱腔菌(Cochliobolus miyabeanusY) ·, -大豆、棉花及其他植物上之剌盤孢(Co/Zeioir/cz/mj屬(例 如各種植物上之梭孢炭疸菌(C· ; -玉米上之突臍蝶抱屬(Exserohilum) ·, -葫蘆上的二孢白粉菌dc/zoracearz/m)及蒼耳單 絲、款儀(Sphaerotheca fuliginea) ·,- Bifidobacteria and Deraxia on corn, grain, rice and lawn (Drech/eraJ) (eg, Helminthosporium ssp. in barley on barley (D) (four), wheat leaf spot blight on wheat (D) triHci_ repentis)); - powdery mildew on the grass (^S/wmer/α powdery mildew); - Botrytis cinerea C7wrea on strawberries, vegetables, flowers and vines (gray m〇 Id)); - disease on the disease / aeiwcae); - corn, soybean, rice and sugar beetle on the genus Cereo (ore genus (such as sugar beet on the beet (C. Z^z_cw / <2)); 118620.doc -45- 200800026 - genus of Helminthosporium (CW/z/iok/z^) on corn, sorghum, rice (eg Helminthosporium on grain, rice) Cochliobolus miyabeanus Y ·, - Soybean, cotton and other plants on the genus Cocos (Co/Zeioir / cz / mj genus (such as various plants on the genus Fusarium oxysporum (C · ; - on corn) Exserohilum ·, - Phytophthora bisporus dc/zoracearz/m on gourd and Sphaerotheca fuliginea ·,
-各種植物上之鐮孢及輪枝孢菌 屬(例如黃萎病菌(K da/ζ/ία幻(例如小麥上之禾穀鐮孢菌 (F. graminearum)) \ - 縠物上之禾頂囊殼菌(Gaewm㈣少gramzWd ,· -穀物及稻米之赤黴(G/6Z^re//a)屬(例如稻米上之弗基克 羅氏赤徽(Gibberella fujikuroiY) ·, -稻米上之穀粒染色錯合物; -玉米及稻米上之長蝶孢屬(例如榖根 結線 KH· graminicola)) ·, -穀物上之雪徽葉枯病菌(Mic/zra而cr/2/wm mva/J / -縠物、香焦及花生上之球腔菌屬(小麥 上之禾生球腔菌(M. gramk/co/甸、香蕉上之香蕉黑條葉 斑病菌(M· /X/z’es/s)); 大豆上之豆薯層鏽菌j^c/^r/n’zz·)及層鏽層 假尾孢菌; -大豆、向曰葵及葡萄藤上之枝枯病菌(T/ramc^pdd屬(葡 118620.doc -46- 200800026 萄藤上之葡萄霜黴(Ρ· WHco/W 、向曰葵上之Ρ· helianthii); -馬鈴薯及西紅柿上的致病疫黴菌 infestans) \ -葡萄藤上的葡萄霜黴病菌(Τ/α謂opara Wiico/aj ; -蘋果樹上的白又絲單囊殼菌/ewcoir/c/za); -榖物上之卷毛狀假小尾孢菌 herpotrichoides) » -蛇麻花及葫蘆上之假霜黴菌屬(例如 黃瓜上之黃瓜霜黴病菌(P. ; -穀物、玉米及蘆筍上之柄鏽菌屬(小麥上之小 麥葉錄病(P. triticina)反票、输窗(P,striformis)、1 筍 之 天門科柄鏽菌(户.; -穀類上的核腔菌(TyrMop/^rW屬; -稻米上之稻梨孢、稻紋炫菌 (Coriz'ezVm 、稻帚枝徽(*Sar6^/aiiz’wm 、水 稻葉鞘腐敗病、稻葉黑粉菌(五 oryzae) / -草坪及穀物上之稻痕病菌(/^rz_cw/arz。grbea); -草坪、稻米、玉米、棉花、油菜軒、向日葵、甜菜、蔬 菜及其他植物上之腐黴菌屬; -棉花、稻米、馬鈐薯、草坪、玉米、油菜籽、馬鈴薯、 甜菜、蔬菜及其他植物上之絲核菌屬f例如 立枯絲核菌(及·;, 118620.doc -47- 200800026 -油菜籽、向日葵及其他植物上之核盤菌(Sc/eroi/WaJ屬 (例如油菜菌核病(& / -小麥上之小麥殼針孢及穎枯殼多抱菌 (Stagonospora nodorum); -葡萄藤上的白粉菌又名:葡萄鉤絲殼 (Uncinula necator)); -玉米及草坪上之*Seiospaer/a ; - 玉米上之綠黑穩病菌(Sphacelotheca reiiinia) ·,- Fusarium and Verticillium on various plants (eg Verticillium dahliae (K da / ζ / ία illusion (such as F. graminearum on wheat) \ - The top of the scorpion Capsular bacterium (Gaewm (four) less gramzWd, · grain and gibberella of rice (G/6Z^re//a) genus (eg Gibberella fujikuroiY on rice), - grain on rice Dyeing complex; - Phytophthora spp. on corn and rice (eg KH graminicola) ·, - Snowy blight on grain (Mic/zra and cr/2/wm mva/J / - sputum, fragrant coke and genus of the genus Coccidia on the peanuts (M. gramk/co/Dian, banana on the banana, black leaf spot pathogen (M· /X/z'es/ s)); Phytophthora serrata j^c/^r/n'zz·) on soybean and Pseudomonas aeruginosa; - Soybean, geranium and vines (T/ Ramc^pdd genus (Portugal 118620.doc -46- 200800026 vine grape downy mildew (Ρ· WHco/W, 曰 上 上 he helianthii); - Phytophthora infestans on potatoes and tomatoes) - Grape downy mildew on vines (Τ/α says opara Wii Co/aj ; - White sclerotium / ewcoir / c / za on apple trees; - Herpotrichoides on the scorpion) » - Helminthosporium on hops and cucurbits (eg cucumber downy mildew on cucumber (P.; - grain, corn and asparagus on the rust fungus (P. triticina on wheat) (P. triticina) counterfeit, window (P, striformis), 1 Phytophthora sinensis (household;; - nucleocapsid bacteria on cereals (TyrMop/^rW genus; - rice porphyra on rice, rice porphyry (Coriz'ezVm, rice lychee emblem (*Sar6^) /aiiz'wm, rice leaf sheath spoilage, rice leaf black powder (five oryzae) / - lawn and grain on rice grains (/^rz_cw/arz.grbea); - lawn, rice, corn, cotton, rapeseed, Pythium on sunflowers, beets, vegetables and other plants; - cotton, rice, horseshoe, turf, corn, rapeseed, potatoes, beets, vegetables and other plants of the genus Rhizoctonia f Bacteria (and·;, 118620.doc -47- 200800026 - Sclerotinia on rapeseed, sunflower and other plants (Sc/eroi/WaJ genus (eg rapeseed) Nuclear disease (& / - wheat on the shell of the needle and the genus Stagonospora nodorum; - the vine on the powdery mildew, also known as: Uncinula necator); - corn and lawn *Seiospaer/a ; - Sphacelotheca reiiinia on corn ·,
-大豆及棉花上之TTz/eva/io/^zj屬/ -穀物之腥黑粉菌(77//…α)屬,· -穀類及甜菜上的黑粉菌(Ustilago)屬;及 -蘋果及梨上之黑星菌(FeWwr/α)屬(黑星病)(例如蘋果上 t 票、I 病{ V,inaequalis、、〇 式I化合物另外適於在材料(例如,木料、紙、塗料分散 液、纖維或織物)保護方面及儲存產品保護方面控制有害 真菌。在木材保護方面,需尤其注意以下有害真菌: 子囊菌綱,例如長嗓殼菌屬 SPP.)、長嗓殼屬spp·)、出芽短梗黴 (Aureobasidium pullulans)、膠 I 抱慝(Sclerophoma s仰·、、 毛殼菌屬(Chaetomium spp·)、腐質黴屬(Humicoia spp·)、 spp·、毛束黴屬(7Wc/2wrw spp.);擔子菌綱,例 如粉抱革囷屬(Ccm/op/zora spp·)、革蓋菌屬(Corio/ws spp·) ' 褐褶菌屬(G/α⑼p/^//謂 spp.)、韌傘屬 spp·)、側耳屬(P/ewroiw spp·)、茯苓屬(Ρ〇η·α Spp.)、龍介 118620.doc -48 - 200800026 屬(Serpw/a spp·)及乾赂菌屬(rjromyca spp·);半知菌綱, 例如麯黴屬spp.)、分枝芽胞黴菌屬 (C/adoiS^or/wm spp·)、青黴菌屬(/Γαζ_ϋζ7//ι^ spp.)、木黴菌 屬(TWc/zWerma spp.)、鏈格孢菌屬(j/iernaria spp·)、擬青 黴菌屬(Paecz7omj;ca spp·);及接合菌綱,例如毛黴菌屬 (Μι/cor spp.);以及在保護材料方面,注意以下酵母:念 珠菌屬(Caec/Ma spp.)及釀酒酵母菌(Saccharomyces cerev/sae) 〇 式I化合物藉由用殺真菌有效量之該等活性化合物處理 真菌或欲加以保護使其不受真菌侵襲之植物、種子、材料 或土壤加以施用。該施用於材料、植物或種子彼真菌感染 之前或之後皆可實施。 該等殺真菌組合物通常包含介於〇.1重量%與95重量%之 間、較佳介於0.5重量%與90重量%之間之活性化合物。 當用於植物保護時,端視期望效果之種類,所施用量係 介於0·01公斤活性化合物/公頃與2·〇公斤活性化合物/公頃 之間。 在種子處理中,通常需要活性化合物之量為1克/100公 斤種子至1000克/100公斤種子、較佳為5克/100公斤種子至 100克/100公斤種子。 當用於材料或所儲存產品之保護時,所施用活性化合物 之量端視施用區域類型及期望效果而定。在材料保護中通 常施用之量係(例如)0.001克活性化合物/立方米經處理材 料至2公斤活性化合物/立方米經處理材料、較佳0.005克活 118620.doc -49- 200800026 性化合物/立方米經處理材料至丨公斤活性化合物/立方米經 處理材料。 式I化合物可以具有不同生物活性之各種結晶改良形式 存在。其亦可構成本發明標的物之一部分。 式I化合物可轉化成常規調配物,例如,溶液、乳液、 懸浮液、粉末、粉劑、膏糊及顆粒1藥形式端視特定期 望用途而定;在每一情況下,應確保本發明化合物能夠精 細而均勻地分佈。 以-已知方式M備該等調配物,例如藉由使該活性化合 物與溶劑及/或載劑摻合’若需要’則可使用乳化劑及分 散劑。適用此目的之溶劑/輔助劑主要係: -水、芳香族溶劑(例如solvesso產品、二甲苯)、石壤(例 却,礦物油餾分)、醇(例如’甲醇、丁醇、戊醇、节 醇)酮(例如’ ί衣己酮、r _丁内酯卜吡咯啶 :乙叫乙二醇二乙㈣)、二醇類、脂肪酸二甲 I胺類、脂肪酸類及脂肪酸醋類。 劑混合物, _上’亦可使用溶 -載劑,例如碾碎之天然礦物 阿領土、黏土、滑石 及碾碎之合成礦物(例如古八埒0 . ^ Λ . . 、巧如呵分散矽石、矽酸 皿)’礼化背丨’例如非離子型及 .氧伸乙基脂肪醇醚、、m:里礼化劑(例如聚 „ , 醚烷基知、酸鹽及芳基硫酸鹽)及分散 ㈣’例如木質素亞硫酸鹽廢液及甲基纖維素。 =適宜表面活性劑係木質素續酸之驗金 及銨鹽、萘磺酸、苯紛基績驗土金屬 丁基萘嶒酸 '烷基芳基 118620.doc -50- 200800026- TTz/eva/io/^zj genus on soybeans and cotton / - genus sphaeroides (77//...α) of the grain, · - genus Ustilago on cereals and beets; and - apple And the genus of black spot (FeWwr/α) on the pear (black spot disease) (for example, apple on t-ticket, I disease { V, inaequalis, 〇 formula I compound is also suitable for materials (for example, wood, paper, paint) Control of harmful fungi in terms of protection of liquids, fibers or fabrics and protection of stored products. In the protection of wood, special attention should be paid to the following harmful fungi: Ascomycetes, such as the genus SPP.) ), Aureobasidium pullulans, scorpion I (Sclerophoma s), Chaetomium spp., Humicioa spp., spp., Hairy mildew ( 7Wc/2wrw spp.); Basidiomycetes, for example, C. genus (Ccm/op/zora spp.), Clostridium (Corio/ws spp.) 'Glycyrrhiza (G/α(9)p/^/ / said spp.), Pleurotus spp·), Pleurotus sp. (P/ewroiw spp.), 茯苓 Ρ〇 (Ρ〇η·α Spp.), Long Jie 118620.doc -48 - 200800026 genus (Serpw/a spp· ) Genus (rjromyca spp.); deuteromycetes, such as Aspergillus spp.), genus Bacillus (C/adoiS^or/wm spp.), Penicillium (/Γαζ_ϋζ7//ι^ spp .), Trichoderma (TWc/zWerma spp.), Alternaria (j/iernaria spp.), Paecilos genus (Paecz7omj; ca spp·); and zygomycetes, such as Mucor (Μι /cor spp.); and in terms of protective materials, note the following yeast: Caec/Ma spp. and Saccharomyces cerev/sae. The compound of formula I is effective by using a fungicidal effective amount. The active compound treats the fungus or the plant, seed, material or soil to be protected from fungal attack. The application can be carried out before or after the application of the fungus infection of the material, plant or seed. Such fungicidal compositions typically comprise between about 1% and 95% by weight, preferably between 0.5% and 90% by weight of active compound. When used for plant protection, depending on the type of desired effect, the applied amount is between 0. 01 kg of active compound per hectare and 2 kg of active compound per hectare. In seed treatment, the amount of active compound is usually required to be from 1 g/100 kg seed to 1000 g/100 kg seed, preferably 5 g/100 kg seed to 100 g/100 kg seed. When used for the protection of materials or stored products, the amount of active compound applied will depend on the type of application area and the desired effect. The amount usually applied in the protection of the material is, for example, 0.001 g of active compound per cubic meter of treated material to 2 kg of active compound per cubic meter of treated material, preferably 0.005 g of live 118620.doc -49-200800026 sex compound/cubic The treated material is 丨 kg of active compound per cubic meter of treated material. The compounds of formula I may exist in various crystalline modified forms having different biological activities. It may also form part of the subject matter of the invention. The compounds of formula I can be converted into conventional formulations, for example, solutions, emulsions, suspensions, powders, powders, pastes and granules, depending on the particular intended use; in each case, it is ensured that the compounds of the invention Finely and evenly distributed. These formulations may be prepared in a known manner, for example, by blending the active compound with a solvent and/or a carrier, if necessary, an emulsifier and a dispersing agent may be used. Solvents/auxiliaries for this purpose are mainly: - water, aromatic solvents (eg, solvesso products, xylene), rocky soils (for example, mineral oil fractions), alcohols (eg 'methanol, butanol, pentanol, section Alcohol) ketones (eg ' ketone ketone, r _butyrolactone pyrrolidine: ethylene glycol ethylene glycol (tetra)), glycols, fatty acid dimethyl amines, fatty acids and fatty acid vinegars. Mixtures, _上' can also use solvent-loading agents, such as crushed natural minerals, territories, clay, talc and crushed synthetic minerals (such as ancient gossip 0. ^ Λ . .矽 皿 ) ' ' 礼 礼 礼 礼 礼 礼 礼 礼 礼 礼 礼 礼 礼 礼 礼 礼 礼 礼 礼 礼 礼 礼 礼 礼 礼 礼 礼 礼 例如 例如 例如 例如 例如 例如 例如 例如 例如 例如 例如 例如 例如 例如 例如 例如And disperse (4) 'such as lignin sulfite waste liquid and methyl cellulose. = Suitable surfactant for lignin continuous acid test gold and ammonium salt, naphthalenesulfonic acid, benzene-based soil test metal butyl naphthoquinone Acid 'alkylaryl 118620.doc -50- 200800026
確酸鹽、烷基硫酸鹽、烷基磺酸鹽、脂族醇硫酸鹽、脂肪 酸及經硫酸化之脂肪醇乙二醇醚,除此之外,所用適宜表 面活性劑亦可係經磺酸化萘及萘衍生物與甲之縮合物、 萘或萘磺酸與苯酚及甲醛之縮合物、聚氧伸乙基辛苯基 趟、經乙氧基化之異辛基苯酚、辛基苯酚、壬基苯紛、烧 基苯基聚乙二醇醚、三丁基苯基聚乙二醇醚、三硬脂基苯 基聚乙二醇醚、烷基芳基聚醚醇、醇及脂族醇環氧乙烷縮 合物、經乙氧基化之蓖麻油、聚氧伸乙基烷基醚、經乙氧 基化之聚氧丙烯、月桂醇聚乙二醇醚縮醛、山梨糖醇酯、 木質素亞硫酸鹽廢液及甲基纖維素。 適用於製備可直接喷灑溶液、乳劑、糊劑或油分散液之 物質係介質之高沸點礦物油餾分,例如煤油或柴油,此外 還包括例如煤焦油及源自植物或動物之油、脂族烴、環烴 及芳族烴(例如甲苯、二甲苯、石蠟、四氫化萘、烷基= 萘或其衍生物)、甲醇、乙醇、丙醇、丁醇、環己醇、環 己酮、異佛爾酮、高極性溶劑(例如二甲基亞砜、曱基 吡咯啶酮及水)。 土 粉劑,即用於噴施之材料及可撒施產品,可藉由混合或 同時研磨活性物質與一固體載劑製備。 " 顆粒(例如經塗佈之顆粒、經浸潰之顆粒及句質顆粒)可 藉由使活性化合物與固體載劑摻合在—起來製備、,。固體 載劑之實例係礦物土’例如矽膠、矽酸鹽、滑石粉、高嶺 土、美國活性白土(attaclay)、S灰石、石灰、白要、紅玄 武土、黃土、黏土、白雲石、石夕藻土、硫_、硫酸鎂、 118620.doc •51- 200800026 氧化鎂、經研磨之合成礦物質;肥料,例如,硫酸銨、磷 酉文錢、硝酸銨、尿素及植物產品,例如,穀類粗粉、樹皮 粗粉、木粉及堅果殼粗粉、纖維素粉末及其他固體載劑。 一般而言,調配物包含自〇·〇i重量%至95重量%間,較 佳自0.1重量%至90重量❶/〇之活性化合物。所用活性化合物 之純度係介於90%至100%之間,較佳介於95%至1〇〇%之間 (根據NMR譜)。 下文為調配物之實例:1 ·用水稀釋之產品: A水溶性濃縮物(SL、LS) 將10重量份數之式I活性化合物溶於9〇重量份數之水或 水溶性溶劑中。作為一替代方案,可添加潤濕劑或其他辅 助劑。經水稀釋時活性化合物可溶解。依照此方法,獲得 一具有10重量%含量之活性化合物之調配物。 B可分散之濃縮物(DC) 將20重量份數之式I活性化合物溶於7〇重量份數之環己 酮中,添加1 0重量份數之分散劑(例如聚乙烯吡咯啶酮)。 經水稀釋後形成一分散液。活性化合物含量係2〇重量%。 C可乳化之濃縮物(EC) 使1 5重量份數之式I活性化合物溶於75重量份數之二甲 苯中,添加十二烷基苯磺酸鈣及乙氧基化蓖麻油(各自添 加5重量份數)。經水稀釋後形成一乳劑。此調配物具有i 5 重量%之活性化合物含量。 D 乳劑(EW、EO、ES) 使25重量份數之式I活性化合物溶於35重量份數之二甲 118620.doc -52- 200800026 苯中,添加十二烷基苯磺酸鈣及乙氧基化蓖麻油(各自添 加5重量份數)。藉助一乳化機(例如,uitraturrax)將此混合 物引入30重量份數之水中並製成一勻質乳劑。經水稀釋後 形成一乳劑。此調配物具有活性化合物含量為25重量%。 E 懸浮液(SC、OD、FS) 在一携:拌球磨機中,將20重量份數之式I活性化合物粉 β 碎,同時添加10重量份數之分散劑及潤濕劑以及70重量份 數之水或有機溶劑,以形成一微細活性化合物懸浮液。經 _ 水稀釋後形成一該活性化合物之穩定懸浮液。調配物中活 性化合物含量係2 0重量%。 F可分散於水之顆粒及水溶性顆粒(WG、SG) 將50重量份數之式I活性化合物細細研磨,同時添加5〇 重量份數之分散劑及潤濕劑,並藉助技術設備(例如擠壓 器、喷霧塔、流化床)製成可分散於水之顆粒或水溶性顆 粒。經水稀釋後形成一活性化合物之穩定分散液或溶液。 I 此調配物之活性化合物含量為5 0重量%。 G可分散於水之粉末及水溶性粉末(WP、SP、SS、WS) 將75重量份數之式I活性化合物於一轉子_定子研磨機中 研磨,同時添加25重量份數之分散劑、潤濕劑及矽膠。經 - 水稀釋後形成一活性化合物之穩定分散液或溶液。調配物 之活性化合物含量係75重量%。 Η凝膠調配物 在一球磨機中,研磨20重量份數之式I活性化合物、1〇 重量份數之分散劑、1重量份數之凝膠劑及7〇重量份數之 H8620.doc -53- 200800026 水或有機溶劑以形成一微細懸浮液。經水稀釋後,獲得一 具有20重量%之活性化合物含量的穩定懸浮液。 2·無需稀釋即可投予之產品 I 粉劑(DP、DS) 將5重量份數之式I活性化合物精細研磨並與95重量份數 * 之微細高嶺土充分混合。藉此形成一具有5重量%之活性 » 化合物含量的粉狀產物。 J 顆粒(GR、FG、GG、MG) _ 精細研磨0.5重量份數之式I活性化合物連同99.5重量份 數之載劑。現行方法係擠出、喷霧乾燥或流化床。藉此形 成一具有〇·5重量%之活性化合物含量的無需稀釋即可投予 之顆粒。 K ULV 溶液(UL)In addition to the acid salts, alkyl sulfates, alkyl sulfonates, aliphatic alcohol sulfates, fatty acids and sulfated fatty alcohol glycol ethers, the suitable surfactants used may also be sulfonated. a condensate of naphthalene and naphthalene derivatives with methyl, a condensate of naphthalene or naphthalenesulfonic acid with phenol and formaldehyde, polyoxyethyl octyl phenyl hydrazine, ethoxylated isooctyl phenol, octyl phenol, hydrazine Benzophenone, alkyl phenyl polyglycol ether, tributyl phenyl polyglycol ether, tristearyl phenyl polyglycol ether, alkyl aryl polyether alcohol, alcohol and aliphatic alcohol Ethylene oxide condensate, ethoxylated castor oil, polyoxyethylene ethyl ether, ethoxylated polyoxypropylene, lauryl polyethylene glycol ether acetal, sorbitol ester, Lignin sulfite waste liquid and methyl cellulose. High-boiling mineral oil fractions suitable for the preparation of materials which can be directly sprayed with solutions, emulsions, pastes or oil dispersions, such as kerosene or diesel, in addition to, for example, coal tar and oils derived from plants or animals, aliphatic Hydrocarbons, cyclic hydrocarbons and aromatic hydrocarbons (such as toluene, xylene, paraffin, tetralin, alkyl = naphthalene or its derivatives), methanol, ethanol, propanol, butanol, cyclohexanol, cyclohexanone, iso Falconone, a highly polar solvent (eg dimethyl sulfoxide, decyl pyrrolidone and water). The earth powder, i.e., the material for spraying and the applicable product, can be prepared by mixing or simultaneously grinding the active material with a solid carrier. " Granules (e.g., coated granules, impregnated granules, and granules) can be prepared by blending the active compound with a solid carrier. Examples of solid carriers are mineral soils such as tannins, citrates, talc, kaolin, attaclay, S-grey, lime, white, red basalt, loess, clay, dolomite, and stone eve. Algae, sulfur, magnesium sulfate, 118620.doc • 51- 200800026 Magnesium oxide, ground synthetic minerals; fertilizers, for example, ammonium sulfate, phosphonium, ammonium nitrate, urea and plant products, for example, cereals Powder, bark coarse powder, wood flour and nut shell meal, cellulose powder and other solid carriers. In general, the formulation comprises from about 5% by weight to about 95% by weight, more preferably from 0.1% by weight to 90% by weight of hydrazine. The purity of the active compound used is between 90% and 100%, preferably between 95% and 1% (according to NMR spectrum). The following are examples of formulations: 1 - Products diluted with water: A Water-soluble concentrate (SL, LS) 10 parts by weight of the active compound of the formula I are dissolved in 9 parts by weight of water or a water-soluble solvent. As an alternative, wetting agents or other auxiliary agents may be added. The active compound can be dissolved by dilution with water. According to this method, a formulation having an active compound content of 10% by weight is obtained. B Dispersible Concentrate (DC) 20 parts by weight of the active compound of the formula I are dissolved in 7 parts by weight of cyclohexanone, and 10 parts by weight of a dispersing agent (for example polyvinylpyrrolidone) are added. After dilution with water, a dispersion is formed. The active compound content is 2% by weight. C emulsifiable concentrate (EC) 15 parts by weight of the active compound of the formula I are dissolved in 75 parts by weight of xylene, calcium dodecylbenzene sulfonate and ethoxylated castor oil are added (each added 5 parts by weight). After dilution with water, an emulsion is formed. This formulation has an active compound content of i 5 wt%. D Emulsion (EW, EO, ES) 25 parts by weight of the active compound of the formula I are dissolved in 35 parts by weight of dimethyl 118620.doc -52-200800026 benzene, adding calcium dodecylbenzene sulfonate and ethoxylate Basecast castor oil (5 parts by weight each). This mixture was introduced into 30 parts by weight of water by means of an emulsifying machine (for example, uitraturrax) to prepare a homogeneous emulsion. After dilution with water, an emulsion is formed. This formulation has an active compound content of 25% by weight. E Suspension (SC, OD, FS) In a carrying: ball mill, 20 parts by weight of the active compound powder β of the formula I is crushed, while adding 10 parts by weight of the dispersant and wetting agent and 70 parts by weight Water or an organic solvent to form a suspension of the fine active compound. After dilution with water, a stable suspension of the active compound is formed. The active compound content of the formulation was 20% by weight. F dispersible in water particles and water-soluble granules (WG, SG) 50 parts by weight of the active compound of the formula I are finely ground, while adding 5 parts by weight of dispersant and wetting agent, and by means of technical equipment ( For example, an extruder, a spray tower, a fluidized bed) are used to form particles or water-soluble particles that are dispersible in water. After dilution with water, a stable dispersion or solution of the active compound is formed. I The active compound content of this formulation is 50% by weight. G can be dispersed in water powder and water-soluble powder (WP, SP, SS, WS) 75 parts by weight of the active compound of formula I is ground in a rotor_stator grinder while adding 25 parts by weight of dispersant, Wetting agent and silicone. After dilution with water, a stable dispersion or solution of the active compound is formed. The active compound content of the formulation is 75% by weight. ΗGel formulation in a ball mill, grinding 20 parts by weight of the active compound of formula I, 1 part by weight of dispersant, 1 part by weight of gelling agent and 7 parts by weight of H8620.doc-53 - 200800026 Water or organic solvent to form a fine suspension. After dilution with water, a stable suspension having an active compound content of 20% by weight is obtained. 2. Products which can be administered without dilution I Powder (DP, DS) 5 parts by weight of the active compound of the formula I are finely ground and thoroughly mixed with 95 parts by weight of the fine kaolin. Thereby, a powdery product having a content of 5% by weight of the active compound is formed. J granules (GR, FG, GG, MG) _ Finely ground 0.5 parts by weight of the active compound of the formula I together with 99.5 parts by weight of the carrier. Current methods are extrusion, spray drying or fluidized beds. Thereby, a granule having a content of 5% by weight of the active compound which can be administered without dilution can be formed. K ULV solution (UL)
、使10重量份數之式I活性化合物溶於90重量份數之有機 溶劑(例如二曱苯)中。藉此形成一具有i0重量%之活性化 合物含量的無需稀釋即可投予之產品。 對於種子處理,通常使用水溶性濃縮物(LS)、懸浮液 (FS)、撒施粉(DS)、可分散於水及水溶性粉劑(ws、ss)、 乳蜊(ES)、可乳化之濃縮物(EC)及凝膠調配物。此等 調配物T以未纟i稀、釋之形式或較佳為經稀釋之形式投予給 種子。可在播種之前實施投藥。 噴撒、撒布或澆注 或自其製備的使用 該等活性化合物可藉由喷灑、噴霧、 等方式以其調配物形式、以原狀態使用 例如,可直接噴灑之溶液、粉末、懸浮液或分 形式使用 118620.doc -54- 200800026 用於撤布之 用途;其欲 盡可能最精 政液a液'油分散液、膏糊、可撒施產品、 物質或顆粒等形式。使用形式完全取決於期望 確保在每一情況下本發明活性化合物能夠處於 細之分佈狀態。 、3水使用形式可藉由添加水使用乳液濃縮物、膏糊或可 m氣末(可潤濕之粉末、油分散液)來製備。為 劑、糊劑或油分散液,可藉由潤濕劑、膠㈣、分散劑:10 parts by weight of the active compound of the formula I are dissolved in 90 parts by weight of an organic solvent such as diphenylbenzene. Thereby, a product which can be administered without dilution can be formed with an active compound content of i0% by weight. For seed treatment, water-soluble concentrate (LS), suspension (FS), powdered (DS), dispersible in water and water-soluble powder (ws, ss), chyle (ES), emulsifiable Concentrate (EC) and gel formulations. These formulations T are administered to the seed in a form that is not dilute, released or preferably diluted. Administration can be carried out prior to sowing. Spraying, spreading or casting or using the active compounds prepared therefrom may be carried out by spraying, spraying, etc. in the form of their formulations, in the original state, for example, directly sprayable solutions, powders, suspensions or fractions. Forms used 118620.doc -54- 200800026 for the purpose of evacuation; it is intended to be as fine as possible in the form of oil liquid dispersions, pastes, spreadable products, substances or granules. The form of use depends entirely on the desire to ensure that the active compound of the invention can be in a finely distributed state in each case. The 3 water use form can be prepared by adding an emulsion concentrate, a paste or a methane (wettable powder, oil dispersion) by adding water. For the agent, paste or oil dispersion, it can be used as a wetting agent, glue (4), dispersant:
乳化蜊使此等物質或其溶於油或溶劑之溶液於水中勻質 化然而’亦可能製備由活性物質、潤濕劑、膠黏劑、分 散劑或乳化劑及(若適合)溶劑或油組成之濃縮物且該等濃 縮物適於用水稀釋。 即用製備物中活性化合物之濃度可在相當寬範圍内變 化。一般而言,此等濃度係.介於0.0001%與1〇%之間較 佳介於0·01%與1%之間。 該等活性化合物亦可極成功地用於超低量方法(u Lv) 中,有可能施用具有超過95重量%的活性化合物之調配 物’或甚至施用不含添加劑之活性化合物。 可向活性化合物中添加各類油、潤濕劑、佐劑、除草 劑、殺真菌劑、其他殺蟲劑,或殺菌劑,適當時甚至可在 即用之前添加(桶混製劑)。該等試劑可以自至 1〇〇··1 ’較佳為自1:10至1〇:1之重量比率與本發明組合物混 合0 鐾於此,適宜佐劑尤其係··經有機改質之聚矽氧烷 如Break Thru S 240⑧;醇燒氧基化物, 例 例如 Atplus 245®、 118620.doc -55- 200800026Emulsifying hydrazine to make these substances or their solutions in oil or solvent homogenized in water. However, it is also possible to prepare active substances, wetting agents, adhesives, dispersants or emulsifiers and, if appropriate, solvents or oils. The concentrates are composed and the concentrates are suitable for dilution with water. The concentration of the active compound in the ready-to-use preparation can vary over a relatively wide range. In general, these concentrations are preferably between 0.0001% and 1% between 0.0001% and 1%. These active compounds can also be used with great success in ultra low volume processes (u Lv), it is possible to apply formulations having more than 95% by weight of active compound or even to apply active compounds without additives. Various oils, wetting agents, adjuvants, herbicides, fungicides, other insecticides, or bactericides may be added to the active compound, and may be added (tank mix) as appropriate, as appropriate. These agents may be mixed with the composition of the present invention in a weight ratio of from 1:10 to 1 :1, preferably in an amount of from 0 to 1. The appropriate adjuvant is especially modified by organic modification. Polyoxyalkylene such as Break Thru S 2408; alcohol alkoxylates, such as Atplus 245®, 118620.doc -55- 200800026
Atplus MBA 1303®、Plurafac LF 300®及 Lutensol ON 30® ; EO/PO嵌段聚合物,例如 Pluronic RPE 2035®及 Genapol B® ;醇乙氧基化物,例如Lutensol XP 80® ;及二辛基磺基 琥拍酸鈉,例如Leophen RA®。Atplus MBA 1303®, Plurafac LF 300® and Lutensol ON 30®; EO/PO block polymers such as Pluronic RPE 2035® and Genapol B®; alcohol ethoxylates such as Lutensol XP 80®; and dioctylsulfonate Sodium sulphate, such as Leophen RA®.
本發明組合物亦可以殺真菌劑之使用形式與其他活性化 合物共存,例如,與除草劑、殺蟲劑、生長調節劑、殺真 菌劑共存或亦與肥料共存。藉由使化合物(I)或包含其之組 合物與一或多種其他活性化合物(尤其是殺真菌劑)混合, 在許多情形中可能擴大活性譜或防止出現耐藥性。在許多 情形中,可達成協同效應。 可與本發明化合物結合使用的殺真菌劑之以下列表乃欲 闡明可能的組合,而非對其加以限制: 史卓比尿類 口坐史卓賓(azoxystrobin)、二莫西史卓賓(dimoxystrobin)、 烯將菌酉旨(enestroburin)、說号史卓賓(fluoxastrobin)、克收 欣(kresoxim-甲基)、麥脫明諾史卓賓(metominostrobin)、 比可西史卓賓(picoxystrobin)、派拉克史卓賓 (pyraclostrobin)、三氟敏(trifloxystrobin)、歐沙史卓賓 (orysastrobin)、(2·氯-5-[1-(3·曱基苄基氧基亞胺基)乙基] 苄基)胺基甲酸曱酯、(2-氯-5-[l-(6-曱基吡啶-2-基甲氧基 亞胺基)乙基]苄基)胺基曱酸甲酯、2-(鄰-(2,5-二甲基-苯氧 基亞曱基)苯基)-3_曱氧基丙稀酸曱酯; 曱醯胺類 -甲醢苯胺類··般那拉西(benalaxyl)、麥鏽靈 118620.doc -56- 200800026 (benodanil)、波斯卡利(boscalid)、萎鏽靈(carboxin)、 滅普寧(mepronil)、甲吱酿胺(fenfuram)、芬黑沙米 (fenhexamid)、氟托南尼(flutolanil)、夫南麥特 (furametpyr)、滅達樂(metalaxyl)、歐夫瑞絲(ofurace)、 歐殺斯(oxadixyl)、氧化萎鏽靈(oxycarboxin)、D比嗟菌胺 (penthiopyrad)、西福紮麥(thifluzamide)、替丁尼 (tiadinil)、Ν·(4’·溴聯苯基-2-基)-4-二氟甲基-2-曱基噻 唑-5-曱醯胺、N-(4’-三氟曱基聯苯基-2-基)-4-二氟曱基-2-甲基噻唑-5-甲醯胺、Ν-(4·-氯-3’-氟聯苯基-2-基)-4-二 氟甲基-2-曱基噻唑-5-曱醯胺、N-(3’,f-二氣-4-氟聯苯 基-2-基)-3-二氟甲基·1-甲基吡唑-4-甲醯胺、N-(2-氰基 苯基)-3,4-二氣異噻唑-5-甲醯胺; -叛酸醯嗎琳類··二甲馬夫(dimethomorph)、I馬夫 (flumorph); -苯甲醯胺類··象滅歐(flumetover)、氟°比菌胺(fluopicolide) 定苯甲醯胺)、嗤沙麥(zoxamide); -其他甲醯胺類:卡波帕麥(carpropamid)、大克賽美 (diclocymet)、雙炔醢菌胺(mandipropamid)、N-(2-(4-[3-(4-氯苯基)丙-2 -快氧基]-3 -甲氧基苯基)乙基)-2-甲烧石黃 醯基胺基-3-甲基-丁醯胺、N-(2-(4-[3-(4-氣苯基)丙-2-炔 氧基]-3 -甲氧基苯基)乙基)-2 -乙烧石黃酿基胺基-3 -甲基丁 醯胺; 吐類 -三唆類:白特丹羅(bitertanol)、漠克唆(bromuconazole)、 118620.doc -57- 200800026The compositions of the present invention may also be used in combination with other active compounds in the form of fungicides, for example, in combination with herbicides, insecticides, growth regulators, fungicides or also with fertilizers. By mixing the compound (I) or a composition comprising the same with one or more other active compounds (especially fungicides), it is possible in many cases to broaden the spectrum of activity or prevent the occurrence of drug resistance. In many cases, synergies can be achieved. The following list of fungicides that can be used in combination with the compounds of the present invention is intended to clarify possible combinations, but not to limit them: Staples urinary mouth azoxystrobin, dimoxystrobin, alkene Esstroburin, fluoxastrobin, kresoxim-methyl, metominostrobin, picoxystrobin, pyraclostrobin, trifluoro Trifloxystrobin, oresastrobin, (2·chloro-5-[1-(3·decylbenzyloxyimino)ethyl]benzyl)carbazinate, (2- Methyl-5-[l-(6-decylpyridin-2-ylmethoxyimino)ethyl]benzyl)amino decanoate, 2-(o-(2,5-dimethyl) -phenoxyarylene)phenyl)-3-decyloxy decyl decyl ester; decylamine-formaldehyde aniline · benalaxyl, wheat rustling 118620.doc -56 - 200800026 (benodanil), boscalid, carboxin, mepronil, fenfuram, fenhexami Amid), flitolanil, furametpyr, metalaxyl, ofurace, oxadixyl, oxycarboxin, D Penthiopyrad, thifluzamide, tiadinil, Ν·(4'·bromobiphenyl-2-yl)-4-difluoromethyl-2-mercaptothiazole -5-decylamine, N-(4'-trifluoromethylbiphenyl-2-yl)-4-difluoroindol-2-methylthiazole-5-carboxamide, Ν-(4· -Chloro-3'-fluorobiphenyl-2-yl)-4-difluoromethyl-2-mercaptothiazol-5-nonylamine, N-(3',f-digas-4-fluorine Phenyl-2-yl)-3-difluoromethyl·1-methylpyrazole-4-carboxamide, N-(2-cyanophenyl)-3,4-dioxathiazole-5- Methionine; - retinoic acid morphine · dimethomorph, flumorph; - benzamide · flumetover, fluopicolide Benzoylamine), zoxamide; - other methotrexate: carpropamid, diclocymet, mandipropamid, N-(2- (4-[3-(4-chlorophenyl)propane-2 - fast ]]-3-methoxyphenyl)ethyl)-2-carcinogen xanthylamino-3-methyl-butanamine, N-(2-(4-[3-(4-phenylphenyl) )prop-2-ynyloxy]-3-methoxyphenyl)ethyl)-2-ethyl sulphate yellow amine 3-methylbutylimamine; sputum-triterpenoid: white Bitertanol, bromuconazole, 118620.doc -57- 200800026
環克嗤(cyproconazole)、地芬康 °坐(difenoconazole)、浠 嗤醇(diniconazole)、安尼康唆(enilconazole)、環氧康嗤 (epoxiconazole)、芬布康嗤(fenbuconazole)、護石夕得 (flusilazole)、氟喧康吐(fluquinconazole)、護汰芬 (flutriafol)、六康 °坐(hexaconazole) 醯胺嗤 (imibenconazole)、種菌吐(ipconazole)、麥康口坐 (metconazole)、麥環丁尼(myclobutanil)、潘康 口坐 (penconazole)、普克利(propiconazole)、撲硫康 °坐 (prothioconazole)、石夕氟口坐(simeconazole)、得克利 (tebuconazole)、四凱利(tetraconazole)、三泰隆 (triadimenol)、三泰芬(triadimefon)、三替康唆 (triticonazole); -味唆類:賽嗤法米(cyazofamid)、依滅列(imazalil)、稻 痕 S旨(pefurazoate)、撲克拉(prochloraz)、三氟味峻 (triflumizole); - 苯并味嗤類:免賴得(benomyl)、多菌靈(carbendazim)、 夫伯達ϋ坐(fuberidazole)、腐絕(thiabendazole); -其他:衣沙布山(ethaboxam)、土菌靈(etridiazole)、°惡 黴靈(hymexazole); 氮雜環化合物 -ϋ比咬類:扶吉胺(fluazinam)、比利芬羅(pyrifenox)、3-[5-(4-氣苯基)-2,3-二曱基異噁唑啉-3-基]-吡啶; -σ密咬類:乙,紛磺酸酯(bupirimate)、賽普洛 (cyprodinil)、哺菌膝(ferimzone)、芬瑞莫(fenarimol)、 118620.doc -58 - 200800026 米潘尼比林(mepanipyrim)、紐阿利莫(nuarimol)、比利 美沙尼(pyrimethanil); -娘嗓類:賽福寧(triforine); _ σ比洛類:氟二σ惡尼(fludioxonil)、芬比克隆尼 (fenpiclonil); -嗎琳類:阿迪莫夫(aldimorph)、嗎菌靈(dodemorph)、芬 普福(fenpropimorph)、三得芬(tridemorph);Cyproconazole, difenoconazole, diniconazole, enilconazole, epoxiconazole, fenbuconazole, 护石夕(flusilazole), fluquinconazole, flutriafol, hexaconazole imibenconazole, ipconazole, metconazole, maicyclobutyl Myclobutanil, penconazole, propiconazole, prothioconazole, simeconazole, tebuconazole, tetraconazole, three Triadimenol, triadimefon, triticonazole; - miso: cyazofamid, imazalil, pefurazoate, poker (prochloraz), triflumizole; - benzo miso list: benomyl, carbendazim, fuberidazole, thiabendazole; - other : 衣沙布山(ethaboxam ), etridiazole, hymexazole; nitrogen heterocyclic compound-deuterium bite: fluazinam, pyrifenox, 3-[5-(4- Gas phenyl)-2,3-dimercaptoisoxazolin-3-yl]-pyridine; - σ-type bite: B, sulfonate (cypridin), cyprodinil, feeding knee (ferimzone), fenarimol, 118620.doc -58 - 200800026 mepanipyrim, nuarimol, pyrimethanil; - maiden: Safun (triforine); _ σ pylon: fludioxonil, fenpiclonil; - morphine: aldimorph, dodemorph, fenfluk ( Fenpropimorph), tridemorph;
-二魏甲醢亞胺類:依普同(iprodione)、撲滅寧 (procymidone)、免克寧(vinclozolin); 其他:S-甲基阿西本嗤(acibenzolar-S-甲基)、敵菌靈 (anilazine)、蓋普丹(captan)、蓋它福(captafol)、邁隆 (dazomet)、大克美秦(diclomezine)、芬号尼 (fenoxanil)、福爾培(folpet)、芬普比定(fenpropidin)、 泛ϋ惡同(famoxadone)、芬納米同(fenamidone)、辛n塞酮 (octhilinone)、撲殺熱(probenazole)、普杳那兹 (proquinazid)、百快隆(pyroquilon)、奎諾克西芬 (quinoxyfen)、三賽唾(tricyclazole)、5-氣-7-(4-甲基六 氫0比咬-1-基)-6-(2,4,6-三氟苯基)-[1,2,4]三嗤并[1,54]哺 唆、2_ 丁氧基-6 -埃代_3_丙基· 口克稀·4 -酉同、Ν,Ν -二甲 基_3-(3-漠、-6 -氟-2_曱基0引蜂-1-石黃酿基)-[1,2,4]三唾石黃 醯胺; 胺基曱酸酯類及二硫代胺基甲酸酯類 -二硫代胺基甲酸酯類:富爾邦(ferbam)、錳粉克 (mancozeb)、锰乃浦(maneb)、免得爛(metiram)、美坦 118620.doc -59 - 200800026 (metam)、甲基鋅乃浦(propineb)、得恩地(thiram)、鋅乃 浦(zineb)、益穗(ziram); -胺基甲酸酯類:二乙芬卡(diethofencarb)、氟本賽夫利 卡(flubenthiavalicarb)、衣普法利卡(iprovalicarb)、普潘 莫卡化1:〇0&111〇〇&1:13)、3-(4-氯苯基)-3-(2-異丙氧基羰基胺 基-3-甲基丁醯基胺基)丙酸甲酯、N-(l-(l-(4-氰基苯基) 乙磺醯基)丁-2-基)胺基曱酸4-氟苯基酯; 其他殺真菌劑 -脈類:多寧(dodine)、亞胺歐它丁(iminoctadine)、雙脈 辛胺(guazatine); -抗生素類:喜賜黴素(kasugamycin)、多氧黴素類 (polyoxins)、鏈黴素、維利黴素(validamycin)A ; -有機金屬化合物類:三苯基錫鹽; -含硫雜環化合物··亞賜圃(isoprothiolane)、腈硫酉昆 (dithianon); -有機填化合物:護粒松(edifenphos)、福賽得(fosetyl)、 福賽得銘(fosetyl-aliiminum)、丙基喜樂松(iprobenfos)、 白粉松(pyrazophos)、脫克松(tolclofos-methyl)、亞填酸 及其鹽; -有機氯化合物:甲基多保淨(thiophanate-methyl)、四氣 異苯腈(chlorothalonil)、益發靈(dichlofluanid)、對曱抑 菌靈(tolylfluanid)、石黃菌胺(flusulfamide)、酜、六氯代 苯、賓克隆(pencycuron)、奎脫辛(quintozene); -石肖基苯基衍生物:百滿克(binapacryl)、白粉克 118620.doc -60- 200800026 (dinocap)、大脫蜗(dinobuton); - 無機活性化合物:波爾多液(Bordeaux mixture)、乙酸 銅、氫氧化銅、氧氣化銅、鹼式硫酸銅、硫磺; -其他:螺°惡胺(spiroxamime)、 賽扶芬納米 (cyflufenamid)、西莫生尼(cymoxanil)、美查芬隆 (metrafenone) 〇 【實施方式】 合成實例 以下合成實例中所述程序係用於適當修飾該等起始化合 物來製備其他式I化合物。以此方式製得之化合物及物理 數據共同列示於下表中。 實例1 : 5-氣_6-(2,5-二氟-4-曱氧基苯基)-7-(N-乙基-N-(2- 甲基)-2-丙烯-l_基胺基)-;ι,2,4-三唑并[l,5a]嘧啶 在室溫下,將存於30毫升二氣曱烷中之3克(9毫莫 耳)5,7-二氯-6-(2,5-二1-4-曱氧基苯基)-1,2,4-三唾并[1,5&] 哺啶(類似於WO 94/20501藉由使2-胺基-1,2,4-三唑與2_ (2,5_二氟-4-甲氧基苯基)丙二酸二乙酯反專且隨後進行齒 化來製備)、0.9克(9.1宅莫耳)N-乙基-(2 -甲基)-稀丙胺及 0.9克(9毫莫耳)三乙胺攪拌過夜。然後將反應混合物與稀 鹽酸一起混合,並用二氯曱烷萃取水相。將合併的有機相 經為1L酸鎭乾燥並於減壓下濃縮。剩餘物於秒膠RP-18上進 行製備型MPLC(流動相:乙腈/水70:30)加以純化。藉此得 到2.4克(理論值之68%y無色固體狀標題化合物(炫點 129〇C ) 〇 118620.doc -61 - 200800026 tNMMCDClu 以 ppm計): 8·4 (s5 1H); 7.0 (dd5 1H); 6.85 (dd5 1H); 4.9 (s5 1H); 4.8 (s5 ),4·〇 (s,3H),3·75 (m,1H); 3.5 (m,3H); 1.6 (s,3H); l〇5 (t,3H) 實例2 : 5_曱氧基_6_(2,5-二氟·4_甲氧基苯基)_7_(n_乙基_ N_(2-甲基)晞丙基_胺基)],2,4 —三唑并以別嘧啶 •在室溫下,將〇.5克(1.27毫莫耳)5_氯_6_(2,5_二氟甲氧 基苯基)-7-(N_乙基·N_(2_甲基)烯丙基胺基)-1,2,4-三唑并 [1,叫鳴啶(來自實例1}及〇·3克3〇重量%濃度之甲醇鈉溶液 在10毫升甲醇中攪拌過夜。然後將該反應混合物用二氯甲 烷稀釋並用稀鹽酸萃取。將該有機相經硫酸鎂乾燥並於減 壓下濃縮。剩餘物於矽膠RP_18上進行製備型MPLC(流動 相:乙腈/水70:30)加以純化。藉此得到〇.4克(理論值之 81%)無色固體狀標題化合物(熔點=162-164<t)。 h-NMRKDCUd 以 ppm計): φ 8 25 (S’ 1H),6·95 (dd,1H); 6·8 (dd,出);4.9 (s,1H); 4.8 (s, 1H); 4.0 (S, 3H);3.95 (S) 3H); 3.7 (m, 1H); 3.45 (m, 3H); 1.6 (s? 3H); 1.1 (t3 3H) 實例3 · 5_氰基-6-(2,5-二氟_4_甲氧基苯基)·7_(Ν_乙基-N_ , (2_曱基)烯丙基胺基)-l,2,4-三唑并[l,5a]嘧啶 ^在室溫T,將存於10毫升乙猜中之0 5克(127毫莫耳)5_ 氯6-(2,5-一氟-4-曱氧基苯基)_7_(Ν·乙基-义^·甲基)烯丙 基胺基)-1,2,4-三唾并[l,5a]嘴咬(來自實例1)Α〇 85克(3」 毫莫耳)四乙銨氰化物攪拌過夜。然後將該反應混合物用 118620.doc -62- 200800026 稀鹽酸稀釋並用二氯甲烷萃取三次。使合併的有機相經硫 酸鎮乾燥並於減壓下濃縮。將剩餘物藉由矽膠RP_18上之 (製備型MPLC流動相··乙腈/水70:3 0)加以純化。藉此得到 〇·3克(理論值之62%)黃色油狀標題化合物。 h-NMRCCDClhS 以 ppm計): 8.55 (s,ih); 7·05 (dd,1H); 6.9 (dd,1H); 4.95 (s,1H); 4.85 * (s, 1H); 3.85 (m5 1H); 3.6 (m5 3H); 1.6 (s5 3H); 1.1 (t, 3H) 實例4 : 5-甲基-6·(2,5-二氟-4-甲氧基苯基)-7-(N-乙基-N· • (2_曱基)烯丙基胺基)-l,2,4-三唑并[l,5a]嘧啶 4·1· 5 - —甲基丙^一酿基-6-(2,5-二氟-4-甲氧基苯基)_7_(队 乙基-Ν-(2-甲基)烯丙基胺基)-ΐ,2,4-三唑并[l,5a]哺咬 將存於20毫升乙腈中之1克(2.5毫莫耳)5-氯_6-(2,5-二 氟-4-甲氧基本基)-7-(N-乙基-N-(2-甲基)浠丙基胺基)_ 1,2,4_三唑并[l,5a]嘧啶(來自實例丨)及ι·2克(7·5毫莫耳) 二甲基丙二酸鈉於回流下加熱3小時。然後加入另外i 籲克二甲基丙二酸鈉,並繼續加熱酯(HPLC :部分轉 化)。然後將該混合物冷卻至室溫並藉助矽藻土過渡 掉沉澱的黃色固體。將以此方式獲得之黃色固體自矽 藻土機械分離並與二氯曱烷及稀鹽酸之混合物一起檀 ' 拌。然後分離各相並用二氯甲烷再萃取水相兩次。然 後將合併的有機相經硫酸鎂乾燥並濃縮之。剩餘物於 矽膠RP-18上進行製備型MPLC(流動相··乙腈/水60:40) 加以純化。藉此得到〇·2克(理論值之16%)黃素油狀標 題化合物。 118620.doc -63- 200800026 ^-NMR (CDC135 δ 以 ppm計): 8.4 (s,1H); 6·85 (m,2H); 4·9 (s,1H); 4.85 (s,1H); 4·7 (s3 1H); 4.0 (s5 3H); 3.8 (s, 3H); 3.75 (m5 1H); 3.7 (s3 3H); 3.5 (m,3H); 1.6 (s,3H); 1.05 (t,3H) 4·2· 5-甲基-6-(2,5-二氟_4-甲氧基苯基)_7_(N_乙基_N-(2-甲 基)浠丙基胺基)-l,2,4_三嗤并[1,5&]嘧。定 將存於10毫升甲醇中之〇·2克(0.4毫莫耳二甲基丙二 醯基-6-(2,5-二氟-4-甲氧基苯基)_7_(Ν-乙基甲基) 烯丙基胺基)-1,2,4-三唑并[i,5a]嘧啶(實例4丄)及0.13 克5 0重量%濃度之氫氧化鈉溶液於回流下加熱8小時。 然後將該反應混合物用水稀釋、用稀鹽酸酸化並用二 氯甲烷萃取三次。然後將合併的有機相經硫酸鎂乾燥 並濃縮之。於矽膠RP_18上進行製備型MpLC:純化剩餘 物。藉此得到35毫克(理論值之23%)黃色油狀標題化 合物。 W-NMI^CDClhS 以 ppm計)·· 8.35 (s5 1H); 6.95 (dd, 1H); 6.85 (dd5 1H); 4.9 (s, 1H); 4.8 (s,1H); 4.0 (s,3H); 3·75 (m,1H); 3 55 ⑷ 1H); 3.45 (d5 1H); 3.35 (m5 iH); 2.35 (s5 3H); 1.6 (s5 3H); 1·〇5 (t,3H) 表l中所列化合物係以類似方式製備: 118620.doc -64- 200800026- Diweicarbammines: iprodione, procymidone, vinclozolin; others: S-methyl aspirin (acibenzolar-S-methyl), carbendazim (anilazine) ), captan, captafol, dazomet, diclomezine, fenoxanil, folpet, fenpropidin , famoxadone, fenamidone, octhilinone, probenazole, proquinazid, pyroquilon, quinoxen (quinoxyfen), tricyclazole, 5-gas-7-(4-methylhexahydro 0-bit-1-yl)-6-(2,4,6-trifluorophenyl)-[1 ,2,4]三嗤[1,54]Nutrition, 2_Butoxy-6-Edan_3_propyl·Effects 4 -酉,Ν,Ν-dimethyl_3- (3-Mo, -6-fluoro-2_fluorenyl 0-derived bee-1-yellow base)-[1,2,4]-tris-saltamine; amino phthalate and dithio Urethane-dithiocarbamates: ferbam, mancozeb, maneb, free (metiram), Meitan 118620.doc -59 - 200800026 (metam), methyl zinc, propineb, thiram, zineb, ziram; - urethane Class: diethofencarb, flubenthiavalicarb, iprovalicarb, ppanmocaine 1: 〇0&111〇〇&1:13), 3- (4-Chlorophenyl)-3-(2-isopropoxycarbonylamino-3-methylbutanylamino)propionic acid methyl ester, N-(l-(l-(4-cyanophenyl)) 4-fluorophenyl ester of ethionyl)butan-2-yl)amino decanoate; other fungicides - venom: dodine, iminoctadine, dioctylated octylamine Guazatine); - antibiotics: kasugamycin, polyoxins, streptomycin, validamycin A; - organometallic compounds: triphenyltin salt; Sulfur-containing heterocyclic compounds · isoprothiolane, dithianon; - organic filling compounds: edifenphos, fosetyl, fosetyl-aliiminum , propyl shesson (iprobe Nfos), pyrazophos, tolclofos-methyl, sub-acid and its salts; - organochlorine compounds: thiophanate-methyl, chlorothalonil, Dichlofluanid, tolylfluanid, flusulfamide, hydrazine, hexachlorobenzene, pencycuron, quintozene; Binapacryl, white powder gram 118620.doc -60- 200800026 (dinocap), dinobuton; - inorganic active compound: Bordeaux mixture, copper acetate, copper hydroxide, copper oxide, Basic copper sulphate, sulphur; - others: spiroxamime, cyflufenamid, cymoxanil, metrafenone 实施 [embodiment] Synthesis Example The procedures described in the examples are used to suitably modify the starting compounds to prepare other compounds of formula I. The compounds and physical data prepared in this manner are collectively listed in the table below. Example 1: 5-Gas-6-(2,5-Difluoro-4-methoxyphenyl)-7-(N-ethyl-N-(2-methyl)-2-propene-l-yl Amino)-;ι,2,4-triazolo[l,5a]pyrimidine 3 g (9 mmol) 5,7-dichloromethane in 30 ml of dioxane at room temperature -6-(2,5-di-1-4-methoxyphenyl)-1,2,4-tris-[1,5&] guanidine (similar to WO 94/20501 by making 2-amine Base-1,2,4-triazole and diethyl 2_(2,5-difluoro-4-methoxyphenyl)malonate were prepared by reversed and subsequently densified), 0.9 g (9.1 house) Mole) N-ethyl-(2-methyl)-lean propylamine and 0.9 g (9 mmol) of triethylamine were stirred overnight. The reaction mixture was then mixed with dilute hydrochloric acid and the aqueous phase was extracted with dichloromethane. The combined organic phases were dried over 1 mL of EtOAc and evaporated. The residue was purified by preparative MPLC (mobile phase: acetonitrile/water 70:30) on celite RP-18. From this, 2.4 g (68% of theory y colorless solid title compound (Hybrid 129 〇C) 〇118620.doc -61 - 200800026 tNMMCDClu in ppm): 8·4 (s5 1H); 7.0 (dd5 1H) 6.85 (dd5 1H); 4.9 (s5 1H); 4.8 (s5), 4·〇(s, 3H), 3·75 (m, 1H); 3.5 (m, 3H); 1.6 (s, 3H) ; l〇5 (t,3H) Example 2: 5_曱oxy_6_(2,5-difluoro.4_methoxyphenyl)_7_(n_ethyl_N_(2-methyl)anthracene Propyl-amino)], 2,4-triazole and pyrimidine • 5 g (1.27 mmol) of 5_chloro-6-(2,5-difluoromethoxy) at room temperature Phenyl)-7-(N-ethyl·N_(2-methyl)allylamino)-1,2,4-triazolo[1, called acridinium (from Example 1} and 〇·3 The mixture was stirred overnight in 10 mL of MeOH. EtOAc (EtOAc m. Purification of the preparative MPLC (mobile phase: acetonitrile/water 70:30) on EtOAc EtOAc (EtOAc: EtOAc) 164<t). h-NMRKDCUd in ppm): φ 8 25 (S' 1H), 6.95 (dd, 1H); 6·8 (dd, out); 4.9 (s, 1H); 4.8 (s , 1H); 4.0 (S, 3H); 3.95 (S) 3H); 3.7 (m, 1H); 3.45 (m, 3H); 1.6 (s? 3H); 1.1 (t3 3H) Example 3 · 5_Cyanide -6-(2,5-difluoro_4-methoxyphenyl)·7_(Ν_ethyl-N_ , (2-fluorenyl)allylamino)-l,2,4-tri Oxazolo[l,5a]pyrimidine ^ at room temperature T, will be stored in 10 ml of B guess, 0 5 g (127 mmol) 5_ chloro 6-(2,5-fluoro-4-methoxybenzene Base)_7_(Ν·ethyl-yi^·methyl)allylamino)-1,2,4-tris-[1,5a] mouth bite (from example 1) Α〇85 g (3) Millimol) Tetraethylammonium cyanide was stirred overnight. The reaction mixture was then diluted with 118620.doc-62-200800026 diluted hydrochloric acid and extracted three times with dichloromethane. The combined organic phases were dried over sulphuric acid and concentrated under reduced pressure. The residue was purified by silica gel RP_18 (preparative MPLC mobile phase·acetonitrile/water 70:30). The title compound was obtained as a yellow oil (yield: 62%). h-NMRCCDClhS in ppm): 8.55 (s, ih); 7·05 (dd, 1H); 6.9 (dd, 1H); 4.95 (s, 1H); 4.85 * (s, 1H); 3.85 (m5 1H 3.6 (m5 3H); 1.6 (s5 3H); 1.1 (t, 3H) Example 4: 5-methyl-6·(2,5-difluoro-4-methoxyphenyl)-7-( N-ethyl-N· • (2_mercapto)allylamino)-l,2,4-triazolo[l,5a]pyrimidine 4·1· 5 -methylpropane -6-(2,5-difluoro-4-methoxyphenyl)_7_(team ethyl-indole-(2-methyl)allylamino)-indole, 2,4-triazolo[ l,5a] 1 g (2.5 mmol) of 5-chloro-6-(2,5-difluoro-4-methoxybens)-7-(N-B) in 20 ml of acetonitrile --N-(2-methyl) propyl propyl)) 1,2,4-triazolo[l,5a]pyrimidine (from example 丨) and ι·2 g (7.5 mM) Sodium dimethylmalonate was heated under reflux for 3 hours. Then another sodium dimethyl dimethyl malonate was added and the ester was further heated (HPLC: partial conversion). The mixture was then cooled to room temperature and the precipitated yellow solid was transferred with celite. The yellow solid obtained in this way was mechanically separated from the diatomaceous earth and mixed with a mixture of dichloromethane and dilute hydrochloric acid. The phases were then separated and the aqueous phase was extracted twice with dichloromethane. The combined organic phases were dried over magnesium sulfate and concentrated. The residue was purified by preparative MPLC (mobile phase·acetonitrile/water 60:40) on silica gel RP-18. Thus, 2 g (16% of theory) of a flavin oil-like title compound was obtained. 118620.doc -63- 200800026 ^-NMR (CDC135 δ in ppm): 8.4 (s,1H); 6·85 (m,2H); 4·9 (s,1H); 4.85 (s,1H); 4·7 (s3 1H); 4.0 (s5 3H); 3.8 (s, 3H); 3.75 (m5 1H); 3.7 (s3 3H); 3.5 (m, 3H); 1.6 (s, 3H); 1.05 (t ,3H) 4·2· 5-methyl-6-(2,5-difluoro_4-methoxyphenyl)_7_(N_ethyl_N-(2-methyl) propyl propylamino )-l, 2, 4_ 三嗤[1,5&]. 2 g (0.4 mmol) of dimethylpropanediyl-6-(2,5-difluoro-4-methoxyphenyl)_7_(Ν-ethyl) in 10 ml of methanol Methyl)allylamino)-1,2,4-triazolo[i,5a]pyrimidine (Example 4A) and 0.13 g of a 50% by weight sodium hydroxide solution were heated under reflux for 8 hours. The reaction mixture was then diluted with water, acidified with dilute hydrochloric acid and extracted thrice with dichloromethane. The combined organic phases were dried over magnesium sulfate and concentrated. Preparative MpLC was carried out on silica gel RP_18: the residue was purified. This gave 35 mg (23% of theory) of title compound as a yellow oil. W-NMI^CDClhS in ppm)·· 8.35 (s5 1H); 6.95 (dd, 1H); 6.85 (dd5 1H); 4.9 (s, 1H); 4.8 (s, 1H); 4.0 (s, 3H) ; 3·75 (m,1H); 3 55 (4) 1H); 3.45 (d5 1H); 3.35 (m5 iH); 2.35 (s5 3H); 1.6 (s5 3H); 1·〇5 (t,3H) The compounds listed in l are prepared in a similar manner: 118620.doc -64- 200800026
實例 R1 R2 X L1 L2 熔點PC]1),iH-NMR [ppm], HPLC/MS [分鐘/M+H]2) 1 -CH2C(=CH2)(CH3) C2H5 Cl 0CH3 F 熔點 126-129 2 -ch2c(=ch2)(ch3) C2H5 OCH3 OCH3 F 熔點 162-164 3 _ch2c(=ch2)(ch3) C2H5 -CN〇 OCH3 F iH-NMR參見上文 4 -CH2C(=CH2)(CH3) C2H5 ch3 OCH3 F iH-NMR參見上文 5 環戊基 H Cl OCH3 F 溶點73 6 -CH2CH(CH3)CH2CH2CH2- Cl OCH3 F 熔點 124-127 7 -CH2CH2CH2CH2CH2CH2- Cl 0CH3 F 熔點 140-143 8 環己基 H Cl OCH3 F 黃色油狀 9 環丙基 H Cl OCH3 F 熔點 183-184 10 -CH2CH(CH3)CH3 H G1 OCH3 F 熔點116 11 -ch2ch(ch3)ch2ch2- Cl OCH3 F 熔點77-97 12 -ch(ch3)ch2ch2ch2- Cl 0CH3 F HPLC/MS 3.449/380 13a) -ch(ch3)ch(ch3)2 H Cl OCH3 F HPLC/MS 3.548 / 382 14b) •ch(ch3)ch(ch3)2 H Cl OCH3 F HPLC/MS 3.547/382 15b) -ch(ch3)c(ch3)3 H Cl OCH3 F HPLC/MS 3.746/396 16 -ch(ch3)ch2ch2ch2ch2- Cl 0CH3 F 熔點79-100 17a) -ch(ch3)c(ch3)3 H Cl OGH3 F HPLC/MS 3.750 / 396 18 -CH2CH2CH(CH3)CH2CHr Cl OCH3 F 熔點82-90 19a) -CH(CH3)C2H5 H Cl OCH3 F HPLC/MS 3.357 / 368 20 -CH2CH2CH(CH3)CH2CH2- Cl ch3 F 熔點 176-178 21 -CH2C(=CH2)(CH3) C2H5 Cl ch3 F 熔點 141-143 22b) ch(ch3)c(ch3)3 H Cl ch3 F 146-148 23b) _ch(ch3)ch(ch3)2 H Cl ch3 F 123-125 24 ch2cf2cf2cf3 H Cl och3 F 95-105 25c) ch(ch3)c(ch3)3 H Cl OCH3 F 131-134 26 CH2CF3 H Cl OCH3 F HPLC/MS 3.206/394 27 GH2CF3 H Cl ch3 F 154-156 1) 熔點 2) 組合型HPLC-質譜法:HPLC管柱:RP-18管柱(來自 Merck KGaA,Germany之 Chromoiith Speed ROD);移 動相:乙腈 + 0.1%三氟乙酸 (TFA)/水+ 〇·1% 118620.doc -65- 200800026 TFA ’以自5:95至95:5之梯度、5分鐘、在4〇t下。 MS.·四極電喷射離子化,8〇v(陽性模式) a) 對映異構體混合物 b) R異構體 c) S異構體 應用實例 溫室實驗·· 分別製備該等活性化合物或將其共同製備成包括乃毫克 活性化合物之儲液,其使用丙酮及/或DMSO與乳化劑Example R1 R2 X L1 L2 Melting point PC]1), iH-NMR [ppm], HPLC/MS [M/H+2] 2 -CH2C (=CH2) (CH3) C2H5 Cl 0CH3 F Melting point 126-129 2 -ch2c(=ch2)(ch3) C2H5 OCH3 OCH3 F Melting point 162-164 3 _ch2c(=ch2)(ch3) C2H5 -CN〇OCH3 F iH-NMR See above 4 -CH2C(=CH2)(CH3) C2H5 ch3 OCH3 F iH-NMR see above 5 cyclopentyl H Cl OCH3 F melting point 73 6 -CH2CH(CH3)CH2CH2CH2-Cl OCH3 F melting point 124-127 7 -CH2CH2CH2CH2CH2CH2-Cl 0CH3 F melting point 140-143 8 cyclohexyl H Cl OCH3 F yellow oily 9 cyclopropyl H Cl OCH3 F melting point 183-184 10 -CH2CH(CH3)CH3 H G1 OCH3 F melting point 116 11 -ch2ch(ch3)ch2ch2-Cl OCH3 F melting point 77-97 12 -ch(ch3 Ch2ch2ch2-Cl 0CH3 F HPLC/MS 3.449/380 13a) -ch(ch3)ch(ch3)2 H Cl OCH3 F HPLC/MS 3.548 / 382 14b) •ch(ch3)ch(ch3)2 H Cl OCH3 F HPLC/MS 3.547/382 15b) -ch(ch3)c(ch3)3H Cl OCH3F HPLC/MS 3.746/396 16 -ch(ch3)ch2ch2ch2ch2-Cl 0CH3 F Melting point 79-100 17a) -ch(ch3) c(ch3)3 H Cl OGH3 F HPLC/MS 3.750 / 396 18 -CH2CH2CH(CH3)CH2CHr Cl OCH3 F mp 82-90 19a) -CH(CH3)C2H5 H Cl OCH3 F HPLC/MS 3.357 / 368 2 0 -CH2CH2CH(CH3)CH2CH2-Cl ch3 F Melting point 176-178 21 -CH2C(=CH2)(CH3) C2H5 Cl ch3 F Melting point 141-143 22b) ch(ch3)c(ch3)3 H Cl ch3 F 146- 148 23b) _ch(ch3)ch(ch3)2 H Cl ch3 F 123-125 24 ch2cf2cf2cf3 H Cl och3 F 95-105 25c) ch(ch3)c(ch3)3 H Cl OCH3 F 131-134 26 CH2CF3 H Cl OCH3 F HPLC/MS 3.206/394 27 GH2CF3 H Cl ch3 F 154-156 1) Melting point 2) Combined HPLC-mass spectrometry: HPLC column: RP-18 column (Chromoiith Speed ROD from Merck KGaA, Germany); Mobile phase: acetonitrile + 0.1% trifluoroacetic acid (TFA) / water + 〇 · 1% 118620.doc -65- 200800026 TFA 'with a gradient from 5:95 to 95:5, 5 minutes at 4 〇t. MS.·Quaternary electrospray ionization, 8〇v (positive mode) a) Enantiomeric mixture b) R isomer c) S isomer application example Greenhouse experiment·· Prepare these active compounds separately or It is co-prepared to include a stock solution of milligrams of active compound using acetone and/or DMSO with an emulsifier
Uruperol® EL(具有乳化及分散作用的潤濕劑,以經乙氧基 化之烷基苯酚為主)之混合物以99/1之溶劑/乳化劑體積比 率補足至10毫升。隨後,將此混合物用水製成1〇〇毫升。 用上述溶劑/乳化劑/水混合物將此儲液稀釋成下述活性化 合物濃度。 微量測試: 將活性化合物分別調配成存於二甲基亞砜中且濃度為 10000 ppm之儲液。 應用實例1-在預防性施用1天時抗由灰葡萄孢引起的鈴 狀椒葉片上之灰黴病之活性: 使用一具有下述活性化合物濃度之水懸浮液喷灑已完全 長出2至3個葉片的栽培品種「Neusiedler Ideal Elite」之鈐 狀椒葉片至流瀉點。次日,使用含有i ·7 x 1 〇6個孢子/毫 升的灰葡萄孢菌存於2%濃度之拜莫特(biomalt)水溶液中的 孢子懸浮液接種經處理植物。隨後將測試植物置於一處於 118620.doc -66- 200800026 22-24°C及高大氣濕度下之黑暗風土馴化室中。5天後,可 目測該等葉片上之真菌感染程度,以%計。 在此測試中,已用63 ppm來自實例18之化合物處理的植 物顯示無感染,而已用63 ppm 5-氯-7_(4-甲基六氫吼唆-卜 基)-6-(2-氟_4_甲氧基苯基)-1,2,4-三唑并-[l,5-a]嘧啶處理 之植物中30%被感染。未經處理之植物中100%被感染。 在此測試中,已用63 ppm來自實例1、3、4、11、12、 13、14、15、16、17、18、19、22、23、26 及 27 之化合物 處理之植物顯示無感染或感染小於5%,而未經處理之植 物中90%被感染。 應用實例2 _在微量滴定測試中抵抗稻米水稻稻瘦病菌 (blast pathogen)稻梨孢之活性: 將該儲液吸取至微量滴定平板(MTP)上並用基於麥芽之 水性真菌營養培養基將其稀釋至所述活性化合物濃度。隨 後加入稻梨抱之水性孢子懸浮液。將此等平板置於一處於 18 c 度下之水蒸汽飽和室中。接種後第7天時,使用一 吸收光度計量測405奈米處2ΜΤΡβ將所測參數與不含活 性化合物之對照變體的生長及不含真菌且不含活性化合物 之空白值加以比較來確定單獨活性化合物中病原菌之相對 生長(以%計)。 在此Κ中’已用125 PPm來自實例18之化合物處理之 :樣顯示無病原菌生長’而已用125Ppm5_氯·7_(4_甲基六 氣°比咬-1-基)-6-(2 -氟-4-甲 Μ Α ίί* Α、1 1紙4 4 Τ巩基本基)_1,2,4-三唑并-[l55_a] 嘧啶處理之試樣顯示39%相對生長。 118620.doc -67 - 200800026 應用實例3 -在微量滴定測試中抵抗晚疫病病原菌致病 疫毒(Phytophthora infestans)之活性 將該儲液吸取至微量滴定平板(Μτρ)上並使用基於豌豆 汁之水性真菌營養培養基將其稀釋至所述活性化合物濃 度。然後加入致病疫毒之水性遊動孢子懸浮液。將此等平 板置於一處於18°C溫度下之水蒸汽飽和室中。接種後第7 天時’使用一吸收光度計量測4〇5奈米處之MTp。將所測 參數與不含活性化合物之對照變體的生長及不含真菌且不 含活性化合物之空白值加以比較來確定單獨活性化合物中 病原菌之相對生長(以%計)。 在此測試中,已用31 ppm來自實例15之化合物處理之試 樣顯示5%病原菌生長,而已用3 1 ppm 5 -氣_7-((1 (R)-甲基-2,2-二曱基丙基)胺基)-6-(2-氟-4-甲氧基苯基;)4,2,4-三唑 并-[l,5-a]嘧啶處理之試樣顯示72%相對生長。 應用實例4-在微量滴定測試(Alteso)中抵抗早疫病病原 函底腐病菌(Alternaria Solani)之活性A mixture of Uruperol® EL (wetting agent with emulsification and dispersion, based on ethoxylated alkyl phenol) was made up to 10 ml with a solvent/emulsifier volume ratio of 99/1. Subsequently, this mixture was made into 1 ml of water with water. This stock solution was diluted with the above solvent/emulsifier/water mixture to the following active compound concentration. Microtest: The active compounds were separately formulated into stock solutions in dimethyl sulfoxide at a concentration of 10,000 ppm. Application Example 1 - Activity against gray mold on bell pepper leaves caused by Botrytis cinerea at 1 day of prophylactic application: Spraying with an aqueous suspension having the following active compound concentration has completely grown 2 to The leaf of the three leaf cultivars "Neusiedler Ideal Elite" leaves to the diarrhea point. The next day, the treated plants were inoculated with a spore suspension containing i.7 x 1 〇6 spores/ml of Botrytis cinerea in a 2% aqueous solution of bimalt (biomalt). The test plants were then placed in a dark soil domestication room at 118620.doc -66 - 200800026 22-24 ° C and high atmospheric humidity. After 5 days, the degree of fungal infection on the leaves was visually observed in %. In this test, 63 ppm of plants treated with the compound of Example 18 showed no infection, while 63 ppm 5-chloro-7-(4-methylhexahydroindole-bu)-6-(2-fluoro) was used. 30% of plants treated with _4_methoxyphenyl)-1,2,4-triazolo-[l,5-a]pyrimidine were infected. 100% of untreated plants are infected. In this test, plants treated with 63 ppm of compounds from Examples 1, 3, 4, 11, 12, 13, 14, 15, 16, 17, 18, 19, 22, 23, 26 and 27 showed no infection. Or infection is less than 5%, and 90% of untreated plants are infected. Application Example 2 _ Resistance to rice blast pathogen rice porphyra in a microtiter test: The stock solution was pipetted onto a microtiter plate (MTP) and diluted with a malt-based aqueous fungal nutrient medium. To the concentration of the active compound. The aqueous spore suspension of Pear is then added. The plates were placed in a water vapor saturation chamber at 18 c degrees. On the 7th day after inoculation, an absorbance measurement was used to measure 2 ΜΤΡβ at 405 nm. The measured parameters were compared with the growth of the control variant containing no active compound and the blank value without fungi and without the active compound. Relative growth (in %) of pathogenic bacteria in the active compound alone. In this sputum 'has been treated with 125 PPm of compound from Example 18: the sample shows no pathogen growth' and has been used with 125Ppm5_chloro·7_(4_methyl hexa-6 ratio -6 base)-6-(2 -Fluoro-4-carbenium Α ίί* Α, 1 1 paper 4 4 Τ 基本 base) _1,2,4-triazolo-[l55_a] The pyrimidine-treated sample showed 39% relative growth. 118620.doc -67 - 200800026 Application Example 3 - Resistance to Phytophthora infestans in a microtiter test The solution was pipetted onto a microtiter plate (Μτρ) and used for water based on pea juice The fungal nutrient medium dilutes it to the active compound concentration. An aqueous zoospore suspension of the disease-causing epidemic is then added. The plates were placed in a water vapor saturation chamber at a temperature of 18 °C. On the 7th day after inoculation, an MTp at 4 〇 5 nm was measured using an absorbance luminosity. The relative growth (in %) of the pathogens in the individual active compounds was determined by comparing the measured parameters to the growth of the control variant without the active compound and the blank value without fungi and without the active compound. In this test, 31 ppm of the sample treated with the compound of Example 15 showed 5% pathogen growth, while 3 1 ppm 5 - gas _7-((1 (R)-methyl-2,2- The sample treated with mercaptopropyl)amino)-6-(2-fluoro-4-methoxyphenyl;) 4,2,4-triazolo-[l,5-a]pyrimidine showed 72% Relative growth. Application Example 4 - Resistance to early blight pathogens Alternaria Solani in a microtiter test (Alteso)
將該儲液吸取至微量滴定平板(MTP)上並使用基於麥芽 之水性真菌營養培養基將其稀釋至所述活性化合物濃度。 隨後加入底腐病菌(Alternaria Solani)之水性孢子懸浮液。 將此等平板置於一處於1溫度下之水蒸汽飽和室中。接 種後弟7天時,使用一吸收光度計量測4〇5奈米處之MTP。 將所測參數與不含活性化合物之對照變體的生長及不含真 菌且不含活性化合物之空白值加以比較來確定單獨活性化 合物中病原菌之相對生長(以%計)。I 118620.doc -68- 200800026 在此/則忒中,已用0·125 ppm來自實例25之化合物處理 之試樣顯示41%相對生長,而已用0.125 ppm 5-氯-7- ((2,2,2-三氟_1(8)-曱基乙基)胺基_6-(2,5_二氟_4_甲氧基苯 基)_1,2,4-二唑并·嘧啶處理之試樣顯示1〇〇%相對生 長。 應用只例5-抵抗藉由柄鏽菌(puccinia rec〇n(jita)引起的 小麥褐銹病之治療活性 用葉録病(柄鏽菌)之孢子懸浮液接種栽培品種”Kanzler" 之盆栽小麥秧苗葉片。然後將該等植株盆置於在 下具向空氣濕度(90至95%)之室中24小時。在此期間,孢 子萌發並且芽管穿入葉片組織内。第二天,使用具有下述 活性化合物濃度之上述活性化合物溶液喷灑該等經感染植 株至流瀉點。在喷塗液已經乾燥後,將測試植株在一溫度 介於20 C與22°C之間且相對空氣濕度為65%至7〇%的溫室 中培養7天。隨後測定葉片上銹病真菌發展之程度。 在此測試中,已用250 PPm來自實例21之化合物處理之 植株顯示感染低於5%,而已用25〇 ppm 5_氯_7_(冰(2_甲基) 烯丙基·Ν-乙基胺基氟_4_曱基苯基三唑并_ [l,5-a]嘧啶處理之植株顯示1〇〇%被感染。未經處理之植株 中100%被感染。 應用實例6-抵抗藉由底腐病菌所引起的番茄早疫病之 活性 用具有下述活性化合物濃度之水性懸浮液喷灑盆栽番祐 植株之葉片至流液點。第二天,用存於2% bi〇malt溶液中 118620.doc -69- 200800026 且具有〇· 17χ 106孢子/毫升密度之底腐病菌孢子水性懸浮液 感染該等葉片。隨後,將植株置於一溫度介於20°C與22°C 間之水蒸汽飽和室中。5天後,未經處理但經感染之對照 植物之病情已發展到能夠目測其感染分值(以%計)之程 度。 在此測試中,已用63 ppm來自實例1、2、3、4、11、 12 、 13 、 14 、 15 、 16 、 17 、 18 、 19 、 21 、 22 、 23 、 24 、 26 及27之化合物處理之植株顯示無感染或感染低於1〇%,而 _ 未經處理之植株中90%被感染。已用250 ppm實例20之化 合物處理之植株中10%以下被感染。The stock solution was pipetted onto a microtiter plate (MTP) and diluted to the active compound concentration using a malt-based aqueous fungal nutrient medium. An aqueous spore suspension of Alternaria Solani was subsequently added. The plates were placed in a water vapor saturation chamber at a temperature of one. At 7 days after the inoculation, an MTP at 4 〇 5 nm was measured using an absorbance luminosity. The relative growth (in %) of the pathogens in the individual active compounds was determined by comparing the measured parameters to the growth of the control variant without the active compound and the blank value without the fungus and without the active compound. I 118620.doc -68- 200800026 In this case, a sample treated with 0. 125 ppm of the compound from Example 25 showed 41% relative growth, while 0.125 ppm 5-chloro-7- (2, 2,2-Trifluoro-1(8)-mercaptoethyl)amino-6-(2,5-difluoro-4-yloxyphenyl)_1,2,4-diazolopyrimidine treatment The sample showed a relative growth of 1%. Application Example 5 - Resistance to the therapeutic activity of wheat brown rust caused by puccinia rec〇n (jita) with spore suspension of leaf recorded disease (Puccinia reticulata) The cultivar "Kanzler" was planted in potted wheat seedling leaves. The plant pots were then placed in a chamber with a lower air humidity (90 to 95%) for 24 hours. During this time, the spores germinate and the germ tubes penetrate the leaves. In the next day, the infected plants are sprayed to the diarrhea point using the above active compound solution having the following active compound concentrations. After the spray liquid has dried, the test plants are tested at a temperature between 20 C and 22 The culture was carried out for 7 days in a greenhouse at between ° C and relative humidity of 65% to 7 %. The extent of development of rust fungi on the leaves was then determined. Of the plants treated with 250 PPm of the compound from Example 21 showed less than 5% infection, while 25 〇ppm 5_chloro_7_(ice (2_methyl)allyl·Ν-ethylamino fluoride) _4_mercaptophenyltriazolo-[l,5-a]pyrimidine-treated plants showed 1%% infection. 100% of untreated plants were infected. Application Example 6 - Resistance by bottom rot Activity of tomato early blight caused by pathogens Spray the leaves of potted plants to the liquid point with an aqueous suspension having the following concentration of active compound. The next day, use in 2% bi〇malt solution 118620.doc -69- 200800026 and an aqueous suspension of spores of bottom rot fungi with a density of 孢·17χ106 spores/ml infects the leaves. Subsequently, the plants are placed in a water vapor saturation chamber at a temperature between 20 ° C and 22 ° C. After 5 days, the condition of the untreated but infected control plants has progressed to the extent that the infection score (in %) can be visually observed. In this test, 63 ppm has been used from Examples 1, 2, and 3. , 4, 11, 12, 13, 14, 15, 16, 16, 17, 18, 19, 21, 22, 23, 24, 26 and 27 Compound treated plants showed no infection or infection less than 1%, while _ 90% of untreated plants were infected. Less than 10% of plants treated with 250 ppm of Example 20 were infected.
118620.doc -70-118620.doc -70-
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06004006 | 2006-02-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200800026A true TW200800026A (en) | 2008-01-01 |
Family
ID=37897986
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW96106679A TW200800026A (en) | 2006-02-28 | 2007-02-27 | Substituted 6-phenyl-7-amino-[1,2,4]-triazolo[1,5-a] pyrimidines and their use for controlling harmful fungi |
Country Status (3)
Country | Link |
---|---|
AR (1) | AR059649A1 (en) |
TW (1) | TW200800026A (en) |
WO (1) | WO2007099092A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3138307A1 (en) | 2019-05-13 | 2020-11-19 | Ecolab Usa Inc. | 1,2,4-triazolo[1,5-a] pyrimidine derivative as copper corrosion inhibitor |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3130633A1 (en) * | 1981-08-01 | 1983-02-17 | Basf Ag, 6700 Ludwigshafen | 7-AMINO-AZOLO (1,5-A) PYRIMIDINE AND FUNGICIDES CONTAINING THEM |
TW224044B (en) * | 1991-12-30 | 1994-05-21 | Shell Internat Res Schappej B V | |
US5986135A (en) * | 1998-09-25 | 1999-11-16 | American Cyanamid Company | Fungicidal trifluoromethylalkylamino-triazolopyrimidines |
HUP0300798A3 (en) * | 2000-06-30 | 2006-02-28 | Wyeth Corp | Substituted-triazolopyrimidines and their use as anticancer agents and pharmaceutical compositions containing them |
-
2007
- 2007-02-27 AR ARP070100809A patent/AR059649A1/en not_active Application Discontinuation
- 2007-02-27 TW TW96106679A patent/TW200800026A/en unknown
- 2007-02-27 WO PCT/EP2007/051831 patent/WO2007099092A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2007099092A1 (en) | 2007-09-07 |
AR059649A1 (en) | 2008-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200540176A (en) | 5,6-Dialkyl-7-aminotriazolopyrimidines, their preparation and their use for controlling harmful fungi, and compositions comprising these compounds | |
EP1663976B1 (en) | 4-pyridinylmethyl sulfonamide derivatives as fungicidal plant protection agents | |
TW200539809A (en) | 5,6-dialkyl-7-aminotriazolopyrimidines, their preparation and their use for controlling harmful fungi, and compositions comprising these compounds | |
EP1720879A2 (en) | Azolopyrimidine compounds and use thereof for combating parasitic fungi | |
AU2004242850A1 (en) | Substituted pyrazolopyrimidines, methods for the production thereof, use of the same for controlling pathogenic fungi, and agents containing said compounds | |
WO2007101871A1 (en) | Substituted imidazolopyrimidines, method for the production thereof and use thereof for controlling parasitic fungi and agents containing the latter | |
TW200800026A (en) | Substituted 6-phenyl-7-amino-[1,2,4]-triazolo[1,5-a] pyrimidines and their use for controlling harmful fungi | |
WO2007012642A1 (en) | 7-amino-6-thiadiazolyl- and -oxadiazolyl- 1, 2, 4-triazolo [1, 5 -a] pyrimidine compounds and use thereof for the prevention of fungal pests | |
JP2004515502A (en) | 6- (trifluoromethyl-phenyl) -triazolopyrimidines having fungicidal properties | |
US20080227796A1 (en) | 7-Amino-6-Hetaryl-1,2,4-Triazolo[1,5-A]Pyrimidine Compounds and the Use Thereof for Controlling Pathogenic Fungi | |
WO2007113136A1 (en) | Use of substituted triazolopyrimidines for controlling phytopathogenic harmful fungi | |
EP2046794A1 (en) | Fungicidal azolopyrimidines, methods for the production thereof, use thereof for controlling harmful fungi, and substances containing the same | |
EP1765824B1 (en) | Substituted 6-phenyl-7-amino-triazolopyrimidines, method for the production thereof, their use for controlling pathogenic fungi, and agents containing these compounds | |
EP1761544A1 (en) | Triazolopyrimidine compounds and their use for controlling pathogenic fungi | |
WO2006034848A1 (en) | 7-aminomethyl-1,2,4-triazolo[1,5-a]pyrimidine compounds and their use for controlling pathogenic fungi | |
TW200418860A (en) | 5-alkyl-7-aminotriazolopyrimidines, processes and intermediates for their preparation, compositions comprising them and their use for controlling harmful fungi | |
US20080312078A1 (en) | 6-Phenyl-Pyrazolopyrimidine-7-Ylamine Fungicides | |
EP1828190A1 (en) | 7-amino-6-heteroaryl-1,2,4-triazoloý1,5-a¨pyrimidines and to the use thereof for combating pathogenic fungi | |
TW200528458A (en) | A novel 6-(2,4,6-trihalophenyl)triazolopyrimidines compound | |
TW200533670A (en) | 6-(aminocarbonylphenyl)triazolopyrimidines, their preparation and their use for controlling harmful fungi, and compositions comprising these compounds | |
BRPI0711546A2 (en) | compounds, use of compounds, crop protection agent, seed, and process to combat phytopathogenic fungi | |
WO2007023020A1 (en) | 7-amino-6-heteroaryl-1,2,4-triazolo[1,5-a]pyrimidine compounds and the use thereof for controlling harmful fungi | |
US20060079537A1 (en) | 2-Substitutued triazolopyrimidines, methods and intermediate products for the production thereof, the use of the same controlling pathogenic fungi, and agents containing said compounds | |
WO2007023018A1 (en) | 7-amino-6-triazolyl-1,2,4-triazolo[1,5-a]pyrimidine compounds and the use thereof for controlling harmful fungi | |
EP1697366B1 (en) | 6-(2-chloro-4-alkoxy-phenyl)-triazolopyrimidine, method for the production thereof and its utilization for controlling fungi and the agents contained therein |